2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web:
www.eosmedchem.comEmail: info@eosmedchem.com ; eosmedchem@gmail.com
| Drug_Names: 2-Chloro-11-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one, CAS: 66427-86-9, stock 116.1g, assay 98.9%, MWt 260.68, Formula C12H9ClN4O, Purity >98%, SMILES O=C1NC2=CN=C(Cl)N=C2N(C)C3=CC=CC=C31, MDL NA |
| Drug_Names: 1-(4-Amino-3-ethoxyphenyl)piperidin-4-ol, CAS: 1130146-98-3, stock 567.4g, assay 98.4%, MWt 236.31, Formula C13H20N2O2, Purity >98%, SMILES NC1=CC=C(C=C1OCC)N2CCC(O)CC2, MDL NA |
| Drug_Names: 1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol, CAS: 433936-13-1, stock 790.2g, assay 98.2%, MWt 251.36, Formula C15H25NO2, Purity >98%, SMILES OC(C1=CC(OC)=CC=C1)(CC)C(C)CN(C)C, MDL NA |
| Drug_Names: 3-(3-Methoxyphenyl)-N,N,2-trimethylpent-3-en-1-amine, CAS: 809282-29-9, stock 196.1g, assay 98.5%, MWt 233.35, Formula C15H23NO, Purity >98%, SMILES CC(CN(C)C)/C(C1=CC(OC)=CC=C1)=C/C, MDL NA |
| Drug_Names: (3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan-1-amine (Hydrochloride), CAS: 1415566-76-5, stock 664.1g, assay 98.9%, MWt 271.83, Formula C15H26ClNO, Purity >98%, SMILES CC(CN(C)C)[C@@H](CC)C1=CC(OC)=CC=C1.Cl, MDL NA |
| Drug_Names: 1,3-Dimethylpiperidin-4-one, CAS: 4629-80-5, stock 163.9g, assay 98.6%, MWt 127.18, Formula C7H13NO, Purity >98%, SMILES O=C1C(C)CN(C)CC1, MDL MFCD00100893 |
| Drug_Names: 3-Amino-4-cyclobutyl-2-hydroxybutanamide hydrochloride, CAS: 394735-23-0, stock 134.5g, assay 98.4%, MWt 208.69, Formula C8H17ClN2O2, Purity >98%, SMILES NC(CC1CCC1)C(C(N)=O)O.Cl, MDL NA |
| Drug_Names: (1R,2S,5S)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylic acid, CAS: 816444-90-3, stock 162.4g, assay 98.8%, MWt 367.48, Formula C19H33N3O4, Purity >98%, SMILES O=C(C(NC(NC(C)(C)C)=O)C(C)(C)C)N(C1)[C@@H]([C@@H]2[C@H]1C(C)2C)C(O)=O, MDL NA |
| Drug_Names: tert-Butyl 1-cyclobutyl-3-hydroxypropan-2-ylcarbamate, CAS: 816429-99-9, stock 743.6g, assay 98.9%, MWt 229.32, Formula C12H23NO3, Purity >98%, SMILES O=C(OC(C)(C)C)NC(CO)CC1CCC1, MDL NA |
| Drug_Names: 2,5-Dichloro-4-(3-nitrophenoxy)pyrimidine, CAS: 76661-24-0, stock 267.8g, assay 98.1%, MWt 286.07, Formula C10H5Cl2N3O3, Purity >98%, SMILES ClC1=C(OC2=CC([N+]([O-])=O)=CC=C2)N=C(N=C1)Cl, MDL NA |
| Drug_Names: 1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine, CAS: 761440-26-0, stock 473.2g, assay 98.1%, MWt 251.28, Formula C12H17N3O3, Purity >98%, SMILES CN(CC1)CCN1C2=CC(OC)=C([N+]([O-])=O)C=C2, MDL MFCD16249532 |
| Drug_Names: Methyl 5-acetyl-2-hydroxybenzoate, CAS: 16475-90-4, stock 424.5g, assay 98%, MWt 194.18, Formula C10H10O4, Purity >98%, SMILES O=C(OC)C1=C(O)C=CC(C(C)=O)=C1, MDL MFCD00040924 |
| Drug_Names: Methyl 5-(2-bromoacetyl)-2-hydroxybenzoate, CAS: 36256-45-8, stock 87.2g, assay 98.1%, MWt 273.08, Formula C10H9BrO4, Purity >98%, SMILES O=C(OC)C1=C(O)C=CC(C(CBr)=O)=C1, MDL MFCD09833483 |
| Drug_Names: Methyl 5-(2-(dibenzylamino)acetyl)-2-hydroxybenzoate, CAS: 36270-04-9, stock 232.5g, assay 98.8%, MWt 389.44, Formula C24H23NO4, Purity >98%, SMILES O=C(OC)C1=C(O)C=CC(C(CN(CC2=CC=CC=C2)CC3=CC=CC=C3)=O)=C1, MDL NA |
| Drug_Names: Methyl 2-acetoxy-5-acetylbenzoate, CAS: 61414-18-4, stock 12.6g, assay 98.9%, MWt 236.22, Formula C12H12O5, Purity >98%, SMILES O=C(OC)C(C=C1C(C)=O)=C(C=C1)OC(C)=O, MDL NA |
| Drug_Names: Methyl 5-acetyl-2-(benzyloxy)benzoate, CAS: 27475-09-8, stock 4.4g, assay 98.2%, MWt 284.31, Formula C17H16O4, Purity >98%, SMILES O=C(OC)C(C=C(C=C1)C(C)=O)=C1OCC2=CC=CC=C2, MDL NA |
| Drug_Names: Methyl 2-(benzyloxy)-5-(2-bromoacetyl)benzoate, CAS: 27475-14-5, stock 555.7g, assay 98.8%, MWt 363.20, Formula C17H15BrO4, Purity >98%, SMILES O=C(OC)C(C=C(C=C1)C(CBr)=O)=C1OCC2=CC=CC=C2, MDL NA |
| Drug_Names: 1-Chloro-2-iodo-4-nitrobenzene, CAS: 74534-15-9, stock 47.9g, assay 98.8%, MWt 283.45, Formula C6H3ClINO2, Purity >98%, SMILES ClC(C=CC([N+]([O-])=O)=C1)=C1I, MDL MFCD11521301 |
| Drug_Names: (2-(7-(3,4-Dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-ylamino)pyridin-3-yl)methanol, CAS: 1415564-51-0, stock 649.6g, assay 98.3%, MWt 377.40, Formula C20H19N5O3, Purity >98%, SMILES OCC1=CC=CN=C1NC2=NC(C3=CC=C(OC)C(OC)=C3)=CC4=NC=CN24, MDL NA |
| Drug_Names: Methyl 2-aminonicotinate, CAS: 14667-47-1, stock 121.2g, assay 98.6%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES O=C(OC)C1=CC=CN=C1N, MDL MFCD00128872 |
| Drug_Names: 4-(4-Chlorophenoxy)benzene-1-sulfonyl chloride, CAS: 191327-30-7, stock 326.6g, assay 98.4%, MWt 303.16, Formula C12H8Cl2O3S, Purity >98%, SMILES O=S(C(C=C1)=CC=C1OC2=CC=C(Cl)C=C2)(Cl)=O, MDL NA |
| Drug_Names: 1-Chloro-4-phenoxybenzene, CAS: 7005-72-3, stock 387.9g, assay 98.5%, MWt 204.65, Formula C12H9ClO, Purity >98%, SMILES ClC1=CC=C(C=C1)OC2=CC=CC=C2, MDL MFCD00055431 |
| Drug_Names: 4-((4-(4-Chlorophenoxy)phenylthio)methyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide, CAS: 193021-88-4, stock 238.3g, assay 98.2%, MWt 393.88, Formula C19H20ClNO4S, Purity >98%, SMILES O=C(NO)C1(CCOCC1)CSC(C=C2)=CC=C2OC3=CC=C(Cl)C=C3, MDL NA |
| Drug_Names: 4-((4-(4-Chlorophenoxy)phenylthio)methyl)tetrahydro-2H-pyran-4-carboxylic acid, CAS: 193021-78-2, stock 409.9g, assay 98.7%, MWt 378.87, Formula C19H19ClO4S, Purity >98%, SMILES O=C(O)C1(CCOCC1)CSC(C=C2)=CC=C2OC3=CC=C(Cl)C=C3, MDL NA |
| Drug_Names: (4-(4-Chlorophenoxy)phenyl)(methyl)sulfane, CAS: 225652-11-9, stock 118.8g, assay 98.9%, MWt 250.74, Formula C13H11ClOS, Purity >98%, SMILES ClC1=CC=C(C=C1)OC(C=C2)=CC=C2SC, MDL NA |
| Drug_Names: (S)-3-bromo-5-(pyrrolidin-2-yl)pyridine dioxalate, CAS: 1415566-39-0, stock 614g, assay 98.2%, MWt 407.17, Formula C13H15BrN2O8, Purity >98%, SMILES O=C(O)C(O)=O.O=C(O)C(O)=O.BrC1=CN=CC([C@H]2NCCC2)=C1, MDL NA |
| Drug_Names: Ethyl 5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazine-6-carboxylate, CAS: 427878-70-4, stock 817.6g, assay 98.5%, MWt 221.21, Formula C10H11N3O3, Purity >98%, SMILES O=C1C2=C(C)C(C(OCC)=O)=CN2N=CN1, MDL MFCD11044884 |
| Drug_Names: Diethyl 3-methyl-1H-pyrrole-2,4-dicarboxylate, CAS: 5448-16-8, stock 383.7g, assay 98.2%, MWt 225.24, Formula C11H15NO4, Purity >98%, SMILES O=C(OCC)C1=CNC(C(OCC)=O)=C1C, MDL MFCD00030385 |
| Drug_Names: 4-Chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine, CAS: 529508-56-3, stock 26.8g, assay 98.5%, MWt 167.60, Formula C7H6ClN3, Purity >98%, SMILES ClC1=NC=NN2C1=C(C)C=C2, MDL MFCD12924549 |
| Drug_Names: (3R,4R)-4-Azidopiperidin-3-ol, CAS: 859854-78-7, stock 226.4g, assay 98.8%, MWt 142.16, Formula C5H10N4O, Purity >98%, SMILES O[C@@H]1CNCC[C@H]1N=[N+]=[N-], MDL NA |
| Drug_Names: 4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol, CAS: 1415559-37-3, stock 680.2g, assay 98.9%, MWt 368.43, Formula C19H24N6O2, Purity >98%, SMILES OC(C(CC1)N)CN1CC2=C3C(NC4=CC(OC)=CC=C4)=NC=NN3C=C2, MDL NA |
| Drug_Names: N-((4-Chloropyrrolo[2,1-f][1,2,4]triazin-5-yl)methyl)-N,N-diethylethanaminium bromide, CAS: 859205-90-6, stock 48g, assay 98.9%, MWt 347.68, Formula C13H20BrClN4, Purity >98%, SMILES CC[N+](CC)(CC)CC1=C2C(Cl)=NC=NN2C=C1.[Br-], MDL NA |
| Drug_Names: 6-Bromo-8-methoxyisoquinoline, CAS: 1415564-97-4, stock 60.4g, assay 98.9%, MWt 238.08, Formula C10H8BrNO, Purity >98%, SMILES BrC1=CC2=C(C=NC=C2)C(OC)=C1, MDL NA |
| Drug_Names: 3,5-Dibromo-4-formylbenzonitrile, CAS: 1415560-03-0, stock 674.4g, assay 98.1%, MWt 288.92, Formula C8H3Br2NO, Purity >98%, SMILES N#CC1=CC(Br)=C(C=O)C(Br)=C1, MDL NA |
| Drug_Names: 4-Bromo-6-cyanobenzo[b]thiophene-2-carboxylic acid, CAS: 1415564-52-1, stock 267.4g, assay 98.4%, MWt 282.11, Formula C10H4BrNO2S, Purity >98%, SMILES N#CC1=CC2=C(C(Br)=C1)C=C(C(O)=O)S2, MDL NA |
| Drug_Names: 3,5-Dibromo-4-methylbenzamide, CAS: 289039-51-6, stock 310.5g, assay 98.5%, MWt 292.96, Formula C8H7Br2NO, Purity >98%, SMILES O=C(N)C1=CC(Br)=C(C)C(Br)=C1, MDL NA |
| Drug_Names: [4-(Methoxycarbonyl)phenyl]methyl, CAS: 84237-64-9, stock 423.8g, assay 98.1%, MWt 149.17, Formula C9H9O2, Purity >98%, SMILES [CH2]C1=CC=C(C(OC)=O)C=C1, MDL NA |
| Drug_Names: 3,5-Dibromobenzoic acid, CAS: 618-58-6, stock 754.5g, assay 98.1%, MWt 279.91, Formula C7H4Br2O2, Purity >98%, SMILES O=C(O)C1=CC(Br)=CC(Br)=C1, MDL MFCD00051758 |
| Drug_Names: Methyl 3,4-bis(benzyloxy)benzoate, CAS: 54544-05-7, stock 710.4g, assay 98.8%, MWt 348.39, Formula C22H20O4, Purity >98%, SMILES O=C(OC)C(C=C1)=CC(OCC2=CC=CC=C2)=C1OCC3=CC=CC=C3, MDL NA |
| Drug_Names: Methyl 4,5-bis(benzyloxy)-2-nitrobenzoate, CAS: 1415564-82-7, stock 162.8g, assay 98.6%, MWt 393.39, Formula C22H19NO6, Purity >98%, SMILES O=C(OC)C1=CC(OCC2=CC=CC=C2)=C(C=C1[N+]([O-])=O)OCC3=CC=CC=C3, MDL NA |
| Drug_Names: Methyl 2-amino-4,5-bis(benzyloxy)benzoate, CAS: 1415560-78-9, stock 40.4g, assay 98.3%, MWt 363.41, Formula C22H21NO4, Purity >98%, SMILES O=C(OC)C(C(N)=C1)=CC(OCC2=CC=CC=C2)=C1OCC3=CC=CC=C3, MDL NA |
| Drug_Names: (E)-methyl 4,5-bis(benzyloxy)-2-((dimethylamino)methyleneamino)benzoate, CAS: 1415565-93-3, stock 240.8g, assay 98.7%, MWt 418.49, Formula C25H26N2O4, Purity >98%, SMILES O=C(OC)C(C(/N=C/N(C)C)=C1)=CC(OCC2=CC=CC=C2)=C1OCC3=CC=CC=C3, MDL NA |
| Drug_Names: 6,7-Bis(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbonitrile, CAS: 1415564-53-2, stock 174.2g, assay 98.4%, MWt 382.41, Formula C24H18N2O3, Purity >98%, SMILES N#CC1=CNC2=CC(OCC3=CC=CC=C3)=C(OCC4=CC=CC=C4)C=C2C1=O, MDL NA |
| Drug_Names: 3-Quinolinecarbonitrile, 4-chloro-6,7-bis(phenylmethoxy)-, CAS: 1822792-24-4, stock 105.7g, assay 98.1%, MWt 400.86, Formula C24H17ClN2O2, Purity >98%, SMILES N#CC1=C(Cl)C2=CC(OCC3=CC=CC=C3)=C(OCC4=CC=CC=C4)C=C2N=C1, MDL NA |
| Drug_Names: (S)-2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)acetonitrile, CAS: 1185516-79-3, stock 607.4g, assay 98.5%, MWt 199.25, Formula C13H13NO, Purity >98%, SMILES N#CC[C@H]1C2=C(CC1)C=CC3=C2CCO3, MDL NA |
| Drug_Names: (2S)-1-[(1S)-1-(Dicyclohexylphosphino)ethyl]-2-(diphenylphosphino)ferrocene, CAS: 162291-02-3, stock 63.7g, assay 98.5%, MWt 594.53, Formula C36H44FeP2, Purity >98%, SMILES [][Fe][].C[C@H](P(C1CCCCC1)C2CCCCC2)c3cccc3P(C4=CC=CC=C4)C5=CC=CC=C5.c6cccc6, MDL MFCD00800285 |
| Drug_Names: Acetylferrocene, CAS: 1271-55-2, stock 721.2g, assay 98.3%, MWt 228.07, Formula C12H12FeO, Purity >98%, SMILES [][Fe][].O=C(C)c1cccc1.c2cccc2, MDL NA |
| Drug_Names: (S)-1-Ferrocenylethanol, CAS: 33136-66-2, stock 642.9g, assay 99%, MWt 230.08, Formula C12H14FeO, Purity >98%, SMILES [][Fe][].C[C@H](O)c1cccc1.c2cccc2, MDL NA |
| Drug_Names: (S)-(-)-N,N-Dimethyl-1-ferrocenylethylamine, CAS: 31886-57-4, stock 605.5g, assay 98.7%, MWt 257.15, Formula C14H19FeN, Purity >98%, SMILES [][Fe][].C[C@H](N(C)C)c1cccc1.C2CCCC2, MDL MFCD00066272 |
| Drug_Names: (R)-(3-methylpiperazin-1-yl)(phenyl)methanone, CAS: 357263-39-9, stock 244g, assay 98.5%, MWt 204.27, Formula C12H16N2O, Purity >98%, SMILES O=C(C1=CC=CC=C1)N2C[C@@H](C)NCC2, MDL NA |
| Drug_Names: 2-(4Methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-oxoacetic acid, CAS: 611197-53-6, stock 55.2g, assay 98.7%, MWt 220.18, Formula C10H8N2O4, Purity >98%, SMILES O=C(C(O)=O)C1=CNC2=NC=CC(OC)=C12, MDL NA |
| Drug_Names: 6-(Hydroxymethyl)-4-phenylchroman-2-ol, CAS: 959624-24-9, stock 612.6g, assay 98.7%, MWt 256.30, Formula C16H16O3, Purity >98%, SMILES OC1CC(C2=CC=CC=C2)C(C=C3CO)=C(C=C3)O1, MDL NA |
| Drug_Names: N-[trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl]acetamide, CAS: 882660-40-4, stock 834.5g, assay 98.2%, MWt 279.42, Formula C16H29N3O, Purity >98%, SMILES O=C(C)N[C@@H]1CC[C@H](CC1)N2CCN(CC3CC3)CC2, MDL NA |
| Drug_Names: 4-(Dibenzylamino)cyclohexanone, CAS: 149506-79-6, stock 336.2g, assay 98.7%, MWt 293.40, Formula C20H23NO, Purity >98%, SMILES O=C1CCC(CC1)N(CC2=CC=CC=C2)CC3=CC=CC=C3, MDL MFCD16659682 |
| Drug_Names: trans-4-(Dibenzylamino)cyclohexanol, CAS: 149506-81-0, stock 180.9g, assay 98%, MWt 295.42, Formula C20H25NO, Purity >98%, SMILES O[C@H]1CC[C@@H](CC1)N(CC2=CC=CC=C2)CC3=CC=CC=C3, MDL NA |
| Drug_Names: 3-(Methylthio)propyl 4-methylbenzenesulfonate, CAS: 187722-18-5, stock 709g, assay 98.9%, MWt 260.37, Formula C11H16O3S2, Purity >98%, SMILES O=S(C(C=C1)=CC=C1C)(OCCCSC)=O, MDL MFCD09841016 |
| Drug_Names: 3-(Methylsulfonyl)propyl 4-methylbenzenesulfonate, CAS: 263400-88-0, stock 44.1g, assay 98.4%, MWt 292.37, Formula C11H16O5S2, Purity >98%, SMILES O=S(C(C=C1)=CC=C1C)(OCCCS(=O)(C)=O)=O, MDL MFCD22124592 |
| Drug_Names: 4'-Hydroxy-2',6'-dimethylbiphenyl-3-carbaldehyde, CAS: 805250-31-1, stock 583.3g, assay 98.8%, MWt 226.27, Formula C15H14O2, Purity >98%, SMILES O=CC1=CC(C(C(C)=C2)=C(C)C=C2O)=CC=C1, MDL NA |
| Drug_Names: 4-(chloromethyl)-7-hydroxy-2H-chromen-2-one, CAS: 25392-41-0, stock 456.3g, assay 98.5%, MWt 210.61, Formula C10H7ClO3, Purity >98%, SMILES O=C1OC(C=C2O)=C(C=C2)C(CCl)=C1, MDL MFCD00467168 |
| Drug_Names: Methyl 2-(6-hydroxybenzofuran-3-yl)acetate, CAS: 726174-52-3, stock 586.9g, assay 98%, MWt 206.19, Formula C11H10O4, Purity >98%, SMILES O=C(OC)CC1=COC2=CC(O)=CC=C12, MDL MFCD24344345 |
| Drug_Names: (2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methanol, CAS: 1000413-85-3, stock 19.8g, assay 98.8%, MWt 348.46, Formula C19H24O4S, Purity >98%, SMILES O=S(CCCOC1=CC(C)=C(C(C)=C1)C2=CC=CC(CO)=C2)(C)=O, MDL NA |
| Drug_Names: 2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-carbaldehyde, CAS: 1000413-84-2, stock 649.1g, assay 98.8%, MWt 346.44, Formula C19H22O4S, Purity >98%, SMILES O=S(CCCOC1=CC(C)=C(C(C)=C1)C2=CC=CC(C=O)=C2)(C)=O, MDL NA |
| Drug_Names: Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, CAS: 805250-17-3, stock 252g, assay 98.7%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES O=C(OC)CC1COC2=CC(O)=CC=C12, MDL NA |
| Drug_Names: (S)-methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, CAS: 1000414-38-9, stock 519.1g, assay 98.5%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES O=C(OC)C[C@@H]1COC2=CC(O)=CC=C12, MDL MFCD20488619 |
| Drug_Names: (R)-methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, CAS: 1234474-58-8, stock 845g, assay 98.6%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES O=C(OC)C[C@H]1COC2=CC(O)=CC=C12, MDL NA |
| Drug_Names: 5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine, CAS: 115170-40-6, stock 264.5g, assay 98.7%, MWt 199.05, Formula C7H7BrN2, Purity >98%, SMILES BrC1=CN=C(NCC2)C2=C1, MDL MFCD06659750 |
| Drug_Names: 2-Amidinopyrimidine hydrochloride, CAS: 138588-40-6, stock 828.2g, assay 98.6%, MWt 158.59, Formula C5H7ClN4, Purity >98%, SMILES N=C(N)C1=NC=CC=N1.Cl, MDL MFCD02677965 |
| Drug_Names: N-(2-Butylbenzofuran-5-yl)methanesulfonamide, CAS: 437652-07-8, stock 21.2g, assay 99%, MWt 267.34, Formula C13H17NO3S, Purity >98%, SMILES O=S(NC1=CC=C2OC(CCCC)=CC2=C1)(C)=O, MDL MFCD16660182 |
| Drug_Names: Dibenzyl 1-(4-(methoxycarbonyl)phenyl)-2-methylhydrazine-1,2-dicarboxylate, CAS: 1415560-10-9, stock 20.2g, assay 98.4%, MWt 448.47, Formula C25H24N2O6, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N(C)N(C(C=C2)=CC=C2C(OC)=O)C(OCC3=CC=CC=C3)=O, MDL NA |
| Drug_Names: tert-Butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate, CAS: 190964-91-1, stock 252.2g, assay 98.3%, MWt 283.41, Formula C15H29N3O2, Purity >98%, SMILES O=C(OC(C)(C)C)N1CCC(CC1)N(CC2)CCN2C, MDL NA |
| Drug_Names: 1-Methyl-4-(piperidin-4-yl)piperazine, CAS: 53617-36-0, stock 344.8g, assay 98.4%, MWt 183.29, Formula C10H21N3, Purity >98%, SMILES CN1CCN(CC1)C2CCNCC2, MDL MFCD03274729 |
| Drug_Names: N7,N7-Dimethyl-3-(3-methylphenyl)-1,7-isoquinolinediamine, CAS: 1029008-73-8, stock 188.6g, assay 98.8%, MWt 277.36, Formula C18H19N3, Purity >98%, SMILES NC1=NC(C2=CC(C)=CC=C2)=CC3=CC=C(N(C)C)C=C13, MDL NA |
| Drug_Names: 4-(7-(Dimethylamino)-3-m-tolylisoquinolin-1-ylamino)-4-oxobutanoic acid, CAS: 1415564-54-3, stock 283.9g, assay 98.1%, MWt 377.44, Formula C22H23N3O3, Purity >98%, SMILES O=C(CCC(O)=O)NC1=NC(C2=CC(C)=CC=C2)=CC3=CC=C(N(C)C)C=C13, MDL NA |
| Drug_Names: (S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-Bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol, CAS: 128387-35-9, stock 380.9g, assay 98.4%, MWt 575.03, Formula C34H62O3Si2, Purity >98%, SMILES C[C@@]12[C@](CC[C@@H]2[C@@H](CO)C)([H])/C(CCC1)=C/C=C3C([C@@H](O[Si](C)(C(C)(C)C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C/3)=C, MDL NA |
| Drug_Names: Methyl 4-formyl-3-nitrobenzoate, CAS: 153813-69-5, stock 524.4g, assay 98.7%, MWt 209.16, Formula C9H7NO5, Purity >98%, SMILES O=C(OC)C1=CC=C(C=O)C([N+]([O-])=O)=C1, MDL MFCD04039968 |
| Drug_Names: 2-Phenylquinoline-7-carboxylic acid, CAS: 841297-69-6, stock 605.4g, assay 98.8%, MWt 249.26, Formula C16H11NO2, Purity >98%, SMILES O=C(O)C1=CC=C2C(N=C(C3=CC=CC=C3)C=C2)=C1, MDL MFCD12924847 |
| Drug_Names: (2-Phenylquinolin-7-yl)methanol, CAS: 361457-37-6, stock 397.5g, assay 98.5%, MWt 235.28, Formula C16H13NO, Purity >98%, SMILES OCC1=CC=C2C(N=C(C3=CC=CC=C3)C=C2)=C1, MDL MFCD12924848 |
| Drug_Names: 2-Phenylquinoline-7-carbaldehyde, CAS: 867162-43-4, stock 835.5g, assay 98.5%, MWt 233.26, Formula C16H11NO, Purity >98%, SMILES O=CC1=CC=C2C(N=C(C3=CC=CC=C3)C=C2)=C1, MDL MFCD12924846 |
| Drug_Names: 3-Methylenecyclobutanecarboxylic acid, CAS: 15760-36-8, stock 377.1g, assay 98.4%, MWt 112.13, Formula C6H8O2, Purity >98%, SMILES C=C1CC(C(O)=O)C1, MDL MFCD00101901 |
| Drug_Names: (3-Chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methanol, CAS: 867162-41-2, stock 852.7g, assay 98.1%, MWt 347.80, Formula C20H14ClN3O, Purity >98%, SMILES ClC1=NC=CN=C1C(O)C2=CC=C3C(N=C(C4=CC=CC=C4)C=C3)=C2, MDL NA |
| Drug_Names: (3-Chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methanamine, CAS: 867162-37-6, stock 466.3g, assay 98.2%, MWt 346.81, Formula C20H15ClN4, Purity >98%, SMILES NC(C1=CC=C2C(N=C(C3=CC=CC=C3)C=C2)=C1)C4=NC=CN=C4Cl, MDL NA |
| Drug_Names: 2-((3-Chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methyl)isoindoline-1,3-dione, CAS: 867162-39-8, stock 525.1g, assay 98.8%, MWt 476.91, Formula C28H17ClN4O2, Purity >98%, SMILES O=C1N(C(C2=CC(N=C(C=C3)C4=CC=CC=C4)=C3C=C2)C5=NC=CN=C5Cl)C(C6=C1C=CC=C6)=O, MDL NA |
| Drug_Names: N-((3-Chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methyl)-3-methylenecyclobutanecarboxamide, CAS: 867163-52-8, stock 889.6g, assay 98.7%, MWt 440.92, Formula C26H21ClN4O, Purity >98%, SMILES O=C(C1CC(C1)=C)NC(C2=CC=C3C(N=C(C4=CC=CC=C4)C=C3)=C2)C5=NC=CN=C5Cl, MDL NA |
| Drug_Names: 7-(8-Chloro-3-(3-methylenecyclobutyl)imidazo[1,5-a]pyrazin-1-yl)-2-phenylquinoline, CAS: 867163-50-6, stock 158.7g, assay 98.9%, MWt 422.91, Formula C26H19ClN4, Purity >98%, SMILES C=C1CC(C1)C2=NC(C3=CC=C4C(N=C(C5=CC=CC=C5)C=C4)=C3)=C6N2C=CN=C6Cl, MDL NA |
| Drug_Names: 3-(8-Chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)cyclobutanone, CAS: 867165-62-6, stock 844.8g, assay 98.4%, MWt 424.88, Formula C25H17ClN4O, Purity >98%, SMILES O=C1CC(C1)C2=NC(C3=CC=C4C(N=C(C5=CC=CC=C5)C=C4)=C3)=C6N2C=CN=C6Cl, MDL NA |
| Drug_Names: tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate, CAS: 414910-15-9, stock 721.6g, assay 98.2%, MWt 254.33, Formula C13H22N2O3, Purity >98%, SMILES O=C(N1CCN(C(C2CC2)=O)CC1)OC(C)(C)C, MDL MFCD03930967 |
| Drug_Names: 2-((3R,5R)-3,5-bis(tert-butyldimethylsilyloxy)cyclohexylidene)ethanol, CAS: 139356-37-9, stock 562.4g, assay 98.3%, MWt 386.72, Formula C20H42O3Si2, Purity >98%, SMILES C[Si](C(C)(C)C)(C)O[C@H](C/C(C1)=C\CO)C[C@@H]1O[Si](C)(C)C(C)(C)C, MDL NA |
| Drug_Names: (1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxymethoxy)-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-one, CAS: 100858-26-2, stock 342g, assay 98.6%, MWt 336.51, Formula C21H36O3, Purity >98%, SMILES O=C1[C@@]2([H])[C@@](CCC1)(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)(C)OCOC)CC2, MDL NA |
| Drug_Names: benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate, CAS: 274693-53-7, stock 223.4g, assay 98.2%, MWt 307.34, Formula C16H21NO5, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N[C@H](C2)[C@H]3[C@@H]([C@H]2O)OC(C)(C)O3, MDL MFCD21362984 |
| Drug_Names: 2-Bromoimidazo[2,1-b]thiazole, CAS: 944581-09-3, stock 105.1g, assay 98.6%, MWt 203.06, Formula C5H3BrN2S, Purity >98%, SMILES BrC1=CN2C(S1)=NC=C2, MDL NA |
| Drug_Names: 3-Methylisothiazol-5-amine hydrochloride, CAS: 52547-00-9, stock 519.8g, assay 98.5%, MWt 150.63, Formula C4H7ClN2S, Purity >98%, SMILES NC1=CC(C)=NS1.[H]Cl, MDL MFCD00012716 |
| Drug_Names: tert-Butyl (1-cyclobutyl-3-oxopropan-2-yl)carbamate, CAS: 394735-19-4, stock 687.2g, assay 98.7%, MWt 227.30, Formula C12H21NO3, Purity >98%, SMILES O=C(OC(C)(C)C)NC(CC1CCC1)C([H])=O, MDL MFCD22124609 |
| Drug_Names: (1S,2S,5R)-methyl 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate, CAS: 1932478-97-1, stock 836.9g, assay 98.7%, MWt 169.22, Formula C9H15NO2, Purity >98%, SMILES O=C(OC)[C@@H]1[C@@H]2C(C)(C)[C@@H]2CN1, MDL NA |
| Drug_Names: (1S,2S,5R)-3-tert-butyl 2-methyl 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate, CAS: 569679-06-7, stock 534.9g, assay 98.9%, MWt 269.34, Formula C14H23NO4, Purity >98%, SMILES O=C(OC(C)(C)C)N1[C@H](C(OC)=O)[C@H]2C([C@H]2C1)(C)C, MDL NA |
| Drug_Names: (R)-1-methyl-4-(methylsulfinyl)benzene, CAS: 1519-39-7, stock 412.3g, assay 98.1%, MWt 154.23, Formula C8H10OS, Purity >98%, SMILES O=[S@](C)C(C=C1)=CC=C1C, MDL MFCD00151502 |
| Drug_Names: N-Boc-3-Amino-4-iodopyridine, CAS: 154048-89-2, stock 849.3g, assay 98.4%, MWt 320.13, Formula C10H13IN2O2, Purity >98%, SMILES O=C(OC(C)(C)C)NC(C=NC=C1)=C1I, MDL MFCD04973410 |
| Drug_Names: 3-(4-chlorobutyl)-1H-indole-5-carbonitrile, CAS: 143612-79-7, stock 595.4g, assay 98.1%, MWt 232.71, Formula C13H13ClN2, Purity >98%, SMILES ClCCCCC1=CNC2=CC=C(C#N)C=C21, MDL NA |
| Drug_Names: 5-(Piperazin-1-yl)benzofuran-2-carboxamide, CAS: 183288-46-2, stock 715.8g, assay 98.2%, MWt 245.28, Formula C13H15N3O2, Purity >98%, SMILES O=C(N)C1=CC2=CC(N3CCNCC3)=CC=C2O1, MDL MFCD20486139 |
| Drug_Names: (R)-2-Amino-3-methoxypropanoic acid hydrochloride, CAS: 86118-10-7, stock 893.5g, assay 98.7%, MWt 155.58, Formula C4H10ClNO3, Purity >98%, SMILES COC[C@H](C(O)=O)N.Cl, MDL MFCD11099371 |
| Drug_Names: 5-Chlorothiophene-2-carboxylic acid, CAS: 24065-33-6, stock 497.3g, assay 98.4%, MWt 162.59, Formula C5H3ClO2S, Purity >98%, SMILES O=C(O)C1=CC=C(Cl)S1, MDL MFCD00041426 |
| Drug_Names: 3-(6-Chloro-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yloxy)-4-methylbenzoic acid, CAS: 1415564-64-5, stock 616.3g, assay 98.6%, MWt 432.97, Formula C21H25ClN2O4Si, Purity >98%, SMILES O=C(O)C1=CC(OC2=C3C(N(COCC[Si](C)(C)C)C=C3)=NC(Cl)=C2)=C(C)C=C1, MDL NA |
| Drug_Names: (S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one, CAS: 870281-86-0, stock 67.3g, assay 98.5%, MWt 297.33, Formula C17H16FN3O, Purity >98%, SMILES O=C1N(C2=CC=CC=C2)C([C@H](CC)N)=NC3=CC=CC(F)=C13, MDL NA |
| Drug_Names: tert-Butyl 2-chloropyridine-4-carbamate, CAS: 234108-73-7, stock 109.9g, assay 99%, MWt 228.68, Formula C10H13ClN2O2, Purity >98%, SMILES O=C(OC(C)(C)C)NC1=CC=NC(Cl)=C1, MDL MFCD07781158 |
| Drug_Names: tert-Butyl 1-(4-bromophenyl)cyclobutylcarbamate, CAS: 1032350-06-3, stock 202.8g, assay 98.9%, MWt 326.23, Formula C15H20BrNO2, Purity >98%, SMILES O=C(OC(C)(C)C)NC1(CCC1)C(C=C2)=CC=C2Br, MDL MFCD18072661 |
| Drug_Names: tert-Butyl (2-chloro-3-formylpyridin-4-yl)carbamate, CAS: 893423-62-6, stock 412.9g, assay 98.2%, MWt 256.69, Formula C11H13ClN2O3, Purity >98%, SMILES O=C(OC(C)(C)C)NC1=CC=NC(Cl)=C1C=O, MDL MFCD16659013 |
| Drug_Names: tert-Butyl 1-(4-cyanophenyl)cyclobutylcarbamate, CAS: 1032349-97-5, stock 697.2g, assay 98.7%, MWt 272.34, Formula C16H20N2O2, Purity >98%, SMILES N#CC1=CC=C(C=C1)C2(CCC2)NC(OC(C)(C)C)=O, MDL MFCD15071414 |
| Drug_Names: 1-(4-Bromophenyl)cyclobutanecarboxylic acid, CAS: 151157-49-2, stock 810.3g, assay 98.1%, MWt 255.11, Formula C11H11BrO2, Purity >98%, SMILES BrC(C=C1)=CC=C1C2(C(O)=O)CCC2, MDL MFCD08443165 |
| Drug_Names: tert-Butyl (1-(4-(5-chloro-3-phenyl-1,6-naphthyridin-2-yl)phenyl)cyclobutyl)carbamate, CAS: 1032349-99-7, stock 230.5g, assay 98.5%, MWt 486.00, Formula C29H28ClN3O2, Purity >98%, SMILES O=C(OC(C)(C)C)NC1(CCC1)C2=CC=C(C=C2)C3=NC4=CC=NC(Cl)=C4C=C3C5=CC=CC=C5, MDL NA |
| Drug_Names: (R)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, CAS: 152286-30-1, stock 712.8g, assay 98.5%, MWt 193.20, Formula C10H11NO3, Purity >98%, SMILES O=C([C@@H]1NCC2=C(C=CC(O)=C2)C1)O, MDL MFCD00171281 |
| Drug_Names: (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate, CAS: 270257-39-1, stock 119.4g, assay 98.1%, MWt 384.49, Formula C21H24N2O3S, Purity >98%, SMILES N#CC1(CCN(CC1)CC2=CC=CC=C2)COS(C3=CC=C(C)C=C3)(=O)=O, MDL MFCD12407802 |
| Drug_Names: tert-Butyl 7-benzyl-2,7-diazaspiro[3.5]nonane-2-carboxylate, CAS: 929301-99-5, stock 365.1g, assay 98.1%, MWt 316.44, Formula C19H28N2O2, Purity >98%, SMILES O=C(OC(C)(C)C)N1CC2(CCN(CC3=CC=CC=C3)CC2)C1, MDL MFCD11111843 |
| Drug_Names: 7-Cyclopropyl-2,7-diazaspiro[3.5]nonane (dihydrochloride), CAS: 1415562-71-8, stock 788.4g, assay 98.5%, MWt 239.19, Formula C10H20Cl2N2, Purity >98%, SMILES N(CCC12CNC1)(CC2)C3CC3.Cl.Cl, MDL NA |
| Drug_Names: N-Benzylbis(2-chloroethyl)amine hydrochloride, CAS: 10429-82-0, stock 174.1g, assay 98.2%, MWt 268.61, Formula C11H16Cl3N, Purity >98%, SMILES ClCCN(CCCl)CC1=CC=CC=C1.Cl, MDL NA |
| Drug_Names: 1-Benzyl-4-(hydroxymethyl)piperidine-4-carbonitrile, CAS: 162686-53-5, stock 159.7g, assay 98.1%, MWt 230.31, Formula C14H18N2O, Purity >98%, SMILES N#CC1(CO)CCN(CC1)CC2=CC=CC=C2, MDL MFCD12406111 |
| Drug_Names: N1-(4-methoxybenzyl)-N7,N7-dimethyl-3-m-tolylisoquinoline-1,7-diamine, CAS: 1248622-41-4, stock 533.1g, assay 98.1%, MWt 397.51, Formula C26H27N3O, Purity >98%, SMILES CN(C)C1=CC=C2C(C(NCC(C=C3)=CC=C3OC)=NC(C4=CC(C)=CC=C4)=C2)=C1, MDL NA |
| Drug_Names: 7-(Dimethylamino)-3-m-tolylisoquinolin-1(2H)-one, CAS: 1248621-37-5, stock 723.7g, assay 98.5%, MWt 278.35, Formula C18H18N2O, Purity >98%, SMILES O=C1NC(C2=CC(C)=CC=C2)=CC3=CC=C(N(C)C)C=C13, MDL NA |
| Drug_Names: 1-Chloro-N,N-dimethyl-3-m-tolylisoquinolin-7-amine, CAS: 1248621-84-2, stock 708g, assay 98.3%, MWt 296.79, Formula C18H17ClN2, Purity >98%, SMILES ClC1=NC(C2=CC(C)=CC=C2)=CC3=CC=C(N(C)C)C=C13, MDL NA |
| Drug_Names: 2-(4-(4-Chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid, CAS: 571170-81-5, stock 85.5g, assay 98.4%, MWt 435.90, Formula C21H19ClFNO4S, Purity >98%, SMILES O=S(C1=CC(F)=CC2=C1N(CC(C=C3)=CC=C3Cl)C4=C2CCC4CC(O)=O)(C)=O, MDL MFCD23135607 |
| Drug_Names: (S)-1-amino-3-methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one (2R,3R)-2,3-bis(4-methylbenzoyloxy)succinate, CAS: 425386-58-9, stock 55g, assay 98.2%, MWt 576.59, Formula C31H32N2O9, Purity >98%, SMILES O=C(C1=CC=C(C)C=C1)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C2=CC=C(C)C=C2)=O.O=C3[C@@H](N)C4=CC=CC=C4CCN3C, MDL NA |
| Drug_Names: Methyl 3'-(ethylsulfonyl)-4-methyl-5-nitrobiphenyl-3-carboxylate, CAS: 1005499-49-9, stock 91.7g, assay 98.5%, MWt 363.39, Formula C17H17NO6S, Purity >98%, SMILES O=S(C1=CC=CC(C2=CC(C(OC)=O)=C(C)C(N(=O)=O)=C2)=C1)(CC)=O, MDL NA |
| Drug_Names: Methyl 5-((3-bromo-4-methylpyridin-2-yl)(tert-butoxycarbonyl)amino)-3'-(ethylsulfonyl)-4-methylbiphenyl-3-carboxylate, CAS: 1415562-73-0, stock 792.2g, assay 98.7%, MWt 603.52, Formula C28H31BrN2O6S, Purity >98%, SMILES O=C(OC(C)(C)C)N(C1=CC(C2=CC(S(=O)(CC)=O)=CC=C2)=CC(C(OC)=O)=C1C)C3=C(Br)C(C)=CC=N3, MDL NA |
| Drug_Names: 5-(3-(Ethylsulfonyl)phenyl)-4,8-dimethyl-9H-pyrido[2,3-b]indole-7-carboxylic acid, CAS: 934542-76-4, stock 149.4g, assay 98%, MWt 408.47, Formula C22H20N2O4S, Purity >98%, SMILES O=S(C1=CC=CC(C2=CC(C(O)=O)=C(C)C3=C2C4=C(N=CC=C4C)N3)=C1)(CC)=O, MDL NA |
| Drug_Names: Methyl 5-bromo-2-methyl-3-nitrobenzoate, CAS: 220514-28-3, stock 475.9g, assay 98.6%, MWt 274.07, Formula C9H8BrNO4, Purity >98%, SMILES O=N(C1=CC(Br)=CC(C(OC)=O)=C1C)=O, MDL MFCD07781280 |
| Drug_Names: 2-(3-(Ethylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 2096331-73-4, stock 509.4g, assay 98.6%, MWt 296.19, Formula C14H21BO4S, Purity >98%, SMILES O=S(C1=CC(B(OC(C)2C)OC2(C)C)=CC=C1)(CC)=O, MDL NA |
| Drug_Names: (1S,5R,Z)-5-(tert-butyldimethylsilyloxy)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-methylenecyclohexanol, CAS: 132054-64-9, stock 207.5g, assay 98.1%, MWt 530.90, Formula C33H58O3Si, Purity >98%, SMILES C=C([C@H](C[C@H](O[Si](C)(C)C(C)(C)C)C/1)O)C1=C/C=C2[C@@]3([H])[C@@](CCC/2)(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC3, MDL NA |
| Drug_Names: 4-(6-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-2-(2-(tetrahydro-2H-pyran-2-yl)-2H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl)morpholine, CAS: 1146955-37-4, stock 10.4g, assay 98.2%, MWt 597.75, Formula C28H35N7O4S2, Purity >98%, SMILES O=S(N(CC1)CCN1CC2=CC3=C(C(N4CCOCC4)=NC(C5=CC=CC6=NN(C7OCCCC7)C=C56)=N3)S2)(C)=O, MDL NA |
| Drug_Names: (R)-tert-butyl 2-(1-(4-(ethoxycarbonyl)phenyl)ethyl)hydrazinecarboxylate, CAS: 870822-90-5, stock 877.8g, assay 98.7%, MWt 308.37, Formula C16H24N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)NN[C@H](C)C1=CC=C(C=C1)C(OCC)=O, MDL NA |
| Drug_Names: (4-(Prop-1-en-2-yl)-1,3-phenylene)bis(oxy)bis(methylene)dibenzene, CAS: 747414-16-0, stock 760.4g, assay 98.3%, MWt 330.42, Formula C23H22O2, Purity >98%, SMILES C=C(C)C(C=C1)=C(OCC2=CC=CC=C2)C=C1OCC3=CC=CC=C3, MDL MFCD20264842 |
| Drug_Names: 1-(2,4-Bis(benzyloxy)phenyl)ethanone, CAS: 22877-01-6, stock 871.8g, assay 98.3%, MWt 332.39, Formula C22H20O3, Purity >98%, SMILES O=C(C)C1=C(OCC2=CC=CC=C2)C=C(OCC3=CC=CC=C3)C=C1, MDL MFCD00101153 |
| Drug_Names: Ethyl 4-(2,4-bis(benzyloxy)-5-isopropylphenyl)-2-hydroxy-4-oxobut-2-enoate, CAS: 747414-19-3, stock 715.3g, assay 98.7%, MWt 474.54, Formula C29H30O6, Purity >98%, SMILES O=C(C1=C(OCC2=CC=CC=C2)C=C(OCC3=CC=CC=C3)C(C(C)C)=C1)/C=C(O)/C(OCC)=O, MDL MFCD22124631 |
| Drug_Names: 1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone, CAS: 747414-17-1, stock 888.1g, assay 98.4%, MWt 194.23, Formula C11H14O3, Purity >98%, SMILES O=C(C)C1=CC(C(C)C)=C(O)C=C1O, MDL MFCD12827976 |
| Drug_Names: 4-(4-bromobenzyl)morpholine, CAS: 132833-51-3, stock 848.5g, assay 98.1%, MWt 256.14, Formula C11H14BrNO, Purity >98%, SMILES BrC(C=C1)=CC=C1CN2CCOCC2, MDL MFCD00979535 |
| Drug_Names: 1-(2,4-Bis(benzyloxy)-5-isopropylphenyl)ethanone, CAS: 747414-18-2, stock 539.9g, assay 98.6%, MWt 374.47, Formula C25H26O3, Purity >98%, SMILES O=C(C)C1=CC(C(C)C)=C(OCC2=CC=CC=C2)C=C1OCC3=CC=CC=C3, MDL MFCD22124632 |
| Drug_Names: 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethylisoxazole-3-carboxamide, CAS: 747414-21-7, stock 154.1g, assay 98.3%, MWt 470.56, Formula C29H30N2O4, Purity >98%, SMILES O=C(NCC)C1=NOC(C2=C(OCC3=CC=CC=C3)C=C(OCC4=CC=CC=C4)C(C(C)C)=C2)=C1, MDL NA |
| Drug_Names: 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide, CAS: 747414-24-0, stock 613.1g, assay 98.2%, MWt 645.79, Formula C40H43N3O5, Purity >98%, SMILES O=C(NCC)C1=NOC(C(C(OCC2=CC=CC=C2)=C3)=CC(C(C)C)=C3OCC4=CC=CC=C4)=C1C(C=C5)=CC=C5CN6CCOCC6, MDL NA |
| Drug_Names: 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-4-iodoisoxazole-3-carboxamide, CAS: 747414-22-8, stock 830g, assay 98.7%, MWt 596.46, Formula C29H29IN2O4, Purity >98%, SMILES IC(C(C(NCC)=O)=NO1)=C1C(C(OCC2=CC=CC=C2)=C3)=CC(C(C)C)=C3OCC4=CC=CC=C4, MDL NA |
| Drug_Names: Ethyl 5-(2,4-bis(benzyloxy)-5-isopropylphenyl)isoxazole-3-carboxylate, CAS: 747414-20-6, stock 660.3g, assay 98.7%, MWt 471.54, Formula C29H29NO5, Purity >98%, SMILES O=C(OCC)C1=NOC(C2=C(OCC3=CC=CC=C3)C=C(OCC4=CC=CC=C4)C(C(C)C)=C2)=C1, MDL NA |
| Drug_Names: 1-Ethyl-4-(methylsulfonyl)piperidine, CAS: 1415562-90-1, stock 887.9g, assay 98.5%, MWt 191.29, Formula C8H17NO2S, Purity >98%, SMILES O=S(C(CC1)CCN1CC)(C)=O, MDL NA |
| Drug_Names: N-Ethyl-4-hydroxypiperidine, CAS: 3518-83-0, stock 48g, assay 99%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES OC1CCN(CC)CC1, MDL MFCD00006509 |
| Drug_Names: ((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane), CAS: 115540-28-8, stock 37.9g, assay 98.2%, MWt 641.17, Formula C40H72O2Si2, Purity >98%, SMILES C=C([C@@H](C[C@H](O[Si](C)(C)C(C)(C)C)C/1)O[Si](C)(C)C(C)(C)C)C1=C\C=C2[C@@]3([H])[C@@](CCC\2)(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC3, MDL NA |
| Drug_Names: 2-Methoxy-5-methylbenzaldehyde, CAS: 7083-19-4, stock 811.3g, assay 98.3%, MWt 150.17, Formula C9H10O2, Purity >98%, SMILES O=CC1=C(OC)C=CC(C)=C1, MDL MFCD02261770 |
| Drug_Names: 2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate, CAS: 40412-06-4, stock 882.8g, assay 98.8%, MWt 282.38, Formula C13H14O3S2, Purity >98%, SMILES O=S(C1=CC=C(C)C=C1)(OCCC2=CC=CS2)=O, MDL NA |
| Drug_Names: (S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine, CAS: 101403-24-1, stock 641.3g, assay 98%, MWt 219.32, Formula C14H21NO, Purity >98%, SMILES COC1=C(CC[C@@H]2NCCC)C(C2)=CC=C1, MDL NA |
| Drug_Names: 2-(3,4-Dimethoxyphenyl)ethanimidamide hydrochloride, CAS: 6487-89-4, stock 823.8g, assay 98.4%, MWt 230.69, Formula C10H15ClN2O2, Purity >98%, SMILES N=C(N)CC1=CC=C(C(OC)=C1)OC.Cl, MDL NA |
| Drug_Names: 2-(1-hydroxyethyl)-5-phenylpentanoic acid, CAS: 439084-21-6, stock 743.8g, assay 98.3%, MWt 222.28, Formula C13H18O3, Purity >98%, SMILES O=C(O)C(CCCC1=CC=CC=C1)C(C)O, MDL NA |
| Drug_Names: N-(1-(3-(3,4-dimethoxybenzyl)-5-oxo-4,5-dihydro-1,2,4-triazin-6-yl)ethyl)acetamide, CAS: 439084-06-7, stock 754.8g, assay 98.3%, MWt 332.35, Formula C16H20N4O4, Purity >98%, SMILES O=C1C(C(C)NC(C)=O)=NN=C(CC2=CC=C(OC)C(OC)=C2)N1, MDL NA |
| Drug_Names: Methyl 2-acetyl-5-phenylpentanoate, CAS: 97228-23-4, stock 140.8g, assay 99%, MWt 234.29, Formula C14H18O3, Purity >98%, SMILES O=C(OC)C(CCCC1=CC=CC=C1)C(C)=O, MDL NA |
| Drug_Names: 4-(2-Chloro-6-(tetrahydro-2H-pyran-4-yl)pyrimidin-4-yl)morpholine, CAS: 1415562-55-8, stock 382.5g, assay 98.8%, MWt 283.75, Formula C13H18ClN3O2, Purity >98%, SMILES ClC1=NC(C2CCOCC2)=CC(N3CCOCC3)=N1, MDL NA |
| Drug_Names: (S)-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) 4-methylbenzenesulfinate, CAS: 1517-82-4, stock 344.2g, assay 98.8%, MWt 294.45, Formula C17H26O2S, Purity >98%, SMILES O=[S@](C(C=C1)=CC=C1C)O[C@H]2[C@H](C(C)C)CC[C@@H](C)C2, MDL MFCD23701383 |
| Drug_Names: tert-Butyl pyridin-3-ylcarbamate, CAS: 56700-70-0, stock 82.8g, assay 98.1%, MWt 194.23, Formula C10H14N2O2, Purity >98%, SMILES O=C(OC(C)(C)C)NC1=CC=CN=C1, MDL MFCD02179231 |
| Drug_Names: 5-Bromo-2-chloropyrimidine, CAS: 32779-36-5, stock 706.6g, assay 98%, MWt 193.43, Formula C4H2BrClN2, Purity >98%, SMILES ClC(N=C1)=NC=C1Br, MDL MFCD00483232 |
| Drug_Names: 5-Bromo-2-ethoxypyrimidine, CAS: 17758-11-1, stock 102.1g, assay 98.7%, MWt 203.04, Formula C6H7BrN2O, Purity >98%, SMILES BrC1=CN=C(OCC)N=C1, MDL MFCD07375135 |
| Drug_Names: (E)-ethyl 3-(2-ethoxypyrimidin-5-yl)acrylate, CAS: 1314533-99-7, stock 662.2g, assay 98.7%, MWt 222.24, Formula C11H14N2O3, Purity >98%, SMILES O=C(OCC)/C=C/C1=CN=C(OCC)N=C1, MDL NA |
| Drug_Names: Ethyl 3-(2-ethoxypyrimidin-5-yl)propanoate, CAS: 1314534-00-3, stock 313g, assay 98.8%, MWt 224.26, Formula C11H16N2O3, Purity >98%, SMILES O=C(OCC)CCC1=CN=C(OCC)N=C1, MDL NA |
| Drug_Names: 6-Nitroindoline, CAS: 19727-83-4, stock 459.5g, assay 98.2%, MWt 164.16, Formula C8H8N2O2, Purity >98%, SMILES O=[N+]([O-])C1=CC=C2CCNC2=C1, MDL MFCD00005710 |
| Drug_Names: tert-Butyl 6-nitro-1H-indole-1-carboxylate, CAS: 219552-64-4, stock 527.9g, assay 98.4%, MWt 262.26, Formula C13H14N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N1C2=CC([N+]([O-])=O)=CC=C2C=C1, MDL MFCD18206164 |
| Drug_Names: 1-Boc-6-Amino-2,3-dihydroindole, CAS: 129488-00-2, stock 330.1g, assay 98.1%, MWt 234.29, Formula C13H18N2O2, Purity >98%, SMILES O=C(OC(C)(C)C)N1C2=CC(N)=CC=C2CC1, MDL MFCD08059271 |
| Drug_Names: 2-Chloro-6-methylnicotinaldehyde, CAS: 91591-69-4, stock 847.7g, assay 98.4%, MWt 155.58, Formula C7H6ClNO, Purity >98%, SMILES O=CC1=CC=C(C)N=C1Cl, MDL MFCD07368878 |
| Drug_Names: 6-Methyl-1H-pyrazolo[3,4-b]pyridine, CAS: 885269-66-9, stock 146.6g, assay 98.5%, MWt 133.15, Formula C7H7N3, Purity >98%, SMILES CC1=CC=C2C(NN=C2)=N1, MDL MFCD08234559 |
| Drug_Names: 2-Chlorodibenzo[b,f]oxepin-10(11H)-one, CAS: 55595-54-5, stock 119.8g, assay 98.4%, MWt 244.67, Formula C14H9ClO2, Purity >98%, SMILES O=C1C2=CC=CC=C2OC3=C(C=C(Cl)C=C3)C1, MDL MFCD22124642 |
| Drug_Names: 2-Chlorodibenzo[b,f]oxepine, CAS: 25558-88-7, stock 431.4g, assay 98%, MWt 228.67, Formula C14H9ClO, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC3=CC=CC=C3C=C2, MDL MFCD22124643 |
| Drug_Names: Sodium 3-(methoxycarbonyl)-4-oxo-1,4,5,6-tetrahydropyridin-2-olate, CAS: 139122-78-4, stock 283.6g, assay 98.8%, MWt 194.14, Formula C7H9NNaO4+, Purity >98%, SMILES O=C(C1C(OC)=O)NCCC1=O.[Na+], MDL NA |
| Drug_Names: 3-Chloro-4-methylaniline, CAS: 95-74-9, stock 491.6g, assay 98.6%, MWt 141.60, Formula C7H8ClN, Purity >98%, SMILES ClC1=CC(N)=CC=C1C, MDL NA |
| Drug_Names: N-(3-chloro-4-methylphenyl)acetamide, CAS: 7149-79-3, stock 253.5g, assay 98.9%, MWt 183.63, Formula C9H10ClNO, Purity >98%, SMILES O=C(C)NC1=CC=C(C)C(Cl)=C1, MDL NA |
| Drug_Names: N-(2-bromo-5-chloro-4-methylphenyl)acetamide, CAS: 116010-06-1, stock 549.8g, assay 98.3%, MWt 262.53, Formula C9H9BrClNO, Purity >98%, SMILES O=C(C)NC1=C(Br)C=C(C)C(Cl)=C1, MDL MFCD12546456 |
| Drug_Names: 2-Acetamido-4-chloro-5-methylbenzoic acid, CAS: 1204312-39-9, stock 122g, assay 98.2%, MWt 227.64, Formula C10H10ClNO3, Purity >98%, SMILES O=C(O)C1=C(NC(C)=O)C=C(Cl)C(C)=C1, MDL NA |
| Drug_Names: 2-Amino-4-chloro-5-methylbenzoic acid, CAS: 155184-81-9, stock 635.5g, assay 98.3%, MWt 185.61, Formula C8H8ClNO2, Purity >98%, SMILES O=C(O)C1=C(N)C=C(Cl)C(C)=C1, MDL MFCD06658301 |
| Drug_Names: 7-Chloro-2-(chloromethyl)-6-methylquinazolin-4(3H)-one, CAS: 289686-83-5, stock 95.6g, assay 98.6%, MWt 243.09, Formula C10H8Cl2N2O, Purity >98%, SMILES O=C1C(C=C(C)C(Cl)=C2)=C2N=C(CCl)N1, MDL NA |
| Drug_Names: (7-Chloro-3,6-dimethyl-4-oxo-3,4-dihydroquinazolin-2-yl)methyl acetate, CAS: 289686-85-7, stock 380.3g, assay 98.6%, MWt 280.71, Formula C13H13ClN2O3, Purity >98%, SMILES O=C1N(C)C(COC(C)=O)=NC2=C1C=C(C)C(Cl)=C2, MDL NA |
| Drug_Names: (6-(Bromomethyl)-7-chloro-3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methyl acetate, CAS: 289686-86-8, stock 240.6g, assay 98.4%, MWt 359.60, Formula C13H12BrClN2O3, Purity >98%, SMILES O=C(N(C)C(COC(C)=O)=N1)C2=C1C=C(Cl)C(CBr)=C2, MDL NA |
| Drug_Names: tert-Butyl 4-(2-propynylamino)benzoate, CAS: 112888-76-3, stock 90.8g, assay 98.9%, MWt 231.29, Formula C14H17NO2, Purity >98%, SMILES C#CCNC1=CC=C(C=C1)C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: tert-Butyl 4-(((2-(acetoxymethyl)-7-chloro-3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)benzoate, CAS: 289686-87-9, stock 591.4g, assay 98.3%, MWt 509.98, Formula C27H28ClN3O5, Purity >98%, SMILES C#CCN(C1=CC=C(C=C1)C(OC(C)(C)C)=O)CC2=CC(C(N(C)C(COC(C)=O)=N3)=O)=C3C=C2Cl, MDL NA |
| Drug_Names: (7-Chloro-3-methyl-4-oxo-6-((prop-2-ynyl(4-(pyridin-3-ylmethylcarbamoyl)phenyl)amino)methyl)-3,4-dihydroquinazolin-2-yl)methyl acetate, CAS: 1258400-23-5, stock 864.6g, assay 98.9%, MWt 544.00, Formula C29H26ClN5O4, Purity >98%, SMILES C#CCN(C1=CC=C(C=C1)C(NCC2=CC=CN=C2)=O)CC3=CC(C(N(C)C(COC(C)=O)=N4)=O)=C4C=C3Cl, MDL NA |
| Drug_Names: 4-(((7-Chloro-2-(hydroxymethyl)-3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)-N-(pyridin-3-ylmethyl)benzamide, CAS: 1258400-25-7, stock 480.9g, assay 98.6%, MWt 501.96, Formula C27H24ClN5O3, Purity >98%, SMILES C#CCN(C1=CC=C(C=C1)C(NCC2=CC=CN=C2)=O)CC3=CC(C(N(C)C(CO)=N4)=O)=C4C=C3Cl, MDL NA |
| Drug_Names: tert-Butyl 4-aminobenzoate, CAS: 18144-47-3, stock 363.3g, assay 98.7%, MWt 193.24, Formula C11H15NO2, Purity >98%, SMILES O=C(C(C=C1)=CC=C1N)OC(C)(C)C, MDL MFCD00665790 |
| Drug_Names: 4-(Prop-2-ynylamino)-N-(pyridin-3-ylmethyl)benzamide, CAS: 1258400-21-3, stock 582.4g, assay 98.5%, MWt 265.31, Formula C16H15N3O, Purity >98%, SMILES C#CCNC1=CC=C(C=C1)C(NCC2=CC=CN=C2)=O, MDL NA |
| Drug_Names: 4-Amino-N-(pyridin-3-ylmethyl)benzamide, CAS: 491615-37-3, stock 784.2g, assay 98%, MWt 227.26, Formula C13H13N3O, Purity >98%, SMILES O=C(C(C=C1)=CC=C1N)NCC2=CC=CN=C2, MDL NA |
| Drug_Names: Ethyl 4-(prop-2-ynylamino)benzoate, CAS: 101248-36-6, stock 342.1g, assay 98.4%, MWt 203.24, Formula C12H13NO2, Purity >98%, SMILES C#CCNC1=CC=C(C=C1)C(OCC)=O, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl pyrrolidine-1,3-dicarboxylate, CAS: 122684-33-7, stock 879.2g, assay 98.2%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES O=C(OC(C)(C)C)N(CC1)CC1C(OC)=O, MDL MFCD04038683 |
| Drug_Names: (R)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, CAS: 58349-15-8, stock 358.6g, assay 98.3%, MWt 213.70, Formula C11H16ClNO, Purity >98%, SMILES N[C@H]1CC2=C(C(OC)=CC=C2)CC1.Cl, MDL NA |
| Drug_Names: (R)-1,2,3,4-Tetrahydro-5-methoxy-n-propyl-2-naphthalenamine hydrochloride, CAS: 93601-85-5, stock 679.6g, assay 98.5%, MWt 255.78, Formula C14H22ClNO, Purity >98%, SMILES COC1=CC=CC2=C1CC[C@@H](NCCC)C2.Cl, MDL NA |
| Drug_Names: 2-(4-Acetamidophenyl)acetic acid, CAS: 18699-02-0, stock 101.6g, assay 98.1%, MWt 193.20, Formula C10H11NO3, Purity >98%, SMILES O=C(C)NC(C=C1)=CC=C1CC(O)=O, MDL MFCD00196165 |
| Drug_Names: trans-4-Acetamidocyclohexaneacetic acid, CAS: 2901-44-2, stock 254.6g, assay 98.4%, MWt 199.25, Formula C10H17NO3, Purity >98%, SMILES O=C(C)N[C@H](CC1)CC[C@@H]1CC(O)=O, MDL NA |
| Drug_Names: (E)-1-methoxy-3-(2-nitrovinyl)benzene, CAS: 55446-68-9, stock 780.6g, assay 98.7%, MWt 179.17, Formula C9H9NO3, Purity >98%, SMILES COC1=CC(/C=C/[N+]([O-])=O)=CC=C1, MDL NA |
| Drug_Names: tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 158984-83-9, stock 41.9g, assay 98.3%, MWt 249.31, Formula C14H19NO3, Purity >98%, SMILES O=C(OC(C)(C)C)N1CC(C=C2)=C(C=C2O)CC1, MDL MFCD08275034 |
| Drug_Names: tert-Butyl 6-(trifluoromethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 158984-84-0, stock 132.7g, assay 98.4%, MWt 381.37, Formula C15H18F3NO5S, Purity >98%, SMILES O=S(C(F)(F)F)(OC1=CC2=C(C=C1)CN(CC2)C(OC(C)(C)C)=O)=O, MDL NA |
| Drug_Names: Ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate, CAS: 51656-91-8, stock 667.9g, assay 98.9%, MWt 226.27, Formula C12H18O4, Purity >98%, SMILES O=C(OCC)/C=C1CCC2(CC/1)OCCO2, MDL MFCD07779434 |
| Drug_Names: Ethyl 2-(1,4-dioxaspiro[4.5]decan-8-yl)acetate, CAS: 62141-26-8, stock 425.2g, assay 98.7%, MWt 228.28, Formula C12H20O4, Purity >98%, SMILES O=C(OCC)CC1CCC2(CC1)OCCO2, MDL NA |
| Drug_Names: tert-Butyl 6-cyano-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 166398-33-0, stock 356.1g, assay 98%, MWt 258.32, Formula C15H18N2O2, Purity >98%, SMILES N#CC1=CC2=C(C=C1)CN(CC2)C(OC(C)(C)C)=O, MDL MFCD11043755 |
| Drug_Names: Ethyl 2-(4-aminocyclohexyl)acetate, CAS: 343775-23-5, stock 292.3g, assay 99%, MWt 185.26, Formula C10H19NO2, Purity >98%, SMILES O=C(OCC)CC1CCC(CC1)N, MDL NA |
| Drug_Names: (R)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one (Hydrochloride), CAS: 1429311-47-6, stock 820.1g, assay 98.1%, MWt 327.76, Formula C14H18ClN3O4, Purity >98%, SMILES O=C(O[C@@H]1CN)N(C1)C(C=C2)=CC=C2N3C(COCC3)=O.Cl, MDL NA |
| Drug_Names: 4-Chloro-7-ethoxy-6,8-dinitroquinoline-3-carbonitrile, CAS: 1415564-65-6, stock 95.1g, assay 98.3%, MWt 322.66, Formula C12H7ClN4O5, Purity >98%, SMILES CCOC1=C([N+]([O-])=O)C=C2C(N=CC(C#N)=C2Cl)=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Chloro-10,11-dihydrodibenzo[b,f]oxepin-10-ol, CAS: 1415559-87-3, stock 790.9g, assay 98.8%, MWt 246.69, Formula C14H11ClO2, Purity >98%, SMILES OC1C2=CC=CC=C2OC3=C(C=C(Cl)C=C3)C1, MDL NA |
| Drug_Names: 2-Methyl-2-(4-vinylphenyl)propanoic acid, CAS: 1256584-72-1, stock 137.7g, assay 98.1%, MWt 190.24, Formula C12H14O2, Purity >98%, SMILES O=C(O)C(C)(C)C(C=C1)=CC=C1C=C, MDL NA |
| Drug_Names: 9-Ethyl-8-iodo-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile, CAS: 1256584-80-1, stock 292.7g, assay 98.9%, MWt 440.28, Formula C21H17IN2O, Purity >98%, SMILES N#CC1=CC=C2C(C(C3=C4C=C(I)C(CC)=C3)=O)=C(C(C)4C)NC2=C1, MDL NA |
| Drug_Names: Ethyl 3-(3,5-dichlorophenyl)-3-oxopropanoate, CAS: 172168-01-3, stock 827.4g, assay 98.2%, MWt 261.10, Formula C11H10Cl2O3, Purity >98%, SMILES O=C(C1=CC(Cl)=CC(Cl)=C1)CC(OCC)=O, MDL MFCD03424831 |
| Drug_Names: (S)-ethyl 4-(1-(3-(3,5-dichlorophenyl)-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)ethyl)benzoate, CAS: 870823-08-8, stock 193.5g, assay 98.8%, MWt 405.27, Formula C20H18Cl2N2O3, Purity >98%, SMILES O=C(C1)N([C@@H](C)C2=CC=C(C=C2)C(OCC)=O)N=C1C3=CC(Cl)=CC(Cl)=C3, MDL NA |
| Drug_Names: (S)-ethyl 4-(1-(3-(3,5-dichlorophenyl)-5-(trifluoromethylsulfonyloxy)-1H-pyrazol-1-yl)ethyl)benzoate, CAS: 870823-09-9, stock 693.1g, assay 98.2%, MWt 537.34, Formula C21H17Cl2F3N2O5S, Purity >98%, SMILES O=S(OC1=CC(C2=CC(Cl)=CC(Cl)=C2)=NN1[C@@H](C)C3=CC=C(C=C3)C(OCC)=O)(C(F)(F)F)=O, MDL NA |
| Drug_Names: (S)-ethyl 4-(1-(3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzoate, CAS: 870823-10-2, stock 882.7g, assay 98.5%, MWt 545.46, Formula C31H26Cl2N2O3, Purity >98%, SMILES O=C(OCC)C(C=C1)=CC=C1[C@H](C)N(C(C(C=C2)=CC(C2=C3)=CC=C3OC)=C4)N=C4C5=CC(Cl)=CC(Cl)=C5, MDL NA |
| Drug_Names: (S)-4-(1-(3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzoic acid, CAS: 870823-11-3, stock 360.9g, assay 98.7%, MWt 517.40, Formula C29H22Cl2N2O3, Purity >98%, SMILES O=C(O)C(C=C1)=CC=C1[C@H](C)N(C(C(C=C2)=CC(C2=C3)=CC=C3OC)=C4)N=C4C5=CC(Cl)=CC(Cl)=C5, MDL NA |
| Drug_Names: 6-Methoxynaphthalen-2-ylboronic acid, CAS: 156641-98-4, stock 368.3g, assay 98.7%, MWt 202.01, Formula C11H11BO3, Purity >98%, SMILES OB(O)C(C=C1)=CC(C1=C2)=CC=C2OC, MDL MFCD03093087 |
| Drug_Names: Ethyl 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylate (dihydrochloride), CAS: 163521-09-3, stock 464.6g, assay 99%, MWt 543.48, Formula C28H32Cl2N4O3, Purity >98%, SMILES O=C(OCC)C1=CC2=CC(N(CC3)CCN3CCCCC4=CNC5=CC=C(C#N)C=C54)=CC=C2O1.Cl.Cl, MDL NA |
| Drug_Names: (S)-2-Methylpyrrolidine-2-carboxylic acid, CAS: 42856-71-3, stock 198.3g, assay 99%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES C[C@@]1(C(O)=O)CCCN1, MDL MFCD01318647 |
| Drug_Names: 2-(3,4-dimethoxybenzyl)-7-((2S,3S)-2-hydroxy-6-phenylhexan-3-yl)-5-methylimidazo[1,5-f][1,2,4]triazin-4(3H)-one, CAS: 439083-91-7, stock 590.4g, assay 98.4%, MWt 476.57, Formula C27H32N4O4, Purity >98%, SMILES O=C(N1)C(N(N=C1CC2=CC=C(OC)C(OC)=C2)C([C@H](CCCC3=CC=CC=C3)[C@H](C)O)=N4)=C4C, MDL NA |
| Drug_Names: (R)-1-(Naphthalen-1-yl)ethanamine hydrochloride, CAS: 82572-04-1, stock 701.4g, assay 98.6%, MWt 207.70, Formula C12H14ClN, Purity >98%, SMILES N[C@H](C)C1=CC=CC2=C1C=CC=C2.Cl, MDL MFCD07369798 |
| Drug_Names: (2-Butylbenzofuran-3-yl)(4-methoxyphenyl)methanone, CAS: 83790-87-8, stock 201.3g, assay 98.7%, MWt 308.37, Formula C20H20O3, Purity >98%, SMILES O=C(C(C=C1)=CC=C1OC)C2=C(CCCC)OC3=CC=CC=C23, MDL NA |
| Drug_Names: (S)-tert-Butyl 1-hydroxyhexan-2-ylcarbamate, CAS: 116640-16-5, stock 730.3g, assay 98.2%, MWt 217.31, Formula C11H23NO3, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@@H](CCCC)CO, MDL NA |
| Drug_Names: N-Cyclopropylformamide, CAS: 58644-54-5, stock 731.3g, assay 98.9%, MWt 85.10, Formula C4H7NO, Purity >98%, SMILES O=CNC1CC1, MDL MFCD07774134 |
| Drug_Names: (S)-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide, CAS: 1415566-28-7, stock 536.8g, assay 98.1%, MWt 401.44, Formula C19H19N3O5S, Purity >98%, SMILES O=C(O[C@H]1CNC(C2=CC=CS2)=O)N(C1)C(C=C3)=CC=C3N4C(COCC4)=O, MDL NA |
| Drug_Names: (2S,3S,4S,5R,6S)-3,4,5-tris(benzyloxy)-2-(iodomethyl)-6-methoxytetrahydro-2H-pyran, CAS: 85716-43-4, stock 405g, assay 98.3%, MWt 574.45, Formula C28H31IO5, Purity >98%, SMILES IC[C@H]1O[C@H](OC)[C@H](OCC2=CC=CC=C2)[C@@H](OCC3=CC=CC=C3)[C@@H]1OCC4=CC=CC=C4, MDL NA |
| Drug_Names: 2-Methyl-1-(naphthalen-2-yl)-2-nitropropan-1-ol, CAS: 77740-81-9, stock 370.7g, assay 98.1%, MWt 245.27, Formula C14H15NO3, Purity >98%, SMILES OC(C([N+]([O-])=O)(C)C)C1=CC=C2C=CC=CC2=C1, MDL NA |
| Drug_Names: (S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoic acid, CAS: 1208245-85-5, stock 852.6g, assay 98.5%, MWt 390.54, Formula C18H34N2O5S, Purity >98%, SMILES O=S(CC1(CCCCC1)NC(N[C@@H](C(C)(C)C)C(O)=O)=O)(C(C)(C)C)=O, MDL NA |
| Drug_Names: (1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, CAS: 1229337-32-9, stock 259.2g, assay 98.6%, MWt 527.72, Formula C26H45N3O6S, Purity >98%, SMILES O=S(CC1(CCCCC1)NC(N[C@@H](C(C)(C)C)C(N2[C@H](C(O)=O)[C@@H]3[C@H](C2)C(C)3C)=O)=O)(C(C)(C)C)=O, MDL NA |
| Drug_Names: (1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-N-((3S)-1-(cyclopropylamino)-2-hydroxy-1-oxoheptan-3-yl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, CAS: 1208245-90-2, stock 344.6g, assay 98.8%, MWt 709.98, Formula C36H63N5O7S, Purity >98%, SMILES O=S(CC1(CCCCC1)NC(N[C@@H](C(C)(C)C)C(N2[C@H](C(N[C@@H](CCCC)C(O)C(NC3CC3)=O)=O)[C@@H]4[C@H](C2)C(C)4C)=O)=O)(C(C)(C)C)=O, MDL NA |
| Drug_Names: 3-Bromoimidazo[1,2-a]pyridine, CAS: 4926-47-0, stock 76.6g, assay 98.8%, MWt 197.03, Formula C7H5BrN2, Purity >98%, SMILES BrC1=CN=C2N1C=CC=C2, MDL MFCD00014556 |
| Drug_Names: (S)-2-methylpyrrolidine-2-carboxylic acid hydrochloride, CAS: 1508261-86-6, stock 567.5g, assay 98.7%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES C[C@@]1(C(O)=O)CCCN1.Cl, MDL NA |
| Drug_Names: (3aS,4S,5S,6R,7aS)-4-(ethoxycarbonyl)-6-ethyl-1-oxooctahydro-1H-indene-5-carboxylic acid, CAS: 130274-13-4, stock 883.2g, assay 98.4%, MWt 282.33, Formula C15H22O5, Purity >98%, SMILES O=C(OCC)[C@H]([C@H]1C(O)=O)[C@](CC2)([H])[C@](C2=O)([H])C[C@H]1CC, MDL NA |
| Drug_Names: 5-Hydroxy-3,4-dihydronaphthalen-1(2H)-one, CAS: 28315-93-7, stock 323.3g, assay 98%, MWt 162.19, Formula C10H10O2, Purity >98%, SMILES O=C1C2=CC=CC(O)=C2CCC1, MDL MFCD00001693 |
| Drug_Names: 2-(Benzylamino)cyclohexanol, CAS: 51925-39-4, stock 473.2g, assay 98.2%, MWt 205.30, Formula C13H19NO, Purity >98%, SMILES OC1C(NCC2=CC=CC=C2)CCCC1, MDL MFCD00451976 |
| Drug_Names: (1R,2R)-2-(benzylamino)cyclohexanol (2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate, CAS: 1106691-66-0, stock 511.5g, assay 98.1%, MWt 978.00, Formula C53H55NO17, Purity >98%, SMILES O=C(O)[C@@H]([C@H](C(O)=O)OC(C1=CC=C(C)C=C1)=O)OC(C2=CC=C(C)C=C2)=O.O[C@H]3[C@H](NCC4=CC=CC=C4)CCCC3.O=C(O)[C@@H]([C@H](C(O)=O)OC(C5=CC=C(C)C=C5)=O)OC(C6=CC=C(C)C=C6)=O, MDL NA |
| Drug_Names: benzyl benzyl((1R,2R)-2-hydroxycyclohexyl)carbamate, CAS: 906802-32-2, stock 212.2g, assay 98.5%, MWt 339.43, Formula C21H25NO3, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N(CC2=CC=CC=C2)[C@H](CCCC3)[C@@H]3O, MDL NA |
| Drug_Names: (R)-2,5-Dioxotetrahydrofuran-3-yl acetate, CAS: 79814-40-7, stock 543g, assay 98.3%, MWt 158.11, Formula C6H6O5, Purity >98%, SMILES O=C([C@@H]1OC(C)=O)OC(C1)=O, MDL MFCD00145214 |
| Drug_Names: 5-Iodoindolin-2-one, CAS: 193354-13-1, stock 199.5g, assay 98%, MWt 259.04, Formula C8H6INO, Purity >98%, SMILES O=C1NC2=CC=C(I)C=C2C1, MDL MFCD08669500 |
| Drug_Names: Diethyl 2-((4-chlorophenylamino)methylene)malonate, CAS: 19056-79-2, stock 431.4g, assay 98.3%, MWt 297.73, Formula C14H16ClNO4, Purity >98%, SMILES O=C(OCC)/C(C(OCC)=O)=C/NC1=CC=C(Cl)C=C1, MDL NA |
| Drug_Names: Ethyl 6-bromo-4-(4-methyl-3-nitrophenylamino)quinoline-3-carboxylate, CAS: 1415562-32-1, stock 381.8g, assay 98.7%, MWt 430.25, Formula C19H16BrN3O4, Purity >98%, SMILES O=C(OCC)C1=C(NC2=CC=C(C)C([N+]([O-])=O)=C2)C3=CC(Br)=CC=C3N=C1, MDL NA |
| Drug_Names: 1-(3-Amino-4-methylphenyl)-9-bromobenzo[h][1,6]naphthyridin-2(1H)-one, CAS: 1415565-13-7, stock 699.9g, assay 98.2%, MWt 380.24, Formula C19H14BrN3O, Purity >98%, SMILES O=C(C=C1)N(C2=CC=C(C)C(N)=C2)C3=C1C=NC4=CC=C(Br)C=C34, MDL NA |
| Drug_Names: 1-(3-amino-4-methylphenyl)-9-(furan-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one, CAS: 1415564-67-8, stock 415.6g, assay 98.3%, MWt 367.40, Formula C23H17N3O2, Purity >98%, SMILES O=C(C=C1)N(C2=CC=C(C)C(N)=C2)C(C3=C4)=C1C=NC3=CC=C4C5=COC=C5, MDL NA |
| Drug_Names: (R)-benzyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate, CAS: 196601-68-0, stock 101.7g, assay 98.3%, MWt 342.39, Formula C19H22N2O4, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N[C@H](COC)C(NCC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: (R)-benzyl 1-(benzylamino)-3-hydroxy-1-oxopropan-2-ylcarbamate, CAS: 219835-31-1, stock 265.1g, assay 98.8%, MWt 328.36, Formula C18H20N2O4, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N[C@H](CO)C(NCC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: 5-Methoxy-2-nitroaniline, CAS: 16133-49-6, stock 203.2g, assay 98.4%, MWt 168.15, Formula C7H8N2O3, Purity >98%, SMILES [O-][N+](C1=CC=C(OC)C=C1N)=O, MDL MFCD00179573 |
| Drug_Names: (S)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol, CAS: 260389-90-0, stock 422g, assay 98.8%, MWt 341.49, Formula C22H31NO2, Purity >98%, SMILES OCC1=CC([C@H](C2=CC=CC=C2)CCN(C(C)C)C(C)C)=C(C=C1)O, MDL NA |
| Drug_Names: (Z)-3-chloro-3-(3-fluorophenyl)acrylonitrile, CAS: 1192875-03-8, stock 730.9g, assay 98.7%, MWt 181.59, Formula C9H5ClFN, Purity >98%, SMILES FC1=CC(/C(Cl)=C/C#N)=CC=C1, MDL NA |
| Drug_Names: (S)-tert-Butyl 3-(3-amino-5-(3-fluorophenyl)thiophene-2-carboxamido)piperidine-1-carboxylate, CAS: 1192875-04-9, stock 558.1g, assay 98.4%, MWt 419.51, Formula C21H26FN3O3S, Purity >98%, SMILES O=C(C1=C(C=C(S1)C2=CC=CC(F)=C2)N)N[C@H]3CCCN(C3)C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: 5-Chlorobenzo[d]oxazole-2-thiol, CAS: 22876-19-3, stock 862.8g, assay 98%, MWt 185.63, Formula C7H4ClNOS, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC(S)=N2, MDL MFCD00175241 |
| Drug_Names: tert-Butyl (2-((5-chlorobenzo[d]oxazol-2-yl)amino)ethyl)carbamate, CAS: 1144509-75-0, stock 459.8g, assay 98.5%, MWt 311.76, Formula C14H18ClN3O3, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC(NCCNC(OC(C)(C)C)=O)=N2, MDL MFCD22124906 |
| Drug_Names: 5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid, CAS: 956317-36-5, stock 290.4g, assay 98.1%, MWt 203.20, Formula C10H9N3O2, Purity >98%, SMILES O=C(C1=C(C=CC(C)=C1)N2N=CC=N2)O, MDL MFCD18382679 |
| Drug_Names: 5-Methyl-2-(1H-1,2,3-triazol-1-yl)benzoic acid, CAS: 1149352-55-5, stock 483.7g, assay 98.9%, MWt 203.20, Formula C10H9N3O2, Purity >98%, SMILES O=C(C1=C(C=CC(C)=C1)N2N=NC=C2)O, MDL NA |
| Drug_Names: tert-Butyl 2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)amino)ethylcarbamate, CAS: 1276666-10-4, stock 587.3g, assay 98.8%, MWt 381.85, Formula C18H24ClN3O4, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC(N(CCNC(OC(C)(C)C)=O)CCC(C)=O)=N2, MDL NA |
| Drug_Names: 4-((2-aminoethyl)(5-chlorobenzo[d]oxazol-2-yl)amino)butan-2-one dimethanesulfonate, CAS: 1276666-12-6, stock 519.5g, assay 98.4%, MWt 473.95, Formula C15H24ClN3O8S2, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC(N(CCN)CCC(C)=O)=N2.O=S(O)(C)=O.O=S(O)(C)=O, MDL NA |
| Drug_Names: (R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole (2S,3S)-2,3-bis(benzoyloxy)succinate, CAS: 1276666-14-8, stock 538.4g, assay 98.8%, MWt 624.04, Formula C31H30ClN3O9, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC(N3CCN[C@@H](CC3)C)=N2.O=C(O)[C@@H](OC(C4=CC=CC=C4)=O)[C@H](OC(C5=CC=CC=C5)=O)C(O)=O, MDL NA |
| Drug_Names: (R)-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole, CAS: 1266975-27-2, stock 634.3g, assay 98.5%, MWt 265.74, Formula C13H16ClN3O, Purity >98%, SMILES ClC1=CC2=C(C=C1)OC(N3CCN[C@@H](CC3)C)=N2, MDL MFCD22124911 |
| Drug_Names: 2-(Benzo[d]thiazol-2-yl)-2-(2-chloropyrimidin-4-yl)acetonitrile, CAS: 345986-38-1, stock 892.8g, assay 98.3%, MWt 286.74, Formula C13H7ClN4S, Purity >98%, SMILES ClC1=NC(C(C2=NC3=CC=CC=C3S2)C#N)=CC=N1, MDL NA |
| Drug_Names: Methyl 4-(morpholinomethyl)benzoate, CAS: 68453-56-5, stock 600g, assay 98.7%, MWt 235.28, Formula C13H17NO3, Purity >98%, SMILES O=C(C1=CC=C(C=C1)CN2CCOCC2)OC, MDL NA |
| Drug_Names: (4-(Morpholinomethyl)phenyl)methanol, CAS: 91271-65-7, stock 97.3g, assay 98.3%, MWt 207.27, Formula C12H17NO2, Purity >98%, SMILES OCC1=CC=C(C=C1)CN2CCOCC2, MDL NA |
| Drug_Names: Methyl 4-(2-methoxy-2-oxoethyl)benzoate, CAS: 52787-14-1, stock 465.8g, assay 98.5%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES O=C(CC1=CC=C(C=C1)C(OC)=O)OC, MDL MFCD07779210 |
| Drug_Names: 2-hydroxy-6-methylnicotinonitrile, CAS: 4241-27-4, stock 47.7g, assay 98.9%, MWt 134.14, Formula C7H6N2O, Purity >98%, SMILES OC1=C(C=CC(C)=N1)C#N, MDL NA |
| Drug_Names: 2-Chloro-6-methylnicotinonitrile, CAS: 28900-10-9, stock 83.3g, assay 98.7%, MWt 152.58, Formula C7H5ClN2, Purity >98%, SMILES ClC1=C(C=CC(C)=N1)C#N, MDL MFCD00082767 |
| Drug_Names: Ethyl 5-aminobenzofuran-2-carboxylate, CAS: 174775-48-5, stock 253.9g, assay 98.9%, MWt 205.21, Formula C11H11NO3, Purity >98%, SMILES NC1=CC=C2OC(C(OCC)=O)=CC2=C1, MDL MFCD08275091 |
| Drug_Names: N-(biphenyl-2-yl)-2-chloro-N-methylacetamide, CAS: 955879-95-5, stock 201.4g, assay 98.1%, MWt 259.73, Formula C15H14ClNO, Purity >98%, SMILES CN(C1=CC=CC=C1C2=CC=CC=C2)C(CCl)=O, MDL NA |
| Drug_Names: 2-Hydroxy-N,N-dimethyl-3-nitrobenzamide, CAS: 66952-65-6, stock 785.6g, assay 98.1%, MWt 210.19, Formula C9H10N2O4, Purity >98%, SMILES OC1=C(C=CC=C1C(N(C)C)=O)[N+]([O-])=O, MDL NA |
| Drug_Names: (R)-1-(5-Methylfuran-2-yl)propan-1-amine hydrochloride, CAS: 779340-50-0, stock 338.1g, assay 98.9%, MWt 175.66, Formula C8H14ClNO, Purity >98%, SMILES CC1=CC=C(O1)[C@@H](CC)N.Cl, MDL MFCD22124917 |
| Drug_Names: (S)-ethyl 2-amino-4-fluoro-4-methylpentanoate, CAS: 156047-39-1, stock 17.1g, assay 98.4%, MWt 177.22, Formula C8H16FNO2, Purity >98%, SMILES N[C@H](C(OCC)=O)CC(F)(C)C, MDL NA |
| Drug_Names: (S)-4-fluoro-4-methyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanoic acid, CAS: 875272-89-2, stock 138g, assay 98.5%, MWt 461.47, Formula C21H23F4NO4S, Purity >98%, SMILES O=S(C1=CC=C(C=C1)C2=CC=C(C=C2)[C@H](N[C@H](C(O)=O)CC(F)(C)C)C(F)(F)F)(C)=O, MDL NA |
| Drug_Names: 1-(4-Bromophenyl)-2,2,2-trifluoroethanone, CAS: 16184-89-7, stock 301.8g, assay 99%, MWt 253.02, Formula C8H4BrF3O, Purity >98%, SMILES BrC1=CC=C(C=C1)C(C(F)(F)F)=O, MDL MFCD00191862 |
| Drug_Names: 2,2,2-Trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethanone, CAS: 893407-18-6, stock 370.3g, assay 98.9%, MWt 328.31, Formula C15H11F3O3S, Purity >98%, SMILES FC(F)(F)C(C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(C)=O)=O, MDL NA |
| Drug_Names: (S)-ethyl 4-fluoro-4-methyl-2-(pent-4-enamido)pentanoate, CAS: 848949-92-8, stock 332g, assay 98.5%, MWt 259.32, Formula C13H22FNO3, Purity >98%, SMILES CC(C)(F)C[C@@H](C(OCC)=O)NC(CCC=C)=O, MDL NA |
| Drug_Names: (S)-Ethyl 2-amino-4-fluoro-4-methylpentanoate sulfate, CAS: 848949-85-9, stock 637.7g, assay 98.9%, MWt 275.30, Formula C8H18FNO6S, Purity >98%, SMILES N[C@H](C(OCC)=O)CC(F)(C)C.O=S(O)(O)=O, MDL NA |
| Drug_Names: (S)-2-((S)-1-(4-bromophenyl)-2,2,2-trifluoroethylamino)-4-fluoro-4-methylpentanoic acid, CAS: 847358-98-9, stock 818.8g, assay 98.1%, MWt 386.18, Formula C14H16BrF4NO2, Purity >98%, SMILES BrC1=CC=C(C=C1)[C@H](N[C@H](C(O)=O)CC(F)(C)C)C(F)(F)F, MDL NA |
| Drug_Names: 4,4,5,5-Tetramethyl-2-(4-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane, CAS: 603143-27-7, stock 116g, assay 98.7%, MWt 282.16, Formula C13H19BO4S, Purity >98%, SMILES O=S(C1=CC=C(C=C1)B2OC(C)(C(C)(O2)C)C)(C)=O, MDL MFCD05863921 |
| Drug_Names: 1-(4-Bromophenyl)-2,2,2-trifluoroethanol, CAS: 76911-73-4, stock 590.6g, assay 98.2%, MWt 255.03, Formula C8H6BrF3O, Purity >98%, SMILES BrC1=CC=C(C=C1)C(C(F)(F)F)O, MDL MFCD12786801 |
| Drug_Names: Ethyl 4-fluoro-4-methyl-2-pent-4-enamidopentanoate, CAS: 1000995-94-7, stock 710.4g, assay 98.8%, MWt 259.32, Formula C13H22FNO3, Purity >98%, SMILES CC(CC(NC(CCC=C)=O)C(OCC)=O)(C)F, MDL NA |
| Drug_Names: 4-Fluoro-4-methyl-2-(2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanoic acid, CAS: 1415559-56-6, stock 326.5g, assay 98%, MWt 461.47, Formula C21H23F4NO4S, Purity >98%, SMILES O=S(C1=CC=C(C=C1)C2=CC=C(C=C2)C(NC(C(O)=O)CC(F)(C)C)C(F)(F)F)(C)=O, MDL NA |
| Drug_Names: (R)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate (2R,3R)-2,3-dihydroxysuccinate, CAS: 239463-85-5, stock 696.9g, assay 98.2%, MWt 513.54, Formula C26H31N3O8, Purity >98%, SMILES O=C(OCCCN1CCC2=C1C(C#N)=CC(C[C@H](N)C)=C2)C3=CC=CC=C3.OC([C@@H]([C@H](C(O)=O)O)O)=O, MDL MFCD16038449 |
| Drug_Names: 2-[2-Trifluoroethoxyphenoxy]ethyl methanesulfonate, CAS: 160969-03-9, stock 635.1g, assay 98.1%, MWt 314.28, Formula C11H13F3O5S, Purity >98%, SMILES FC(F)(COC1=CC=CC=C1OCCOS(C)(=O)=O)F, MDL NA |
| Drug_Names: Benzyl azepan-3-ylcarbamate, CAS: 1044561-15-0, stock 697g, assay 98.8%, MWt 248.32, Formula C14H20N2O2, Purity >98%, SMILES O=C(NC1CNCCCC1)OCC2=CC=CC=C2, MDL MFCD19687081 |
| Drug_Names: 3-Aminoazepan-2-one hydrochloride, CAS: 29426-64-0, stock 165.9g, assay 98.8%, MWt 164.63, Formula C6H13ClN2O, Purity >98%, SMILES O=C1NCCCCC1N.Cl, MDL MFCD06798179 |
| Drug_Names: Benzyl 2-oxoazepan-3-ylcarbamate, CAS: 108875-45-2, stock 602.2g, assay 99%, MWt 262.30, Formula C14H18N2O3, Purity >98%, SMILES O=C1NCCCCC1NC(OCC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: (S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetic acid, CAS: 848777-30-0, stock 789.7g, assay 98.9%, MWt 263.29, Formula C13H17N3O3, Purity >98%, SMILES O=C(C1=CN=CC=N1)N[C@@H](C2CCCCC2)C(O)=O, MDL MFCD21496260 |
| Drug_Names: N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide, CAS: 301675-24-1, stock 846.6g, assay 98.6%, MWt 282.25, Formula C14H10N4O3, Purity >98%, SMILES O=C(NC1=NC2=CC=CC=C2N1)C3=CC=CC([N+]([O-])=O)=C3, MDL NA |
| Drug_Names: 6-Bromo-N-methyl-2-naphthamide, CAS: 426219-35-4, stock 793.8g, assay 98.1%, MWt 264.12, Formula C12H10BrNO, Purity >98%, SMILES BrC1=CC2=CC=C(C=C2C=C1)C(NC)=O, MDL NA |
| Drug_Names: N-methyl-6-(1-trityl-1H-imidazole-4-carbonyl)-2-naphthamide, CAS: 337521-39-8, stock 381.8g, assay 98.5%, MWt 521.61, Formula C35H27N3O2, Purity >98%, SMILES O=C(C1=CC=C2C(C=CC(C(C3=CN(C=N3)C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)=O)=C2)=C1)NC, MDL NA |
| Drug_Names: (S)-6-(1,3-dihydroxy-1-(1-trityl-1H-imidazol-4-yl)propyl)-N-methyl-2-naphthamide, CAS: 566200-79-1, stock 896g, assay 98.7%, MWt 567.68, Formula C37H33N3O3, Purity >98%, SMILES O=C(C1=CC=C2C(C=CC([C@@](CCO)(C3=CN(C=N3)C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)O)=C2)=C1)NC, MDL NA |
| Drug_Names: Ethyl 2-(3-(benzylamino)oxetan-3-yl)acetate, CAS: 1207175-55-0, stock 123.1g, assay 98.8%, MWt 249.31, Formula C14H19NO3, Purity >98%, SMILES O=C(CC1(COC1)NCC2=CC=CC=C2)OCC, MDL NA |
| Drug_Names: 2-(3-(Benzylamino)oxetan-3-yl)ethanol, CAS: 1223573-34-9, stock 833.8g, assay 99%, MWt 207.27, Formula C12H17NO2, Purity >98%, SMILES OCCC1(COC1)NCC2=CC=CC=C2, MDL NA |
| Drug_Names: 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one, CAS: 503615-03-0, stock 283.7g, assay 98.5%, MWt 303.31, Formula C15H17N3O4, Purity >98%, SMILES O=C1C(N2CCOCC2)=CCCN1C3=CC=C(C=C3)[N+]([O-])=O, MDL MFCD19440872 |
| Drug_Names: 2-Methylbenzenemethanamine, CAS: 89-93-0, stock 457.2g, assay 98.2%, MWt 121.18, Formula C8H11N, Purity >98%, SMILES CC1=CC=CC=C1CN, MDL MFCD00008112 |
| Drug_Names: 1H-indole-5-carbonitrile, CAS: 15861-24-2, stock 40g, assay 98.2%, MWt 142.16, Formula C9H6N2, Purity >98%, SMILES N#CC1=CC=C2NC=CC2=C1, MDL MFCD00005669 |
| Drug_Names: Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate, CAS: 163521-20-8, stock 236.4g, assay 98.6%, MWt 274.32, Formula C15H18N2O3, Purity >98%, SMILES O=C(C1=CC2=CC(N3CCNCC3)=CC=C2O1)OCC, MDL MFCD18252307 |
| Drug_Names: 5-Bromo-3-iodoindazole, CAS: 459133-66-5, stock 27.6g, assay 98.5%, MWt 322.93, Formula C7H4BrIN2, Purity >98%, SMILES BrC1=CC2=C(NN=C2I)C=C1, MDL MFCD07781637 |
| Drug_Names: 5-Bromo-3-iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole, CAS: 918440-14-9, stock 179.7g, assay 98.3%, MWt 453.19, Formula C13H18BrIN2OSi, Purity >98%, SMILES IC1=NN(COCC[Si](C)(C)C)C2=C1C=C(Br)C=C2, MDL NA |
| Drug_Names: 5-Bromo-3-iodo-2-((2-(trimethylsilyl)ethoxy)methyl)-2H-indazole, CAS: 1012104-27-6, stock 382.2g, assay 98.8%, MWt 453.19, Formula C13H18BrIN2OSi, Purity >98%, SMILES IC1=C2C=C(Br)C=CC2=NN1COCC[Si](C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 4-hydroxy-4-(2-(oxiran-2-yl)ethyl)piperidine-1-carboxylate, CAS: 1415562-31-0, stock 658.9g, assay 98.7%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES OC1(CCC2CO2)CCN(C(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: tert-Butyl 4-(but-3-enyl)-4-hydroxypiperidine-1-carboxylate, CAS: 1415560-15-4, stock 521.4g, assay 98%, MWt 255.35, Formula C14H25NO3, Purity >98%, SMILES OC1(CCC=C)CCN(C(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: 1-Boc-4-allyl-4-hydroxypiperidine, CAS: 203662-51-5, stock 56.9g, assay 98.2%, MWt 241.33, Formula C13H23NO3, Purity >98%, SMILES OC1(CC=C)CCN(C(OC(C)(C)C)=O)CC1, MDL MFCD09910310 |
| Drug_Names: tert-Butyl 4-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate, CAS: 374796-29-9, stock 280.2g, assay 98.2%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES OC(CCO1)CC21CCN(C(OC(C)(C)C)=O)CC2, MDL NA |
| Drug_Names: tert-Butyl 1-oxa-9-azaspiro[5.5]undec-3-ene-9-carboxylate, CAS: 374795-40-1, stock 315.8g, assay 98.1%, MWt 253.34, Formula C14H23NO3, Purity >98%, SMILES CC(C)(C)OC(N1CCC2(CC=CCO2)CC1)=O, MDL NA |
| Drug_Names: tert-Butyl 4-allyl-4-(allyloxy)piperidine-1-carboxylate, CAS: 374795-39-8, stock 282.1g, assay 98.4%, MWt 281.39, Formula C16H27NO3, Purity >98%, SMILES C=CCC1(OCC=C)CCN(C(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: 4-Fluoro-3-nitrophenyl pivalate, CAS: 1415564-98-5, stock 893.2g, assay 98.6%, MWt 241.22, Formula C11H12FNO4, Purity >98%, SMILES FC1=CC=C(OC(C(C)(C)C)=O)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: (4aS,6aS,6bR,10S,12aR,14bR)-methyl 10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate, CAS: 1721-57-9, stock 597.4g, assay 98.1%, MWt 512.76, Formula C33H52O4, Purity >98%, SMILES CC1(C)[C@@H](OC(C)=O)CC[C@]2(C)C3CC=C4[C@]5([H])CC(C)(C)CC[C@@](C(OC)=O)5CC[C@](C)4[C@@](C)3CCC12, MDL NA |
| Drug_Names: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine, CAS: 380380-60-9, stock 113.4g, assay 98.1%, MWt 226.03, Formula C6H4BrN5, Purity >98%, SMILES BrC1=CN=C(C2=NN=NN2)C=C1, MDL MFCD08062726 |
| Drug_Names: 5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine, CAS: 380380-64-3, stock 87.8g, assay 98.8%, MWt 240.06, Formula C7H6BrN5, Purity >98%, SMILES CN1N=C(C2=NC=C(Br)C=C2)N=N1, MDL MFCD06796604 |
| Drug_Names: (4-(((Benzyloxy)carbonyl)amino)-2-fluorophenyl)boronic acid, CAS: 874290-59-2, stock 121.7g, assay 98.7%, MWt 289.07, Formula C14H13BFNO4, Purity >98%, SMILES OB(C1=CC=C(NC(OCC2=CC=CC=C2)=O)C=C1F)O, MDL MFCD11501249 |
| Drug_Names: Benzyl (3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)carbamate, CAS: 1220910-89-3, stock 467.5g, assay 98.4%, MWt 404.40, Formula C21H17FN6O2, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)NC2=CC=C(C3=CN=C(C4=NN(C)N=N4)C=C3)C(F)=C2, MDL NA |
| Drug_Names: N-(2-methyl-4-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine, CAS: 796738-71-1, stock 447g, assay 98.8%, MWt 307.31, Formula C16H13N5O2, Purity >98%, SMILES CC1=CC([N+]([O-])=O)=CC=C1NC2=NC=CC(C3=CN=CC=C3)=N2, MDL NA |
| Drug_Names: N-(3-methyl-4-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-3-nitrobenzamide, CAS: 1415560-17-6, stock 755.8g, assay 98.9%, MWt 426.43, Formula C23H18N6O3, Purity >98%, SMILES CC1=CC(NC(C2=CC=CC([N+]([O-])=O)=C2)=O)=CC=C1NC3=NC=CC(C4=CN=CC=C4)=N3, MDL NA |
| Drug_Names: 3-(Dimethylamino)-1-(3-pyridinyl)-2-propene-1-one, CAS: 55314-16-4, stock 333.1g, assay 99%, MWt 176.22, Formula C10H12N2O, Purity >98%, SMILES O=C(/C=C/N(C)C)C1=CC=CN=C1, MDL NA |
| Drug_Names: (4aS,6aR,6bR,10S,12aR,14aR,14bR)-methyl 10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-14-oxo-docosahydropicene-4a-carboxylate, CAS: 25493-94-1, stock 36.3g, assay 98.4%, MWt 528.76, Formula C33H52O5, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@]3([C@]24[H])[H])C)C(OC)=O)C)5C)[C@@H](OC(C)=O)CC[C@]1(C)C5CC4=O, MDL NA |
| Drug_Names: Acetyl methyl epithelanthate, CAS: 65023-20-3, stock 369.7g, assay 98.1%, MWt 526.75, Formula C33H50O5, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@@]3([C@]24[H])[H])C)C(OC)=O)C)5C)[C@@H](OC(C)=O)CC[C@]1(C)C5=CC4=O, MDL NA |
| Drug_Names: (4aS,6aR,6bS,10R,12aS,14aR,14bR)-methyl 10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4a-carboxylate, CAS: 65023-19-0, stock 496.7g, assay 98.5%, MWt 484.71, Formula C31H48O4, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@@]3([C@]24[H])[H])C)C(OC)=O)C)5C)[C@H](O)CC[C@]1(C)C5=CC4=O, MDL NA |
| Drug_Names: Methyl 3,12-dioxoolean-9(11)-en-28-oate, CAS: 218600-50-1, stock 545.6g, assay 98.5%, MWt 482.69, Formula C31H46O4, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@@]3([C@]24[H])[H])C)C(OC)=O)C)5C)C(CC[C@]1(C)C5=CC4=O)=O, MDL MFCD13194179 |
| Drug_Names: (4aS,6aR,6bS,12aS,14aR,14bR,Z)-methyl 11-(hydroxymethylene)-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4a-carboxylate, CAS: 305818-39-7, stock 397.2g, assay 98.2%, MWt 510.70, Formula C32H46O5, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@@]3([C@]24[H])[H])C)C(OC)=O)C)5C)C(C(C[C@]1(C)C5=CC4=O)=CO)=O, MDL NA |
| Drug_Names: (4aS,6aR,6bS,13aS,15aR,15bS)-methyl 2,2,6a,6b,9,9,13a-heptamethyl-15-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,13,13a,15,15a,15b-octadecahydropiceno[2,3-d]isoxazole-4a-carboxylate, CAS: 218600-52-3, stock 769.9g, assay 98.3%, MWt 507.70, Formula C32H45NO4, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@@]3([H])[C@]24[H])C)C(OC)=O)C)5C)C(ON=C6)=C6C[C@]1(C)C5=CC4=O, MDL NA |
| Drug_Names: (4aS,6aR,6bS,12aS,14aR,14bR)-methyl 11-cyano-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,12,12a,14,14a,14b-octadecahydropicene-4a-carboxylate, CAS: 305818-40-0, stock 140g, assay 98.1%, MWt 507.70, Formula C32H45NO4, Purity >98%, SMILES CC(C)(C1CC[C@@]([C@@]2(CC[C@]3(CCC(C)(C[C@@]3([C@]24[H])[H])C)C(OC)=O)C)5C)C(O)=C(C#N)C[C@]1(C)C5=CC4=O, MDL NA |
| Drug_Names: Ethyl (1R,2S,4R)-rel-1-azabicyclo[2.2.1]heptane-2-carboxylate, CAS: 921755-43-3, stock 202.9g, assay 98.8%, MWt 169.22, Formula C9H15NO2, Purity >98%, SMILES [H][C@]1(C(OCC)=O)[N@@](C2)CC[C@@H]2C1, MDL NA |
| Drug_Names: 3-Propoxy-1-(tetrahydrofuran-3-yl)but-3-en-2-amine, CAS: 1255237-45-6, stock 634.2g, assay 98.4%, MWt 199.29, Formula C11H21NO2, Purity >98%, SMILES C=C(OCCC)C(N)CC1CCOC1, MDL NA |
| Drug_Names: Ethyl 1-aza-bicyclo[2.2.1]heptane-2-carboxylate, CAS: 646055-79-0, stock 440g, assay 98.9%, MWt 169.22, Formula C9H15NO2, Purity >98%, SMILES CCOC(C1CC2CCN1C2)=O, MDL NA |
| Drug_Names: 2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid, CAS: 1256584-73-2, stock 629g, assay 98.1%, MWt 318.15, Formula C12H15IO2, Purity >98%, SMILES CCC1=CC=C(C(C)(C(O)=O)C)C=C1I, MDL NA |
| Drug_Names: tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate, CAS: 1256584-75-4, stock 186.9g, assay 98%, MWt 514.40, Formula C25H27IN2O2, Purity >98%, SMILES CCC1=CC=C(C(C(NC2=CC(C#N)=CC=C23)=C3C(OC(C)(C)C)=O)(C)C)C=C1I, MDL MFCD22571223 |
| Drug_Names: 2-(4-Bromophenyl)-2-methylpropanoic acid, CAS: 32454-35-6, stock 620.1g, assay 98.2%, MWt 243.10, Formula C10H11BrO2, Purity >98%, SMILES CC(C)(C(O)=O)C1=CC=C(Br)C=C1, MDL MFCD02684220 |
| Drug_Names: Potassium trifluoro(vinyl)borate, CAS: 13682-77-4, stock 309.4g, assay 98.1%, MWt 133.95, Formula C2H3BF3K, Purity >98%, SMILES C=C[B-](F)(F)F.[K+], MDL MFCD02093335 |
| Drug_Names: 2-(tert-Butoxycarbonyl)-4-methoxy-4-oxobutanoic acid, CAS: 856417-64-6, stock 716.2g, assay 98.8%, MWt 247.25, Formula C10H17NO6, Purity >98%, SMILES OC(C(CC(OC)=O)NC(OC(C)(C)C)=O)=O, MDL MFCD16619508 |
| Drug_Names: 1-Benzyl 4-methyl 2-(tert-butoxycarbonyl)succinate, CAS: 1050238-07-7, stock 448.5g, assay 98.9%, MWt 337.37, Formula C17H23NO6, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)C(CC(OC)=O)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: Dibenzyl 2-fluoromalonate, CAS: 133384-81-3, stock 798.2g, assay 98.5%, MWt 302.30, Formula C17H15FO4, Purity >98%, SMILES O=C(C(F)C(OCC1=CC=CC=C1)=O)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: 4-((4-Methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline, CAS: 694499-26-8, stock 730.7g, assay 98.5%, MWt 273.30, Formula C13H18F3N3, Purity >98%, SMILES NC(C=C1C(F)(F)F)=CC=C1CN2CCN(C)CC2, MDL MFCD09909924 |
| Drug_Names: 3-Ethynyl-Imidazo[1,2-b]pyridazine, CAS: 943320-61-4, stock 736.7g, assay 98.8%, MWt 143.15, Formula C8H5N3, Purity >98%, SMILES C#CC1=CN=C2C=CC=NN21, MDL MFCD17012027 |
| Drug_Names: 4-Chloro-2-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1060815-85-1, stock 146.7g, assay 98.9%, MWt 221.57, Formula C7H3ClF3N3, Purity >98%, SMILES FC(F)(F)C1=NC(NC=C2)=C2C(Cl)=N1, MDL MFCD13189354 |
| Drug_Names: INCB3344 (stereoisomer 1), CAS: 1285539-85-6, stock 851.1g, assay 98.3%, MWt 577.59, Formula C29H34F3N3O6, Purity >98%, SMILES O=C(NCC(N[C@H]1CN([C@@H]2CC[C@](C3=CC=C(OCO4)C4=C3)(O)CC2)C[C@@H]1OCC)=O)C5=CC=CC(C(F)(F)F)=C5, MDL NA |
| Drug_Names: 4-Benzo[1,3]dioxol-5-yl-4-hydroxycyclohexanone, CAS: 150019-57-1, stock 174.6g, assay 98.3%, MWt 234.25, Formula C13H14O4, Purity >98%, SMILES OC(CC1)(C2=CC=C(OCO3)C3=C2)CCC1=O, MDL NA |
| Drug_Names: Methyl 4-bromophenylacetate, CAS: 41841-16-1, stock 361.9g, assay 99%, MWt 229.07, Formula C9H9BrO2, Purity >98%, SMILES BrC1=CC=C(CC(OC)=O)C=C1, MDL MFCD00126844 |
| Drug_Names: Dimethyl 2-(4-bromophenyl)malonate, CAS: 149506-35-4, stock 29.2g, assay 98.3%, MWt 287.11, Formula C11H11BrO4, Purity >98%, SMILES O=C(OC)C(C1=CC=C(Br)C=C1)C(OC)=O, MDL NA |
| Drug_Names: 5-(4-Bromophenyl)-6-hydroxypyrimidin-4(1H)-one, CAS: 706811-25-8, stock 801.2g, assay 98.1%, MWt 267.08, Formula C10H7BrN2O2, Purity >98%, SMILES BrC1=CC=C(C2C(NC=NC2=O)=O)C=C1, MDL NA |
| Drug_Names: 5-(4-Bromophenyl)-4,6-dichloropyrimidine, CAS: 146533-41-7, stock 730.4g, assay 98.9%, MWt 303.97, Formula C10H5BrCl2N2, Purity >98%, SMILES BrC1=CC=C(C2=C(Cl)N=CN=C2Cl)C=C1, MDL MFCD13151897 |
| Drug_Names: N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-propylsulfamide, CAS: 1393813-42-7, stock 488.3g, assay 98.7%, MWt 405.70, Formula C13H14BrClN4O2S, Purity >98%, SMILES BrC1=CC=C(C2=C(NS(NCCC)(=O)=O)N=CN=C2Cl)C=C1, MDL NA |
| Drug_Names: Benzyl [(propylamino)sulfonyl]carbamate, CAS: 92577-65-6, stock 438.4g, assay 98.4%, MWt 272.32, Formula C11H16N2O4S, Purity >98%, SMILES CCCNS(NC(OCC1=CC=CC=C1)=O)(=O)=O, MDL NA |
| Drug_Names: Propylsulfamide, CAS: 147962-41-2, stock 706.1g, assay 98.3%, MWt 138.19, Formula C3H10N2O2S, Purity >98%, SMILES CCCNS(N)(=O)=O, MDL MFCD12755184 |
| Drug_Names: Benzyl (3-fluorophenyl)carbamate, CAS: 149524-47-0, stock 254.5g, assay 98.3%, MWt 245.25, Formula C14H12FNO2, Purity >98%, SMILES FC1=CC=CC(NC(OCC2=CC=CC=C2)=O)=C1, MDL NA |
| Drug_Names: (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one, CAS: 149524-42-5, stock 137.3g, assay 98.4%, MWt 211.19, Formula C10H10FNO3, Purity >98%, SMILES FC1=CC=CC(N2C[C@@](CO)([H])OC2=O)=C1, MDL MFCD08234640 |
| Drug_Names: (R)-3-(3-Fluoro-4-iodophenyl)-5-(hydroxymethyl)oxazolidin-2-one, CAS: 487041-08-7, stock 135.4g, assay 98%, MWt 337.09, Formula C10H9FINO3, Purity >98%, SMILES FC1=C(I)C=CC(N2C[C@@](CO)([H])OC2=O)=C1, MDL NA |
| Drug_Names: (S)-2-((3-(3-fluoro-4-iodophenyl)-2-oxooxazolidin-5-yl)methyl)isoindoline-1,3-dione, CAS: 724793-80-0, stock 740.8g, assay 98.9%, MWt 466.20, Formula C18H12FIN2O4, Purity >98%, SMILES FC1=C(I)C=CC(N2C[C@@](CN3C(C(C=CC=C4)=C4C3=O)=O)([H])OC2=O)=C1, MDL NA |
| Drug_Names: (S)-5-(aminomethyl)-3-(3-fluoro-4-iodophenyl)oxazolidin-2-one, CAS: 627543-03-7, stock 205.8g, assay 98.8%, MWt 336.10, Formula C10H10FIN2O2, Purity >98%, SMILES FC1=C(I)C=CC(N2C[C@@](CN)([H])OC2=O)=C1, MDL NA |
| Drug_Names: (S)-N-[3-(3-Fluoro-4-iodo-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide, CAS: 149524-45-8, stock 91.2g, assay 99%, MWt 378.14, Formula C12H12FIN2O3, Purity >98%, SMILES FC1=C(I)C=CC(N2C[C@@](CNC(C)=O)([H])OC2=O)=C1, MDL NA |
| Drug_Names: Methyl 2-((2-(tert-butyl)phenyl)amino)-2-oxoacetate, CAS: 483334-60-7, stock 480.7g, assay 98.2%, MWt 235.28, Formula C13H17NO3, Purity >98%, SMILES O=C(OC)C(NC1=CC=CC=C1C(C)(C)C)=O, MDL NA |
| Drug_Names: (S)-2-((S)-2-(((benzyloxy)carbonyl)amino)propanamido)-4-(tert-butoxy)-4-oxobutanoic acid, CAS: 3408-50-2, stock 862.3g, assay 98.3%, MWt 394.42, Formula C19H26N2O7, Purity >98%, SMILES OC([C@H](CC(OC(C)(C)C)=O)NC([C@H](C)NC(OCC1=CC=CC=C1)=O)=O)=O, MDL NA |
| Drug_Names: 2-((2-(Tert-butyl)phenyl)amino)-2-oxoacetic acid, CAS: 254751-08-1, stock 13.5g, assay 98.5%, MWt 221.25, Formula C12H15NO3, Purity >98%, SMILES O=C(O)C(NC1=CC=CC=C1C(C)(C)C)=O, MDL NA |
| Drug_Names: Z-Ala-OSu, CAS: 3401-36-3, stock 424.7g, assay 98.9%, MWt 320.30, Formula C15H16N2O6, Purity >98%, SMILES C[C@@H](C(ON1C(CCC1=O)=O)=O)NC(OCC2=CC=CC=C2)=O, MDL MFCD00053548 |
| Drug_Names: (S)-tert-butyl 3-((S)-2-(((benzyloxy)carbonyl)amino)propanamido)-5-bromo-4-oxopentanoate, CAS: 868565-55-3, stock 48.8g, assay 98.9%, MWt 471.34, Formula C20H27BrN2O6, Purity >98%, SMILES O=C(CBr)[C@H](CC(OC(C)(C)C)=O)NC([C@H](C)NC(OCC1=CC=CC=C1)=O)=O, MDL NA |
| Drug_Names: (3S)-tert-butyl 3-((S)-2-(((benzyloxy)carbonyl)amino)propanamido)-4-hydroxy-5-(2,3,5,6-tetrafluorophenoxy)pentanoate, CAS: 868565-58-6, stock 603.3g, assay 98.9%, MWt 558.52, Formula C26H30F4N2O7, Purity >98%, SMILES OC(COC1=C(F)C(F)=CC(F)=C1F)[C@H](CC(OC(C)(C)C)=O)NC([C@H](C)NC(OCC2=CC=CC=C2)=O)=O, MDL NA |
| Drug_Names: (S)-tert-butyl 3-((S)-2-(((benzyloxy)carbonyl)amino)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoate, CAS: 868565-57-5, stock 857.3g, assay 98.8%, MWt 556.50, Formula C26H28F4N2O7, Purity >98%, SMILES O=C(COC1=C(F)C(F)=CC(F)=C1F)[C@H](CC(OC(C)(C)C)=O)NC([C@H](C)NC(OCC2=CC=CC=C2)=O)=O, MDL NA |
| Drug_Names: (S)-tert-butyl 3-((S)-2-(2-((2-(tert-butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoate, CAS: 254750-83-9, stock 86.6g, assay 98.8%, MWt 625.61, Formula C30H35F4N3O7, Purity >98%, SMILES O=C(COC1=C(F)C(F)=CC(F)=C1F)[C@H](CC(OC(C)(C)C)=O)NC([C@H](C)NC(C(NC2=CC=CC=C2C(C)(C)C)=O)=O)=O, MDL NA |
| Drug_Names: (3S)-tert-butyl 3-((S)-2-(2-((2-(tert-butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-hydroxy-5-(2,3,5,6-tetrafluorophenoxy)pentanoate, CAS: 254750-82-8, stock 199.7g, assay 98.9%, MWt 627.62, Formula C30H37F4N3O7, Purity >98%, SMILES OC(COC1=C(F)C(F)=CC(F)=C1F)[C@H](CC(OC(C)(C)C)=O)NC([C@H](C)NC(C(NC2=CC=CC=C2C(C)(C)C)=O)=O)=O, MDL NA |
| Drug_Names: 2-(5-Bromo-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazol-3-ylamino)-1-((1r,4r)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-1H-benzo[d]imidazole-5-carboxylic acid, CAS: 1415565-14-8, stock 193.9g, assay 98.7%, MWt 714.84, Formula C33H48BrN5O4Si2, Purity >98%, SMILES O=C(C1=CC=C2N([C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)C(NC4=NN(COCC[Si](C)(C)C)C5=C4C=C(Br)C=C5)=NC2=C1)O, MDL NA |
| Drug_Names: Ethyl 2-amino-1-[trans-4-[(tert-butyldimethylsilyl)oxy]cyclohexyl]-1H-benzo[d]imidazole-5-carboxylate, CAS: 1012104-43-6, stock 517.9g, assay 98.9%, MWt 417.62, Formula C22H35N3O3Si, Purity >98%, SMILES O=C(C1=CC=C2N([C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)C(N)=NC2=C1)OCC, MDL NA |
| Drug_Names: Ethyl 2-((5-bromo-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazol-3-yl)amino)-1-((1r,4r)-4-((tert-butyldimethylsilyl)oxy)cyclohexyl)-1H-benzo[d]imidazole-5-carboxylate, CAS: 1012104-44-7, stock 420.5g, assay 98.8%, MWt 742.89, Formula C35H52BrN5O4Si2, Purity >98%, SMILES O=C(C1=CC=C2N([C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)C(NC4=NN(COCC[Si](C)(C)C)C5=C4C=C(Br)C=C5)=NC2=C1)OCC, MDL NA |
| Drug_Names: Aminomalonamide, CAS: 62009-47-6, stock 41.8g, assay 98.3%, MWt 117.11, Formula C3H7N3O2, Purity >98%, SMILES O=C(N)C(N)C(N)=O, MDL MFCD00015932 |
| Drug_Names: Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide, CAS: 1237524-82-1, stock 693.2g, assay 98.7%, MWt 162.10, Formula C5H5N3NaO2+, Purity >98%, SMILES O=C1NC=CN=C1C(N)=O.[Na+], MDL NA |
| Drug_Names: 6-Bromo-3-hydroxypyrazine-2-carboxamide, CAS: 259793-88-9, stock 807.6g, assay 98.1%, MWt 218.01, Formula C5H4BrN3O2, Purity >98%, SMILES NC(C1=NC(Br)=CN=C1O)=O, MDL MFCD20528005 |
| Drug_Names: tert-Butyl 3-(2-methoxy-2-oxoethylidene)azetidine-1-carboxylate, CAS: 1105662-87-0, stock 95.2g, assay 98.7%, MWt 227.26, Formula C11H17NO4, Purity >98%, SMILES O=C(OC)/C=C1CN(C(OC(C)(C)C)=O)C\1, MDL MFCD13190429 |
| Drug_Names: tert-Butyl 3-amino-3-(2-methoxy-2-oxoethyl)azetidine-1-carboxylate, CAS: 1105662-89-2, stock 714.2g, assay 98.2%, MWt 244.29, Formula C11H20N2O4, Purity >98%, SMILES NC1(CC(OC)=O)CN(C(OC(C)(C)C)=O)C1, MDL NA |
| Drug_Names: tert-Butyl 3-(3-ethoxy-3-oxopropanamido)-3-(2-methoxy-2-oxoethyl)azetidine-1-carboxylate, CAS: 1105662-91-6, stock 257.3g, assay 98%, MWt 358.39, Formula C16H26N2O7, Purity >98%, SMILES O=C(OC)CC1(NC(CC(OCC)=O)=O)CN(C(OC(C)(C)C)=O)C1, MDL NA |
| Drug_Names: Ethyl 2-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoate, CAS: 1258638-92-4, stock 711.8g, assay 98.6%, MWt 282.31, Formula C14H19FN2O3, Purity >98%, SMILES FC1=C(C(NC)=O)C=CC(NC(C(OCC)=O)(C)C)=C1, MDL NA |
| Drug_Names: 4-Amino-2-fluoro-N-methylbenzamide, CAS: 915087-25-1, stock 376.9g, assay 98.8%, MWt 168.17, Formula C8H9FN2O, Purity >98%, SMILES O=C(NC)C1=C(F)C=C(N)C=C1, MDL MFCD09909322 |
| Drug_Names: 2-Fluoro-N-methyl-4-nitrobenzamide, CAS: 915087-24-0, stock 829.6g, assay 98.3%, MWt 198.15, Formula C8H7FN2O3, Purity >98%, SMILES FC1=C(C=CC([N+]([O-])=O)=C1)C(NC)=O, MDL MFCD09909407 |
| Drug_Names: Ethyl 2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylate, CAS: 691856-86-7, stock 206g, assay 98.3%, MWt 300.28, Formula C17H13FO4, Purity >98%, SMILES O=C(C1=C(C2=CC=C(F)C=C2)OC3=CC=C(O)C=C13)OCC, MDL NA |
| Drug_Names: Ethyl 2-(4-fluorophenyl)-5-isopropoxybenzofuran-3-carboxylate, CAS: 691856-87-8, stock 171.9g, assay 98.1%, MWt 342.36, Formula C20H19FO4, Purity >98%, SMILES O=C(C1=C(C2=CC=C(F)C=C2)OC3=CC=C(OC(C)C)C=C13)OCC, MDL NA |
| Drug_Names: Ethyl 2-(4-fluorophenyl)-5-hydroxy-6-nitrobenzofuran-3-carboxylate, CAS: 691857-46-2, stock 208g, assay 98.4%, MWt 345.28, Formula C17H12FNO6, Purity >98%, SMILES O=C(C1=C(C2=CC=C(F)C=C2)OC3=CC([N+]([O-])=O)=C(O)C=C13)OCC, MDL NA |
| Drug_Names: Ethyl 6-amino-5-cyclopropyl-2-(4-fluorophenyl)benzofuran-3-carboxylate, CAS: 691857-53-1, stock 755.4g, assay 98.3%, MWt 339.36, Formula C20H18FNO3, Purity >98%, SMILES O=C(C1=C(C2=CC=C(F)C=C2)OC3=CC(N)=C(C4CC4)C=C13)OCC, MDL NA |
| Drug_Names: Ethyl 5-cyclopropyl-2-(4-fluorophenyl)-6-(N-(methylsulfonyl)methylsulfonamido)benzofuran-3-carboxylate, CAS: 1185313-40-9, stock 151g, assay 98.1%, MWt 495.54, Formula C22H22FNO7S2, Purity >98%, SMILES O=C(C1=C(C2=CC=C(F)C=C2)OC3=CC(N(S(=O)(C)=O)S(=O)(C)=O)=C(C4CC4)C=C13)OCC, MDL NA |
| Drug_Names: 5-cyclopropyl-2-(4-fluorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxylic acid, CAS: 691857-54-2, stock 601.7g, assay 98.6%, MWt 389.40, Formula C19H16FNO5S, Purity >98%, SMILES O=C(C1=C(C2=CC=C(F)C=C2)OC3=CC(NS(=O)(C)=O)=C(C4CC4)C=C13)O, MDL NA |
| Drug_Names: Ethyl 3-(4-fluorophenyl)-3-oxopropanoate, CAS: 1999-00-4, stock 246.3g, assay 98.9%, MWt 210.20, Formula C11H11FO3, Purity >98%, SMILES FC1=CC=C(C(CC(OCC)=O)=O)C=C1, MDL MFCD03093631 |
| Drug_Names: 3-(Adamantan-1-yl)-4'-bromobiphenyl-4-ol, CAS: 496868-80-5, stock 527g, assay 99%, MWt 383.32, Formula C22H23BrO, Purity >98%, SMILES OC1=CC=C(C2=CC=C(Br)C=C2)C=C1[C@]3(C4)CC5CC(CC4C5)C3, MDL NA |
| Drug_Names: 4-Bromo-1,7-dichloroisoquinoline, CAS: 953421-74-4, stock 253.5g, assay 98.2%, MWt 276.94, Formula C9H4BrCl2N, Purity >98%, SMILES ClC1=CC2=C(Cl)N=CC(Br)=C2C=C1, MDL NA |
| Drug_Names: 8-benzyl-2-phenyl-2,8-diazaspiro[4.5]decane-1,3-dione, CAS: 64097-71-8, stock 102.7g, assay 98.3%, MWt 334.41, Formula C21H22N2O2, Purity >98%, SMILES O=C(C1(C2)CCN(CC3=CC=CC=C3)CC1)N(C4=CC=CC=C4)C2=O, MDL NA |
| Drug_Names: 1-Benzyl-4-(carboxymethyl)piperidine-4-carboxylic acid hydrochloride, CAS: 40117-95-1, stock 91.6g, assay 98.7%, MWt 313.78, Formula C15H20ClNO4, Purity >98%, SMILES O=C(O)CC1(C(O)=O)CCN(CC2=CC=CC=C2)CC1.[H]Cl, MDL NA |
| Drug_Names: 1-Benzyl-4-(cyanomethyl)piperidine-4-carbonitrile, CAS: 86945-27-9, stock 638.9g, assay 98.2%, MWt 239.32, Formula C15H17N3, Purity >98%, SMILES N#CCC1(C#N)CCN(CC2=CC=CC=C2)CC1, MDL MFCD13185971 |
| Drug_Names: 2-Cyanoquinuclidine, CAS: 90196-91-1, stock 239.1g, assay 98.8%, MWt 136.19, Formula C8H12N2, Purity >98%, SMILES N#CC1[N@@](CC2)CC[C@@H]2C1, MDL NA |
| Drug_Names: (2R)-1-Azabicyclo[2.2.2]octane-2-carbonitrile, CAS: 885517-05-5, stock 233.2g, assay 98.1%, MWt 136.19, Formula C8H12N2, Purity >98%, SMILES N#C[C@@H]1N(CC2)CCC2C1, MDL NA |
| Drug_Names: tert-Butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate, CAS: 135716-08-4, stock 848.5g, assay 98.8%, MWt 269.34, Formula C14H23NO4, Purity >98%, SMILES O=C(OCC)/C=C1CCN(C(OC(C)(C)C)=O)CC\1, MDL MFCD12912655 |
| Drug_Names: tert-Butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate, CAS: 135716-09-5, stock 834.5g, assay 98.8%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES O=C(OCC)CC1CCN(C(OC(C)(C)C)=O)CC1, MDL MFCD08275143 |
| Drug_Names: tert-Butyl 4-(2-oxoethyl)piperidine-1-carboxylate, CAS: 142374-19-4, stock 530.1g, assay 98.1%, MWt 227.30, Formula C12H21NO3, Purity >98%, SMILES O=CCC1CCN(C(OC(C)(C)C)=O)CC1, MDL MFCD03425258 |
| Drug_Names: N-Boc-4-Piperidineethanol, CAS: 89151-44-0, stock 64.8g, assay 98.5%, MWt 229.32, Formula C12H23NO3, Purity >98%, SMILES OCCC1CCN(C(OC(C)(C)C)=O)CC1, MDL MFCD03427086 |
| Drug_Names: tert-Butyl 4-(2-cyano-2-hydroxyethyl)piperidine-1-carboxylate, CAS: 885516-98-3, stock 491.2g, assay 98.9%, MWt 254.33, Formula C13H22N2O3, Purity >98%, SMILES OC(C#N)CC1CCN(C(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: Demethoxyencecalin, CAS: 19013-07-1, stock 462g, assay 98.5%, MWt 202.25, Formula C13H14O2, Purity >98%, SMILES CC1(C)C=CC2=CC(C(C)=O)=CC=C2O1, MDL MFCD06200746 |
| Drug_Names: 1-((3S,4S)-4-amino-3-hydroxy-2,2-dimethylchroman-6-yl)ethanone sulfate, CAS: 432049-96-2, stock 288.6g, assay 99%, MWt 333.36, Formula C13H19NO7S, Purity >98%, SMILES O[C@@H]1C(C)(C)OC2=CC=C(C(C)=O)C=C2[C@@H]1N.OS(=O)(O)=O, MDL NA |
| Drug_Names: (R)-4-(Oxiran-2-ylmethyl)morpholine, CAS: 452105-35-0, stock 811.7g, assay 98.3%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES [C@H]1(CN2CCOCC2)OC1, MDL MFCD18830136 |
| Drug_Names: (S)-1-Amino-3-morpholinopropan-2-ol, CAS: 452105-36-1, stock 411g, assay 98.8%, MWt 160.21, Formula C7H16N2O2, Purity >98%, SMILES NC[C@H](O)CN1CCOCC1, MDL MFCD08059563 |
| Drug_Names: 2,5-Dimethyl-3-(4-(trifluoromethyl)benzyl)thiophene, CAS: 1006037-09-7, stock 559.1g, assay 98.6%, MWt 270.31, Formula C14H13F3S, Purity >98%, SMILES CC1=C(CC2=CC=C(C(F)(F)F)C=C2)C=C(C)S1, MDL MFCD17926241 |
| Drug_Names: (2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, CAS: 2110533-80-5, stock 104.1g, assay 98.6%, MWt 612.66, Formula C32H33FO9S, Purity >98%, SMILES CC1=CC=C([C@@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O2)C=C1CC3=CC=C(C4=CC=C(F)C=C4)S3, MDL NA |
| Drug_Names: 2-(2-Fluorophenyl)-3H-Imidazo[4,5-c]pyridine, CAS: 89075-43-4, stock 213.4g, assay 98.1%, MWt 213.21, Formula C12H8FN3, Purity >98%, SMILES FC1=CC=CC=C1C2=NC3=CN=CC=C3N2, MDL NA |
| Drug_Names: 2,4-Bis(trifluoromethyl)benzeneboronic acid, CAS: 153254-09-2, stock 116.6g, assay 98.9%, MWt 257.93, Formula C8H5BF6O2, Purity >98%, SMILES FC(F)(F)C1=CC(C(F)(F)F)=C(B(O)O)C=C1, MDL MFCD01631349 |
| Drug_Names: 2-(((Octahydro-1H-4,7-methanoinden-5-yl)oxy)carbonyl)benzoic acid, CAS: 109821-56-9, stock 424.6g, assay 98.5%, MWt 300.35, Formula C18H20O4, Purity >98%, SMILES O=C(OC1CC2C(CCC3)C3C1C2)C4=CC=CC=C4C(O)=O, MDL NA |
| Drug_Names: 2-((((3aS,4S,5R,7S,7aS)-octahydro-1H-4,7-methanoinden-5-yl)oxy)carbonyl)benzoic acid, CAS: 1096688-06-0, stock 849.4g, assay 98.8%, MWt 300.35, Formula C18H20O4, Purity >98%, SMILES O=C(O[C@@H]1C[C@@]2([H])[C@@](CCC3)([H])[C@@]3([H])[C@]1([H])C2)C4=CC=CC=C4C(O)=O, MDL NA |
| Drug_Names: Ethyl (trans-4-phenylcyclohexyl)acetate, CAS: 1031336-66-9, stock 688g, assay 99%, MWt 246.34, Formula C16H22O2, Purity >98%, SMILES O=C(OCC)C[C@H]1CC[C@H](C2=CC=CC=C2)CC1, MDL NA |
| Drug_Names: (R)-2,5-dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-(phenylthio)propanoate, CAS: 447461-52-1, stock 819g, assay 98%, MWt 428.46, Formula C21H20N2O6S, Purity >98%, SMILES O=C(ON1C(CCC1=O)=O)[C@@H](NC(OCC2=CC=CC=C2)=O)CSC3=CC=CC=C3, MDL NA |
| Drug_Names: (Methyl(oxo)sulfonio)methane (R)-3-(((benzyloxy)carbonyl)amino)-2-oxo-4-(phenylthio)butan-1-ide, CAS: 447461-54-3, stock 720.8g, assay 98.3%, MWt 405.53, Formula C20H23NO4S2, Purity >98%, SMILES O=C(C=S(C)(C)=O)[C@@H](NC(OCC1=CC=CC=C1)=O)CSC2=CC=CC=C2, MDL NA |
| Drug_Names: (R)-benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbamate, CAS: 159878-01-0, stock 791.3g, assay 98.9%, MWt 363.86, Formula C18H18ClNO3S, Purity >98%, SMILES O=C(CCl)[C@@H](NC(OCC1=CC=CC=C1)=O)CSC2=CC=CC=C2, MDL NA |
| Drug_Names: benzyl ((2R,3S)-4-chloro-3-hydroxy-1-(phenylthio)butan-2-yl)carbamate, CAS: 159878-02-1, stock 345.8g, assay 98.8%, MWt 365.87, Formula C18H20ClNO3S, Purity >98%, SMILES O[C@H](CCl)[C@@H](NC(OCC1=CC=CC=C1)=O)CSC2=CC=CC=C2, MDL MFCD06411610 |
| Drug_Names: 2-(Hydroxymethyl)-6-methylpyridin-3-ol, CAS: 42097-42-7, stock 350.6g, assay 98.6%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES CC1=NC(CO)=C(O)C=C1, MDL MFCD00006350 |
| Drug_Names: 2-(Chloromethyl)-6-methyl-3-Pyridinol hydrochloride, CAS: 98280-34-3, stock 752.2g, assay 98.2%, MWt 194.06, Formula C7H9Cl2NO, Purity >98%, SMILES CC1=NC(CCl)=C(O)C=C1.Cl, MDL NA |
| Drug_Names: 3-(2-Amino-4-methylphenyl)propan-1-ol, CAS: 856843-02-2, stock 898.9g, assay 98.7%, MWt 165.23, Formula C10H15NO, Purity >98%, SMILES CC1=CC=C(CCCO)C(N)=C1, MDL MFCD20693776 |
| Drug_Names: Ethyl 3,4-diaminobenzoate, CAS: 37466-90-3, stock 76.3g, assay 98.1%, MWt 180.20, Formula C9H12N2O2, Purity >98%, SMILES NC1=C(N)C=CC(C(OCC)=O)=C1, MDL MFCD00179337 |
| Drug_Names: 2-((5-(Hydroxymethyl)-2-((3-morpholinopropyl)amino)-1H-benzo[d]imidazol-1-yl)methyl)-6-methylpyridin-3-ol, CAS: 857067-39-1, stock 402.7g, assay 98.4%, MWt 411.50, Formula C22H29N5O3, Purity >98%, SMILES CC1=NC(CN(C(NCCCN2CCOCC2)=N3)C4=C3C=C(CO)C=C4)=C(O)C=C1, MDL NA |
| Drug_Names: (5-Oxotricyclo[2.2.1.02,6]heptan-3-yl)methyl acetate, CAS: 110770-75-7, stock 192g, assay 98.7%, MWt 180.20, Formula C10H12O3, Purity >98%, SMILES CC(OCC1C2C3C2CC1C3=O)=O, MDL NA |
| Drug_Names: 3-(Dibutylamino)propyl 4-hydroxybenzoate (Hydrochloride), CAS: 1415565-00-2, stock 632.8g, assay 98.1%, MWt 343.89, Formula C18H30ClNO3, Purity >98%, SMILES O=C(OCCCN(CCCC)CCCC)C1=CC=C(O)C=C1.[H]Cl, MDL NA |
| Drug_Names: tert-Butyl 4-(methylsulfonyl)piperazine-1-carboxylate, CAS: 164331-38-8, stock 436.5g, assay 98.3%, MWt 264.34, Formula C10H20N2O4S, Purity >98%, SMILES O=C(N1CCN(S(=O)(C)=O)CC1)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1029716-44-6, stock 223.1g, assay 98.3%, MWt 266.14, Formula C13H23BN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C2=CN(C(OCC)C)N=C2, MDL MFCD11857753 |
| Drug_Names: (S)-6-Methoxychroman-3-carboxylic acid, CAS: 182570-28-1, stock 817.5g, assay 98.7%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES O=C([C@@H]1COC2=C(C=C(OC)C=C2)C1)O, MDL MFCD10696117 |
| Drug_Names: 3-Chloro-4-(3-trifluoromethyl-phenoxy)-phenylamine, CAS: 40718-14-7, stock 142.2g, assay 98%, MWt 287.66, Formula C13H9ClF3NO, Purity >98%, SMILES ClC1=CC(N)=CC=C1OC2=CC=CC(C(F)(F)F)=C2, MDL NA |
| Drug_Names: 2-Chloro-4-nitro-1-(3-(trifluoromethyl)phenoxy)benzene, CAS: 40718-13-6, stock 216.1g, assay 98.8%, MWt 317.65, Formula C13H7ClF3NO3, Purity >98%, SMILES ClC1=CC([N+]([O-])=O)=CC=C1OC2=CC=CC(C(F)(F)F)=C2, MDL NA |
| Drug_Names: 1,5-Dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one, CAS: 5655-01-6, stock 407g, assay 98.9%, MWt 135.12, Formula C6H5N3O, Purity >98%, SMILES OC1=C2C(C=CN2)=NC=N1, MDL NA |
| Drug_Names: N,1-bis(4-methoxybenzyl)-1H-imidazo[4,5-c]pyridin-4-amine, CAS: 1415559-83-9, stock 284.5g, assay 98.9%, MWt 374.44, Formula C22H22N4O2, Purity >98%, SMILES COC(C=C1)=CC=C1CN2C3=CC=NC(NCC4=CC=C(OC)C=C4)=C3N=C2, MDL NA |
| Drug_Names: tert-Butyl (3H-imidazo[4,5-c]pyridin-4-yl)carbamate, CAS: 934816-43-0, stock 348.1g, assay 98.4%, MWt 234.25, Formula C11H14N4O2, Purity >98%, SMILES O=C(OC(C)(C)C)NC1=NC=CC2=C1NC=N2, MDL NA |
| Drug_Names: tert-Butyl N-[(tert-butoxy)carbonyl]-N-{1H-imidazo[4,5-c]pyridin-4-yl}carbamate, CAS: 934816-44-1, stock 220.1g, assay 98.8%, MWt 334.37, Formula C16H22N4O4, Purity >98%, SMILES O=C(OC(C)(C)C)N(C(OC(C)(C)C)=O)C1=C(N=CN2)C2=CC=N1, MDL NA |
| Drug_Names: Bis(2-methyl-2-propanyl)(1-{(3aS,4R,6aR)-2,2-dimethyl-6-[(trityloxy)methyl]-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl}-1H-imidazo[4,5-c]pyridin-4-yl)imidodicarbonate, CAS: 1207561-02-1, stock 870.9g, assay 99%, MWt 744.87, Formula C44H48N4O7, Purity >98%, SMILES CC1(C)O[C@H]2[C@@H](O1)[C@H](N3C4=CC=NC(N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)=C4N=C3)C=C2COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7, MDL NA |
| Drug_Names: (3aS,4S,6aS)-2,2-dimethyl-4-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 681854-00-2, stock 543.6g, assay 98.3%, MWt 428.52, Formula C28H28O4, Purity >98%, SMILES O[C@]1(COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=C[C@@]5([H])[C@]1([H])OC(C)(C)O5, MDL NA |
| Drug_Names: (3AS,4S,6aR)-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 163226-45-7, stock 265.9g, assay 98.2%, MWt 428.52, Formula C28H28O4, Purity >98%, SMILES O[C@H]1C=C(COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)[C@]5([H])[C@@]1([H])OC(C)(C)O5, MDL NA |
| Drug_Names: 5-Methoxy-1H-benzo[d][1,3]oxazine-2,4-dione, CAS: 67765-42-8, stock 752.7g, assay 98.6%, MWt 193.16, Formula C9H7NO4, Purity >98%, SMILES O=C(O1)NC2=CC=CC(OC)=C2C1=O, MDL NA |
| Drug_Names: 8-Methoxy-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione, CAS: 91105-97-4, stock 154.5g, assay 98.2%, MWt 207.18, Formula C10H9NO4, Purity >98%, SMILES O=C(O1)N(C)C2=CC=CC(OC)=C2C1=O, MDL NA |
| Drug_Names: Ethyl quinuclidine-4-carboxylate, CAS: 22766-68-3, stock 578.7g, assay 98.8%, MWt 183.25, Formula C10H17NO2, Purity >98%, SMILES O=C(OCC)C12CCN(CC2)CC1, MDL NA |
| Drug_Names: (1-Azabicyclo[2.2.2]oct-4-yl)(diphenyl)methanol, CAS: 461648-39-5, stock 421.9g, assay 98.4%, MWt 293.40, Formula C20H23NO, Purity >98%, SMILES OC(C1=CC=CC=C1)(C2=CC=CC=C2)C34CCN(CC4)CC3, MDL NA |
| Drug_Names: 4-Chloro-5-iodo-1H-pyrrolo[2,3-d]pyrimidine, CAS: 123148-78-7, stock 735.6g, assay 98.5%, MWt 279.47, Formula C6H3ClIN3, Purity >98%, SMILES IC1=CNC2=NC=NC(Cl)=C21, MDL MFCD09263258 |
| Drug_Names: (2R,3R,4R,5R)-2-((benzoyloxy)methyl)-5-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydrofuran-3,4-diyl dibenzoate, CAS: 480439-89-2, stock 472.4g, assay 98.7%, MWt 723.90, Formula C32H23ClIN3O7, Purity >98%, SMILES IC1=CN([C@H]2[C@H](OC(C3=CC=CC=C3)=O)[C@H](OC(C4=CC=CC=C4)=O)[C@@H](COC(C5=CC=CC=C5)=O)O2)C6=NC=NC(Cl)=C61, MDL NA |
| Drug_Names: 5-Bromo-2-(o-tolyl)oxazole, CAS: 1391739-99-3, stock 229.6g, assay 98.4%, MWt 238.08, Formula C10H8BrNO, Purity >98%, SMILES CC1=C(C2=NC=C(Br)O2)C=CC=C1, MDL NA |
| Drug_Names: 2-((tert-Butyldimethylsilyl)oxy)ethanamine, CAS: 101711-55-1, stock 78.3g, assay 98.9%, MWt 175.34, Formula C8H21NOSi, Purity >98%, SMILES C[Si](OCCN)(C(C)(C)C)C, MDL MFCD18206132 |
| Drug_Names: trans-Methyl 2-[4-(4-hydroxyphenyl)cyclohexyl]acetate, CAS: 701232-67-9, stock 745.1g, assay 98.6%, MWt 248.32, Formula C15H20O3, Purity >98%, SMILES O=C(OC)C[C@H]1CC[C@H](C2=CC=C(O)C=C2)CC1, MDL NA |
| Drug_Names: trans-Methyl 2-[4-[4-[(trifluoromethylsulfonyl)oxy]phenyl]cyclohexyl]acetate, CAS: 701232-68-0, stock 13.6g, assay 98.9%, MWt 380.38, Formula C16H19F3O5S, Purity >98%, SMILES O=C(OC)C[C@H]1CC[C@H](C2=CC=C(OS(=O)(C(F)(F)F)=O)C=C2)CC1, MDL NA |
| Drug_Names: Methyl 2-((1S,4S)-4-(4-hydroxyphenyl)cyclohexyl)acetate, CAS: 1245708-07-9, stock 285.4g, assay 98.6%, MWt 248.32, Formula C15H20O3, Purity >98%, SMILES O=C(OC)C[C@@H]1CC[C@H](C2=CC=C(O)C=C2)CC1, MDL NA |
| Drug_Names: (2R,4'R,8a'R)-1-(tert-butoxycarbonyl)-6'-oxohexahydrospiro[pyrrolidine-2,7'-pyrrolo[2,1-b][1,3]thiazine]-4'-carboxylic acid, CAS: 894786-94-8, stock 323.1g, assay 98.1%, MWt 356.44, Formula C16H24N2O5S, Purity >98%, SMILES O=C(N1[C@@]2(C[C@@]3([H])SCC[C@H](C(O)=O)N3C2=O)CCC1)OC(C)(C)C, MDL NA |
| Drug_Names: 4,6-Dichloro-N-methylpyrimidin-2-amine, CAS: 10397-15-6, stock 664.7g, assay 98.7%, MWt 178.02, Formula C5H5Cl2N3, Purity >98%, SMILES CNC1=NC(Cl)=CC(Cl)=N1, MDL MFCD02091109 |
| Drug_Names: 4-Cyano-3-fluorophenylboronic acid, CAS: 843663-18-3, stock 318g, assay 98%, MWt 164.93, Formula C7H5BFNO2, Purity >98%, SMILES FC1=CC(B(O)O)=CC=C1C#N, MDL MFCD03411549 |
| Drug_Names: Methyl (3S,6R)-6-methylpiperidine-3-carboxylate (2R,3R)-2,3-dihydroxysuccinate, CAS: 1227911-35-4, stock 500g, assay 98.3%, MWt 307.30, Formula C12H21NO8, Purity >98%, SMILES O=C([C@@H]1CN[C@H](C)CC1)OC.O=C(O)[C@H](O)[C@@H](O)C(O)=O, MDL NA |
| Drug_Names: (3R,6S)-methyl 6-methylpiperidine-3-carboxylate (2R,3R)-2,3-dihydroxysuccinate, CAS: 2070009-48-0, stock 402.4g, assay 98.6%, MWt 307.30, Formula C12H21NO8, Purity >98%, SMILES O=C([C@H]1CN[C@@H](C)CC1)OC.O=C(O)[C@H](O)[C@@H](O)C(O)=O, MDL NA |
| Drug_Names: 2,4-Dichloro-6,7-dimethoxyquinazoline, CAS: 27631-29-4, stock 56.7g, assay 98.9%, MWt 259.09, Formula C10H8Cl2N2O2, Purity >98%, SMILES COC1=CC2=NC(Cl)=NC(Cl)=C2C=C1OC, MDL MFCD00051733 |
| Drug_Names: N-(2-Chloroacetyl)-2-methylbenzamide, CAS: 1415562-56-9, stock 146.9g, assay 99%, MWt 211.64, Formula C10H10ClNO2, Purity >98%, SMILES CC1=C(C(NC(CCl)=O)=O)C=CC=C1, MDL NA |
| Drug_Names: N-(2-chloroacetyl)-2-methoxybenzamide, CAS: 554423-67-5, stock 138.1g, assay 98.3%, MWt 227.64, Formula C10H10ClNO3, Purity >98%, SMILES O=C(NC(CCl)=O)C1=C(OC)C=CC=C1, MDL NA |
| Drug_Names: 4,5-Dibromo-2-(o-tolyl)-1H-imidazole, CAS: 1415564-57-6, stock 251.7g, assay 98.7%, MWt 315.99, Formula C10H8Br2N2, Purity >98%, SMILES BrC1=C(Br)NC(C2=CC=CC=C2C)=N1, MDL NA |
| Drug_Names: 4-Bromo-2-(o-tolyl)-1H-imidazole, CAS: 1049117-87-4, stock 647.3g, assay 98%, MWt 237.10, Formula C10H9BrN2, Purity >98%, SMILES BrC1=CNC(C2=CC=CC=C2C)=N1, MDL NA |
| Drug_Names: 2-(2-methoxyphenyl)-1H-imidazole, CAS: 52091-35-7, stock 773.7g, assay 98.6%, MWt 174.20, Formula C10H10N2O, Purity >98%, SMILES COC1=CC=CC=C1C2=NC=CN2, MDL NA |
| Drug_Names: 4-Bromo-2-(2-methoxyphenyl)-1-methyl-1H-imidazole, CAS: 1415564-66-7, stock 537.7g, assay 98.3%, MWt 267.12, Formula C11H11BrN2O, Purity >98%, SMILES BrC1=CN(C)C(C2=CC=CC=C2OC)=N1, MDL NA |
| Drug_Names: 5-Bromo-1-methyl-2-(o-tolyl)-1H-imidazole, CAS: 1415562-59-2, stock 21.3g, assay 98.8%, MWt 251.12, Formula C11H11BrN2, Purity >98%, SMILES BrC1=CN=C(C2=CC=CC=C2C)N1C, MDL NA |
| Drug_Names: 5-Bromo-2-(2-methoxyphenyl)-1-methyl-1H-imidazole, CAS: 1415564-80-5, stock 879.4g, assay 98.5%, MWt 267.12, Formula C11H11BrN2O, Purity >98%, SMILES BrC1=CN=C(C2=CC=CC=C2OC)N1C, MDL NA |
| Drug_Names: N-(2-bromoethyl)-2-methoxybenzamide, CAS: 1152510-06-9, stock 550.1g, assay 98.9%, MWt 258.11, Formula C10H12BrNO2, Purity >98%, SMILES O=C(NCCBr)C1=C(OC)C=CC=C1, MDL NA |
| Drug_Names: 2-(2-Methoxyphenyl)-4,5-dihydrooxazole, CAS: 74272-88-1, stock 48.5g, assay 98.2%, MWt 177.20, Formula C10H11NO2, Purity >98%, SMILES COC1=C(C2=NCCO2)C=CC=C1, MDL NA |
| Drug_Names: Methyl 5-thiazolecarboxylate, CAS: 14527-44-7, stock 650.2g, assay 99%, MWt 143.16, Formula C5H5NO2S, Purity >98%, SMILES O=C(OC)C1=CN=CS1, MDL MFCD03788563 |
| Drug_Names: Methyl 2-acetylthiazole-5-carboxylate, CAS: 1261080-59-4, stock 770.9g, assay 98.2%, MWt 185.20, Formula C7H7NO3S, Purity >98%, SMILES O=C(C)C1=NC=C(C(OC)=O)S1, MDL NA |
| Drug_Names: 2-Acetylthiazole-5-carboxylic acid, CAS: 1095824-76-2, stock 630.2g, assay 98%, MWt 171.17, Formula C6H5NO3S, Purity >98%, SMILES O=C(C)C1=NC=C(C(O)=O)S1, MDL NA |
| Drug_Names: 5-Chloro-4-(trifluoromethyl)pyridin-2-amine, CAS: 1095823-39-4, stock 343.8g, assay 98.1%, MWt 196.56, Formula C6H4ClF3N2, Purity >98%, SMILES NC1=NC=C(Cl)C(C(F)(F)F)=C1, MDL MFCD18255015 |
| Drug_Names: N-[5-Chloro-4-(trifluoromethyl)-2-pyridinyl]-2-[1-(hydroxyimino)ethyl]-5-thiazolecarboxamide, CAS: 1095823-58-7, stock 634.2g, assay 98.4%, MWt 364.73, Formula C12H8ClF3N4O2S, Purity >98%, SMILES C/C(C1=NC=C(C(NC2=NC=C(Cl)C(C(F)(F)F)=C2)=O)S1)=N\O, MDL NA |
| Drug_Names: 2-(1-Aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide, CAS: 1095823-56-5, stock 0.2g, assay 98%, MWt 350.75, Formula C12H10ClF3N4OS, Purity >98%, SMILES NC(C)C1=NC=C(C(NC2=NC=C(Cl)C(C(F)(F)F)=C2)=O)S1, MDL NA |
| Drug_Names: (R)-2-(1-aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide, CAS: 1095823-62-3, stock 318.6g, assay 98.3%, MWt 350.75, Formula C12H10ClF3N4OS, Purity >98%, SMILES N[C@H](C)C1=NC=C(C(NC2=NC=C(Cl)C(C(F)(F)F)=C2)=O)S1, MDL NA |
| Drug_Names: Ethyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate, CAS: 223788-14-5, stock 454.1g, assay 98.2%, MWt 168.15, Formula C7H8N2O3, Purity >98%, SMILES OC1=NC=NC(C(OCC)=O)=C1, MDL MFCD11113094 |
| Drug_Names: Ethyl 5-chloro-6-hydroxypyrimidine-4-carboxylate, CAS: 1415559-92-0, stock 792.8g, assay 99%, MWt 202.60, Formula C7H7ClN2O3, Purity >98%, SMILES OC1=NC=NC(C(OCC)=O)=C1Cl, MDL NA |
| Drug_Names: Ethyl 5,6-dichloropyrimidine-4-carboxylate, CAS: 1097250-57-1, stock 864.1g, assay 98.1%, MWt 221.04, Formula C7H6Cl2N2O2, Purity >98%, SMILES ClC1=NC=NC(C(OCC)=O)=C1Cl, MDL NA |
| Drug_Names: Ethyl 5-chloro-6-((4-methoxybenzyl)amino)pyrimidine-4-carboxylate, CAS: 1415562-75-2, stock 127.4g, assay 98.1%, MWt 321.76, Formula C15H16ClN3O3, Purity >98%, SMILES ClC1=C(C(OCC)=O)N=CN=C1NCC2=CC=C(OC)C=C2, MDL NA |
| Drug_Names: Ethyl 6-amino-5-chloropyrimidine-4-carboxylate, CAS: 1097250-86-6, stock 115.9g, assay 98.2%, MWt 201.61, Formula C7H8ClN3O2, Purity >98%, SMILES NC1=NC=NC(C(OCC)=O)=C1Cl, MDL NA |
| Drug_Names: 2,4,6-Trimethoxybenzaldehyde oxime, CAS: 51903-38-9, stock 885.7g, assay 98.1%, MWt 211.21, Formula C10H13NO4, Purity >98%, SMILES COC1=C(C(OC)=CC(OC)=C1)/C=N/O, MDL NA |
| Drug_Names: Methyl 7-chlorobenzo[b]thiophene-2-carboxylate, CAS: 550998-56-6, stock 580.9g, assay 98.5%, MWt 226.68, Formula C10H7ClO2S, Purity >98%, SMILES O=C(C1=CC2=CC=CC(Cl)=C2S1)OC, MDL MFCD09027105 |
| Drug_Names: 7-Chloro-1-benzothiophene-2-carboxylic acid, CAS: 90407-16-2, stock 235.9g, assay 98.3%, MWt 212.65, Formula C9H5ClO2S, Purity >98%, SMILES O=C(C1=CC2=CC=CC(Cl)=C2S1)O, MDL MFCD07377072 |
| Drug_Names: N-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)nicotinamide, CAS: 507462-80-8, stock 119.8g, assay 98.4%, MWt 317.14, Formula C13H9BrN4O, Purity >98%, SMILES O=C(C1=CC=CN=C1)NC2=CNC3=NC=C(Br)C=C32, MDL NA |
| Drug_Names: (4-(((Tert-butyldimethylsilyl)oxy)methyl)cyclohexyl)methanol, CAS: 141836-50-2, stock 553g, assay 98.8%, MWt 258.47, Formula C14H30O2Si, Purity >98%, SMILES OCC1CCC(CO[Si](C)(C(C)(C)C)C)CC1, MDL NA |
| Drug_Names: (R)-1-(4-(((tert-butyldimethylsilyl)oxy)methyl)cyclohexyl)-N-((R)-1-phenylethyl)ethanamine, CAS: 672314-45-3, stock 389.5g, assay 99%, MWt 375.66, Formula C23H41NOSi, Purity >98%, SMILES C[C@@H](N[C@@H](C1=CC=CC=C1)C)C2CCC(CO[Si](C)(C(C)(C)C)C)CC2, MDL NA |
| Drug_Names: trans-4-[(R)-1-[(tert-Butyloxycarbonyl)amino]ethyl]cyclohexanecarboxylic acid, CAS: 671815-99-9, stock 790.9g, assay 98.8%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES O=C([C@H]1CC[C@H]([C@H](NC(OC(C)(C)C)=O)C)CC1)O, MDL NA |
| Drug_Names: (S)-2-(1-Boc-2-pyrrolidinyl)acetic acid, CAS: 56502-01-3, stock 699.2g, assay 98.1%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES O=C(N1[C@H](CC(O)=O)CCC1)OC(C)(C)C, MDL MFCD01862939 |
| Drug_Names: (S)-tert-butyl 2-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)pyrrolidine-1-carboxylate, CAS: 483314-82-5, stock 339.4g, assay 98.2%, MWt 329.39, Formula C18H23N3O3, Purity >98%, SMILES CC(C)(C)OC(N1[C@H](CC2=NN=C(C3=CC=CC=C3)O2)CCC1)=O, MDL NA |
| Drug_Names: 5-(2-Fluorophenyl)-2-methyl-1,3-thiazole-4-carboxylic acid, CAS: 522646-43-1, stock 592.8g, assay 98.7%, MWt 237.25, Formula C11H8FNO2S, Purity >98%, SMILES O=C(O)C1=C(C2=CC=CC=C2F)SC(C)=N1, MDL NA |
| Drug_Names: tert-Butyl 3-hydroxy-3-(pyridin-2-yl)azetidine-1-carboxylate, CAS: 1415560-24-5, stock 337.7g, assay 98.1%, MWt 250.29, Formula C13H18N2O3, Purity >98%, SMILES OC1(CN(C(OC(C)(C)C)=O)C1)C2=NC=CC=C2, MDL NA |
| Drug_Names: 3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoic acid, CAS: 391211-97-5, stock 509.9g, assay 98.4%, MWt 393.10, Formula C13H7F3INO2, Purity >98%, SMILES IC1=CC(F)=C(NC2=C(F)C(F)=CC=C2C(O)=O)C=C1, MDL MFCD08690072 |
| Drug_Names: tert-Butyl 2-(3-hydroxy-1-(2,2,2-trifluoroacetyl)azetidin-3-yl)piperidine-1-carboxylate, CAS: 1415559-54-4, stock 685.8g, assay 98.8%, MWt 352.35, Formula C15H23F3N2O4, Purity >98%, SMILES OC1(CN(C(C(F)(F)F)=O)C1)C2CCCCN2C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: tert-Butyl 2-(1-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate, CAS: 1415559-49-7, stock 831.7g, assay 98.9%, MWt 631.43, Formula C26H29F3IN3O4, Purity >98%, SMILES FC1=C(F)C=CC(C(N2CC(C3CCCCN3C(OC(C)(C)C)=O)(O)C2)=O)=C1NC4=CC=C(I)C=C4F, MDL NA |
| Drug_Names: (R)-tert-butyl 2-(1-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate, CAS: 934665-56-2, stock 238g, assay 98.7%, MWt 631.43, Formula C26H29F3IN3O4, Purity >98%, SMILES FC1=C(F)C=CC(C(N2CC([C@H]3CCCCN3C(OC(C)(C)C)=O)(O)C2)=O)=C1NC4=CC=C(I)C=C4F, MDL NA |
| Drug_Names: 2,2,2-Trifluoro-1-(3-hydroxy-3-(pyridin-2-yl)azetidin-1-yl)ethanone, CAS: 1415562-33-2, stock 62.8g, assay 98.5%, MWt 246.19, Formula C10H9F3N2O2, Purity >98%, SMILES OC1(CN(C(C(F)(F)F)=O)C1)C2=NC=CC=C2, MDL NA |
| Drug_Names: tert-Butyl 1-piperidinecarboxylate, CAS: 75844-69-8, stock 466.4g, assay 98.6%, MWt 185.26, Formula C10H19NO2, Purity >98%, SMILES CC(C)(C)OC(N1CCCCC1)=O, MDL MFCD02093935 |
| Drug_Names: 1-Cbz-3-Hydroxyazetidine, CAS: 128117-22-6, stock 165g, assay 98.4%, MWt 207.23, Formula C11H13NO3, Purity >98%, SMILES O=C(N1CC(O)C1)OCC2=CC=CC=C2, MDL MFCD09037849 |
| Drug_Names: Benzyl 3-oxoazetidine-1-carboxylate, CAS: 105258-93-3, stock 726g, assay 98.8%, MWt 205.21, Formula C11H11NO3, Purity >98%, SMILES O=C(N1CC(C1)=O)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: (S)-ethyl 3,4-dihydroxybutanoate, CAS: 108585-47-3, stock 374g, assay 98.1%, MWt 148.16, Formula C6H12O4, Purity >98%, SMILES O[C@@H](CC(OCC)=O)CO, MDL NA |
| Drug_Names: 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione, CAS: 345261-20-3, stock 834.4g, assay 98.9%, MWt 367.40, Formula C23H17N3O2, Purity >98%, SMILES O=C(C(C1=CN2C3=C(CCC2)C=CC=C31)=C4C5=CNC6=C5C=CC=C6)NC4=O, MDL NA |
| Drug_Names: rel-(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione, CAS: 905853-99-8, stock 79.2g, assay 98.6%, MWt 369.42, Formula C23H19N3O2, Purity >98%, SMILES O=C([C@@H](C1=CN2CCCC3=CC=CC1=C23)[C@@H]4C5=CNC6=C5C=CC=C6)NC4=O, MDL NA |
| Drug_Names: tert-Butyl 2-oxopyrrolidine-1-carboxylate, CAS: 85909-08-6, stock 424.4g, assay 98.9%, MWt 185.22, Formula C9H15NO3, Purity >98%, SMILES O=C1CCCN1C(OC(C)(C)C)=O, MDL MFCD00674099 |
| Drug_Names: tert-Butyl (4-oxo-4-phenylbutyl)carbamate, CAS: 116437-41-3, stock 253.4g, assay 98.5%, MWt 263.33, Formula C15H21NO3, Purity >98%, SMILES O=C(OC(C)(C)C)NCCCC(C1=CC=CC=C1)=O, MDL MFCD08060130 |
| Drug_Names: tert-Butyl (3-(5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)propyl)carbamate, CAS: 913731-98-3, stock 161.1g, assay 98.3%, MWt 433.51, Formula C22H25F2N3O2S, Purity >98%, SMILES O=C(OC(C)(C)C)NCCCC1(C2=CC=CC=C2)SC(C3=C(F)C=CC(F)=C3)=NN1, MDL NA |
| Drug_Names: tert-Butyl (3-(5-(2,5-difluorophenyl)-3-(1H-imidazole-1-carbonyl)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)propyl)carbamate, CAS: 1431698-07-5, stock 773g, assay 98.8%, MWt 527.59, Formula C26H27F2N5O3S, Purity >98%, SMILES O=C(OC(C)(C)C)NCCCC1(C2=CC=CC=C2)SC(C3=CC(F)=CC=C3F)=NN1C(N4C=CN=C4)=O, MDL NA |
| Drug_Names: tert-Butyl (3-(5-(2,5-difluorophenyl)-3-(methoxy(methyl)carbamoyl)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)propyl)carbamate, CAS: 1079843-60-9, stock 649.1g, assay 98.2%, MWt 520.59, Formula C25H30F2N4O4S, Purity >98%, SMILES O=C(OC(C)(C)C)NCCCC1(C2=CC=CC=C2)SC(C3=CC(F)=CC=C3F)=NN1C(N(C)OC)=O, MDL NA |
| Drug_Names: S-Methyl 2,5-difluorobenzothioate, CAS: 1146210-64-1, stock 387.6g, assay 98.8%, MWt 188.19, Formula C8H6F2OS, Purity >98%, SMILES FC1=CC(C(SC)=O)=C(F)C=C1, MDL NA |
| Drug_Names: Methyl 2,5-difluorobenzodithioate, CAS: 1146210-65-2, stock 741.6g, assay 99%, MWt 204.26, Formula C8H6F2S2, Purity >98%, SMILES FC1=CC(C(SC)=S)=C(F)C=C1, MDL NA |
| Drug_Names: 2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride, CAS: 953789-37-2, stock 34.6g, assay 99%, MWt 268.61, Formula C11H16Cl3N, Purity >98%, SMILES ClC1=CC=C(CCNCC(C)Cl)C=C1.Cl, MDL MFCD11046660 |
| Drug_Names: Ethyl 3-[[3-amino-4-(methylamino)benzoyl](pyridin-2-yl)amino]propionate, CAS: 212322-56-0, stock 192.1g, assay 98.6%, MWt 342.39, Formula C18H22N4O3, Purity >98%, SMILES O=C(OCC)CCN(C(C1=CC=C(NC)C(N)=C1)=O)C2=NC=CC=C2, MDL NA |
| Drug_Names: 1,7-Dichloro-4-methoxyisoquinoline, CAS: 630423-36-8, stock 571.5g, assay 98%, MWt 228.07, Formula C10H7Cl2NO, Purity >98%, SMILES ClC1=NC=C(OC)C2=CC=C(Cl)C=C21, MDL NA |
| Drug_Names: (2S,4R)-1-(tert-butoxycarbonyl)-4-((7-chloro-4-methoxyisoquinolin-1-yl)oxy)pyrrolidine-2-carboxylic acid, CAS: 1028252-15-4, stock 507.4g, assay 98.3%, MWt 422.86, Formula C20H23ClN2O6, Purity >98%, SMILES ClC1=CC=C2C(C(O[C@H]3CN(C(OC(C)(C)C)=O)[C@H](C(O)=O)C3)=NC=C2OC)=C1, MDL NA |
| Drug_Names: tert-Butyl ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate, CAS: 630421-48-6, stock 92.8g, assay 98.7%, MWt 330.40, Formula C14H22N2O5S, Purity >98%, SMILES O=C(NS(C1CC1)(=O)=O)[C@@]2(NC(OC(C)(C)C)=O)C[C@H]2C=C, MDL MFCD16295005 |
| Drug_Names: 2,5-Difluorobenzothiohydrazide hydrochloride, CAS: 1018690-17-9, stock 30.6g, assay 98.5%, MWt 224.66, Formula C7H7ClF2N2S, Purity >98%, SMILES NNC(C1=CC(F)=CC=C1F)=S.Cl, MDL NA |
| Drug_Names: Phenolphthalein anilide, CAS: 6607-41-6, stock 649.8g, assay 98.3%, MWt 393.43, Formula C26H19NO3, Purity >98%, SMILES OC1=CC=C(C(C2=CC=C(O)C=C2)(N3C4=CC=CC=C4)C5=CC=CC=C5C3=O)C=C1, MDL NA |
| Drug_Names: 2-Amino-5-bromo-4-methyl-3-nitropyridine, CAS: 100367-40-6, stock 168g, assay 98.1%, MWt 232.03, Formula C6H6BrN3O2, Purity >98%, SMILES CC1=C([N+]([O-])=O)C(N)=NC=C1Br, MDL MFCD00092197 |
| Drug_Names: 5-Bromo-4-methyl-3-nitropyridin-2(1H)-one, CAS: 228410-90-0, stock 324.3g, assay 98.1%, MWt 233.02, Formula C6H5BrN2O3, Purity >98%, SMILES CC1=C([N+]([O-])=O)C(O)=NC=C1Br, MDL MFCD06659520 |
| Drug_Names: 5-Bromo-2-methoxy-3-nitro-4-picoline, CAS: 884495-14-1, stock 470.2g, assay 98.9%, MWt 247.05, Formula C7H7BrN2O3, Purity >98%, SMILES CC1=C([N+]([O-])=O)C(OC)=NC=C1Br, MDL MFCD06659504 |
| Drug_Names: 5-Bromo-4-[2-(dimethylamino)ethenyl]-2-methoxy-3-nitropyridine, CAS: 917918-81-1, stock 294.2g, assay 98.4%, MWt 302.12, Formula C10H12BrN3O3, Purity >98%, SMILES BrC1=CN=C(OC)C([N+]([O-])=O)=C1/C=C/N(C)C, MDL NA |
| Drug_Names: 2,5-Dimethoxy-4-[2-(dimethylamino)ethenyl]-3-nitropyridine, CAS: 917918-82-2, stock 848.1g, assay 98.4%, MWt 253.25, Formula C11H15N3O4, Purity >98%, SMILES COC1=NC=C(OC)C(/C=C/N(C)C)=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 4,7-Dimethoxy-1H-pyrrolo[2,3-c]pyridine hydrochloride, CAS: 917918-79-7, stock 621.6g, assay 98.8%, MWt 214.65, Formula C9H11ClN2O2, Purity >98%, SMILES COC1=NC=C(OC)C2=C1NC=C2.Cl, MDL NA |
| Drug_Names: 4-Methoxy-1H-pyrrolo[2,3-c]pyridin-7(6H)-one, CAS: 917918-80-0, stock 201.6g, assay 98.3%, MWt 164.16, Formula C8H8N2O2, Purity >98%, SMILES O=C1C(NC=C2)=C2C(OC)=CN1, MDL NA |
| Drug_Names: 7-chloro-4-methoxy-1H-pyrrolo[2,3-c]pyridine hydrochloride, CAS: 917918-83-3, stock 28.6g, assay 98.3%, MWt 219.07, Formula C8H8Cl2N2O, Purity >98%, SMILES ClC1=NC=C(OC)C2=C1NC=C2.Cl, MDL NA |
| Drug_Names: NSC 202575, CAS: 7170-01-6, stock 766.1g, assay 99%, MWt 83.09, Formula C3H5N3, Purity >98%, SMILES CC1=NNC=N1, MDL NA |
| Drug_Names: Methyl 2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetate, CAS: 701214-00-8, stock 355.6g, assay 98.2%, MWt 315.28, Formula C14H13N5O4, Purity >98%, SMILES COC1=C2C(C(C(OC)=O)=O)=CNC2=C(N3C=NC(C)=N3)N=C1, MDL NA |
| Drug_Names: 1-Benzoylpiperazine hydrochloride, CAS: 56227-55-5, stock 142.3g, assay 98.1%, MWt 226.70, Formula C11H15ClN2O, Purity >98%, SMILES O=C(N1CCNCC1)C2=CC=CC=C2.Cl, MDL MFCD00459578 |
| Drug_Names: tert-Butyl 4-benzoylpiperazine-1-carboxylate, CAS: 77278-38-7, stock 625.6g, assay 98.2%, MWt 290.36, Formula C16H22N2O3, Purity >98%, SMILES O=C(N1CCN(C(OC(C)(C)C)=O)CC1)C2=CC=CC=C2, MDL NA |
| Drug_Names: 4-Amino-5-cyano-2-hydroxy-3-methyl-benzoic acid ethyl ester, CAS: 72817-85-7, stock 98.4g, assay 98.4%, MWt 220.22, Formula C11H12N2O3, Purity >98%, SMILES OC1=C(C(OCC)=O)C=C(C#N)C(N)=C1C, MDL MFCD02089547 |
| Drug_Names: 2-Cyano-N-cyclopropyl-N-((2-fluoro-4-iodophenyl)carbamoyl)acetamide, CAS: 871700-26-4, stock 823.4g, assay 98.4%, MWt 387.15, Formula C13H11FIN3O2, Purity >98%, SMILES IC1=CC(F)=C(NC(N(C(CC#N)=O)C2CC2)=O)C=C1, MDL NA |
| Drug_Names: N'-[1-Cyclopropyl-3-(2-fluoro-4-iodophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]-N,N-dimethylformamidine, CAS: 871700-30-0, stock 733.3g, assay 98.3%, MWt 442.23, Formula C16H16FIN4O2, Purity >98%, SMILES IC1=CC(F)=C(N2C(N(C(C=C2/N=C/N(C)C)=O)C3CC3)=O)C=C1, MDL NA |
| Drug_Names: 8-Acetyl-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6-methylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, CAS: 1431697-95-8, stock 663.8g, assay 98.7%, MWt 511.24, Formula C19H15FIN3O5, Purity >98%, SMILES IC1=CC(F)=C(N2C(N(C(C(C(O)=C(C)C3=O)=C2N3C(C)=O)=O)C4CC4)=O)C=C1, MDL NA |
| Drug_Names: (1R,2S)-1-amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide hydrochloride, CAS: 630421-49-7, stock 735.4g, assay 98.6%, MWt 266.75, Formula C9H15ClN2O3S, Purity >98%, SMILES O=C(NS(C1CC1)(=O)=O)[C@@]2([C@H](C=C)C2)N.Cl, MDL NA |
| Drug_Names: 2-Acetamidonon-8-enoic acid, CAS: 924309-93-3, stock 809.7g, assay 98.8%, MWt 213.27, Formula C11H19NO3, Purity >98%, SMILES C=CCCCCCC(C(O)=O)NC(C)=O, MDL MFCD17014859 |
| Drug_Names: (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid, CAS: 552335-47-4, stock 741.3g, assay 98.3%, MWt 384.47, Formula C19H32N2O6, Purity >98%, SMILES C=CCCCCC[C@H](NC(OC(C)(C)C)=O)C(N1[C@H](C(O)=O)C[C@@H](O)C1)=O, MDL NA |
| Drug_Names: (R)-2-aminonon-8-enoic acid, CAS: 1427467-46-6, stock 254.9g, assay 98.6%, MWt 171.24, Formula C9H17NO2, Purity >98%, SMILES C=CCCCCC[C@H](C(O)=O)N, MDL NA |
| Drug_Names: tert-Butyl 4-(3-oxobutanoyl)piperazine-1-carboxylate, CAS: 401566-77-6, stock 740.2g, assay 98.8%, MWt 270.32, Formula C13H22N2O4, Purity >98%, SMILES O=C(CC(C)=O)N1CCN(C(OC(C)(C)C)=O)CC1, MDL MFCD22376654 |
| Drug_Names: N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline, CAS: 147266-92-0, stock 639.1g, assay 98.6%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES O[C@H]1C[C@H](C(O)=O)N(C(OC(C)(C)C)=O)C1, MDL NA |
| Drug_Names: (R)-tert-butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate, CAS: 1415908-67-6, stock 95.7g, assay 98.6%, MWt 300.37, Formula C13H20N2O4S, Purity >98%, SMILES O=C(C[C@@H]1C(N2CSCC2)=O)CN1C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: N-Boc-4-oxo-L-proline, CAS: 84348-37-8, stock 510.9g, assay 98%, MWt 229.23, Formula C10H15NO5, Purity >98%, SMILES CC(C)(OC(N1CC(C[C@H]1C(O)=O)=O)=O)C, MDL MFCD01860669 |
| Drug_Names: (R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid, CAS: 364077-84-9, stock 25.2g, assay 99%, MWt 229.23, Formula C10H15NO5, Purity >98%, SMILES CC(C)(OC(N1CC(C[C@@H]1C(O)=O)=O)=O)C, MDL MFCD06409980 |
| Drug_Names: Thiazolidine hydrochloride, CAS: 14446-47-0, stock 761.9g, assay 99%, MWt 125.62, Formula C3H8ClNS, Purity >98%, SMILES C1CSCN1.Cl, MDL MFCD20483376 |
| Drug_Names: tert-Butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate, CAS: 401566-78-7, stock 560.1g, assay 98%, MWt 342.44, Formula C19H26N4O2, Purity >98%, SMILES CC1=NN(C2=CC=CC=C2)C(N3CCN(C(OC(C)(C)C)=O)CC3)=C1, MDL NA |
| Drug_Names: tert-Butyl 4-(3-(2-phenylhydrazono)butanoyl)piperazine-1-carboxylate, CAS: 1415220-05-1, stock 594.5g, assay 98.8%, MWt 360.45, Formula C19H28N4O3, Purity >98%, SMILES C/C(CC(N1CCN(C(OC(C)(C)C)=O)CC1)=O)=N/NC2=CC=CC=C2, MDL NA |
| Drug_Names: (S)-Methyl indoline-2-carboxylate hydrochloride, CAS: 96056-64-3, stock 45.8g, assay 98.5%, MWt 213.66, Formula C10H12ClNO2, Purity >98%, SMILES O=C([C@H]1NC2=C(C=CC=C2)C1)OC.Cl, MDL NA |
| Drug_Names: (S)-methyl 1-acetylindoline-2-carboxylate, CAS: 110592-39-7, stock 847g, assay 98.2%, MWt 219.24, Formula C12H13NO3, Purity >98%, SMILES O=C([C@H]1N(C(C)=O)C2=C(C=CC=C2)C1)OC, MDL NA |
| Drug_Names: (S)-1-(2-(hydroxymethyl)indolin-1-yl)ethan-1-one, CAS: 297765-25-4, stock 156.5g, assay 98.3%, MWt 191.23, Formula C11H13NO2, Purity >98%, SMILES OC[C@H]1N(C(C)=O)C2=C(C=CC=C2)C1, MDL NA |
| Drug_Names: (4-(5-Fluoropyrimidin-2-yl)phenyl)methanol, CAS: 1139432-29-3, stock 445.5g, assay 98.7%, MWt 204.20, Formula C11H9FN2O, Purity >98%, SMILES FC1=CN=C(C2=CC=C(CO)C=C2)N=C1, MDL NA |
| Drug_Names: 2-(4-(Chloromethyl)phenyl)-5-fluoropyrimidine, CAS: 1139432-30-6, stock 848.4g, assay 98%, MWt 222.65, Formula C11H8ClFN2, Purity >98%, SMILES FC1=CN=C(C2=CC=C(CCl)C=C2)N=C1, MDL NA |
| Drug_Names: Ethyl 5-(tert-butylthio)-2,2-dimethyl-4-oxopentanoate, CAS: 136558-13-9, stock 622.8g, assay 98.5%, MWt 260.39, Formula C13H24O3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(CSC(C)(C)C)=O, MDL MFCD04116143 |
| Drug_Names: Ethyl 3-(3-(tert-Butylthio)-5-methoxy-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 1431697-75-4, stock 0.1g, assay 99%, MWt 363.51, Formula C20H29NO3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1)=C(SC(C)(C)C)C2=C1C=CC(OC)=C2, MDL NA |
| Drug_Names: Ethyl 3-(3-(tert-Butylthio)-1-(4-(5-fluoropyrimidin-2-yl)benzyl)-5-methoxy-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 1431698-04-2, stock 253.6g, assay 98.8%, MWt 549.70, Formula C31H36FN3O3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1CC2=CC=C(C3=NC=C(F)C=N3)C=C2)=C(SC(C)(C)C)C4=C1C=CC(OC)=C4, MDL NA |
| Drug_Names: Ethyl 3-(3-(tert-butylthio)-1-(4-(5-fluoropyrimidin-2-yl)benzyl)-5-hydroxy-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 1245899-93-7, stock 39.2g, assay 98.4%, MWt 535.67, Formula C30H34FN3O3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1CC2=CC=C(C3=NC=C(F)C=N3)C=C2)=C(SC(C)(C)C)C4=C1C=CC(O)=C4, MDL NA |
| Drug_Names: (S)-ethyl 3-(5-((1-acetylindolin-2-yl)methoxy)-3-(tert-butylthio)-1-(4-(5-fluoropyrimidin-2-yl)benzyl)-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 1431699-64-7, stock 295.6g, assay 99%, MWt 708.88, Formula C41H45FN4O4S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1CC2=CC=C(C3=NC=C(F)C=N3)C=C2)=C(SC(C)(C)C)C4=C1C=CC(OC[C@H]5N(C(C)=O)C6=C(C=CC=C6)C5)=C4, MDL NA |
| Drug_Names: tert-Butyl (S)-2-((tosyloxy)methyl)indoline-1-carboxylate, CAS: 197460-26-7, stock 62.2g, assay 98.5%, MWt 403.49, Formula C21H25NO5S, Purity >98%, SMILES CC(C)(C)OC(N1[C@H](COS(C2=CC=C(C)C=C2)(=O)=O)CC3=C1C=CC=C3)=O, MDL NA |
| Drug_Names: Ethyl 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-methoxy-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 154325-76-5, stock 429.9g, assay 98.3%, MWt 488.08, Formula C27H34ClNO3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1CC2=CC=C(Cl)C=C2)=C(SC(C)(C)C)C3=C1C=CC(OC)=C3, MDL NA |
| Drug_Names: Ethyl 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-hydroxy-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 154325-77-6, stock 853.8g, assay 98.6%, MWt 474.06, Formula C26H32ClNO3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1CC2=CC=C(Cl)C=C2)=C(SC(C)(C)C)C3=C1C=CC(O)=C3, MDL NA |
| Drug_Names: Ethyl 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoate, CAS: 189239-02-9, stock 358.9g, assay 98.1%, MWt 615.22, Formula C36H39ClN2O3S, Purity >98%, SMILES O=C(OCC)C(C)(C)CC(N1CC2=CC=C(Cl)C=C2)=C(SC(C)(C)C)C3=C1C=CC(OCC4=NC5=CC=CC=C5C=C4)=C3, MDL NA |
| Drug_Names: 1-(2-Chlorophenyl)ethanol, CAS: 13524-04-4, stock 210g, assay 98.9%, MWt 156.61, Formula C8H9ClO, Purity >98%, SMILES ClC1=C(C(C)O)C=CC=C1, MDL MFCD00041037 |
| Drug_Names: 2-((1-(2-Chlorophenyl)ethoxy)carbonyl)benzoic acid, CAS: 1431698-00-8, stock 179.9g, assay 98.6%, MWt 304.73, Formula C16H13ClO4, Purity >98%, SMILES ClC1=C(C(C)OC(C2=CC=CC=C2C(O)=O)=O)C=CC=C1, MDL NA |
| Drug_Names: 3,4-Dinitro-1H-pyrrolo[2,3-b]pyridine 7-oxide, CAS: 1431698-08-6, stock 792g, assay 98.3%, MWt 224.13, Formula C7H4N4O5, Purity >98%, SMILES [O-][N+]1=C(NC=C2[N+]([O-])=O)C2=C([N+]([O-])=O)C=C1, MDL NA |
| Drug_Names: 2-(3-phenylprop-2-enamido)acetic acid, CAS: 16534-24-0, stock 571.7g, assay 98.3%, MWt 205.21, Formula C11H11NO3, Purity >98%, SMILES O=C(NCC(O)=O)/C=C/C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(4-Chlorobenzyl)-1-(4-methoxyphenyl)hydrazine, CAS: 62646-04-2, stock 499.5g, assay 98.1%, MWt 262.73, Formula C14H15ClN2O, Purity >98%, SMILES NN(C1=CC=C(OC)C=C1)CC2=CC=C(Cl)C=C2, MDL NA |
| Drug_Names: (S)-2,3-Dihydro-1H-inden-1-amine hydrochloride, CAS: 32457-23-1, stock 45.7g, assay 98.5%, MWt 169.65, Formula C9H12ClN, Purity >98%, SMILES N[C@H]1CCC2=CC=CC=C21.Cl, MDL MFCD16661198 |
| Drug_Names: Ethyl 2-acetylpent-4-enoate, CAS: 610-89-9, stock 446.5g, assay 98.8%, MWt 170.21, Formula C9H14O3, Purity >98%, SMILES CC(C(CC=C)C(OCC)=O)=O, MDL MFCD00026877 |
| Drug_Names: (3R)-2-oxo-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-3-yl acetate, CAS: 1431704-20-9, stock 55.2g, assay 98.7%, MWt 182.17, Formula C9H10O4, Purity >98%, SMILES O=C1[C@H](OC(C)=O)C2CC=CC2O1, MDL NA |
| Drug_Names: N-[(1R)-2,3-dihydro-1H-inden-1-yl]-2-ethoxyacetamide, CAS: 1431699-54-5, stock 640.6g, assay 98.3%, MWt 219.28, Formula C13H17NO2, Purity >98%, SMILES CCOCC(N[C@@H]1CCC2=CC=CC=C21)=O, MDL NA |
| Drug_Names: Ethyl 2-acetyl-2-(4-chlorobenzyl)pent-4-enoate, CAS: 93026-34-7, stock 557.6g, assay 98.3%, MWt 294.77, Formula C16H19ClO3, Purity >98%, SMILES CC(C(CC=C)(CC1=CC=C(Cl)C=C1)C(OCC)=O)=O, MDL NA |
| Drug_Names: Ethyl 2-(4-chlorobenzyl)pent-4-enoate, CAS: 1431698-12-2, stock 547g, assay 98.2%, MWt 252.74, Formula C14H17ClO2, Purity >98%, SMILES CCOC(C(CC1=CC=C(Cl)C=C1)CC=C)=O, MDL NA |
| Drug_Names: 2-(4-Chlorobenzyl)pent-4-enoic acid, CAS: 91393-56-5, stock 703g, assay 98.5%, MWt 224.68, Formula C12H13ClO2, Purity >98%, SMILES OC(C(CC1=CC=C(Cl)C=C1)CC=C)=O, MDL NA |
| Drug_Names: Methyl (1-(4-chlorophenyl)pent-4-en-2-yl)carbamate, CAS: 18605-65-7, stock 86.7g, assay 98.2%, MWt 253.72, Formula C13H16ClNO2, Purity >98%, SMILES O=C(OC)NC(CC1=CC=C(Cl)C=C1)CC=C, MDL NA |
| Drug_Names: Methyl (1-(4-chlorophenyl)pent-4-en-2-yl)(ethoxymethyl)carbamate, CAS: 177707-16-3, stock 648.8g, assay 98.3%, MWt 311.80, Formula C16H22ClNO3, Purity >98%, SMILES COC(N(C(CC1=CC=C(Cl)C=C1)CC=C)COCC)=O, MDL NA |
| Drug_Names: (2R,4S)-methyl 4-acetamido-2-(4-chlorobenzyl)piperidine-1-carboxylate, CAS: 177707-17-4, stock 606.5g, assay 98.5%, MWt 324.80, Formula C16H21ClN2O3, Purity >98%, SMILES O=C(N1[C@H](CC2=CC=C(Cl)C=C2)C[C@@H](NC(C)=O)CC1)OC, MDL NA |
| Drug_Names: N-((2R,4S)-2-(4-chlorobenzyl)piperidin-4-yl)acetamide hydrochloride, CAS: 183683-28-5, stock 770.6g, assay 98.3%, MWt 303.23, Formula C14H20Cl2N2O, Purity >98%, SMILES CC(NC1CC(CC2=CC=C(Cl)C=C2)NCC1)=O.[H]Cl, MDL NA |
| Drug_Names: (S)-2-chloro-2-oxo-1-phenylethyl acetate, CAS: 51019-44-4, stock 395.5g, assay 98.1%, MWt 212.63, Formula C10H9ClO3, Purity >98%, SMILES O=C(Cl)[C@H](C1=CC=CC=C1)OC(C)=O, MDL NA |
| Drug_Names: (S)-2-((2R,4S)-4-acetamido-2-(4-chlorobenzyl)piperidin-1-yl)-2-oxo-1-phenylethyl acetate, CAS: 177707-21-0, stock 390.4g, assay 98.6%, MWt 442.94, Formula C24H27ClN2O4, Purity >98%, SMILES ClC1=CC=C(C=C1)C[C@H]2N(C([C@H](C3=CC=CC=C3)OC(C)=O)=O)CC[C@H](NC(C)=O)C2, MDL NA |
| Drug_Names: (S)-2-((2S,4R)-4-acetamido-2-(4-chlorobenzyl)piperidin-1-yl)-2-oxo-1-phenylethyl acetate, CAS: 177770-52-4, stock 326.7g, assay 98%, MWt 442.94, Formula C24H27ClN2O4, Purity >98%, SMILES ClC1=CC=C(C=C1)C[C@@H]2N(C([C@H](C3=CC=CC=C3)OC(C)=O)=O)CC[C@@H](NC(C)=O)C2, MDL NA |
| Drug_Names: (2R,4S)-2-(4-chloro-benzyl)-piperidine-4-amine, CAS: 177707-18-5, stock 180.9g, assay 98.8%, MWt 224.73, Formula C12H17ClN2, Purity >98%, SMILES N[C@@H]1C[C@@H](CC2=CC=C(Cl)C=C2)NCC1, MDL NA |
| Drug_Names: ((2R,4S)-4-amino-2-(4-chlorobenzyl)piperidin-1-yl)(3,5-bis(trifluoromethyl)phenyl)methanone, CAS: 177707-22-1, stock 768.5g, assay 98.6%, MWt 464.83, Formula C21H19ClF6N2O, Purity >98%, SMILES N[C@@H]1C[C@@H](CC2=CC=C(Cl)C=C2)N(C(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=O)CC1, MDL NA |
| Drug_Names: 1-Chloro-2-nitro-4-(phenylsulfonyl)benzene, CAS: 4779-36-6, stock 400.6g, assay 98.8%, MWt 297.71, Formula C12H8ClNO4S, Purity >98%, SMILES ClC1=CC=C(S(C2=CC=CC=C2)(=O)=O)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 5-(Phenylsulfonyl)-2-(trifluoromethyl)aniline, CAS: 915763-83-6, stock 652.3g, assay 98.6%, MWt 301.28, Formula C13H10F3NO2S, Purity >98%, SMILES NC1=CC(S(C2=CC=CC=C2)(=O)=O)=CC=C1C(F)(F)F, MDL NA |
| Drug_Names: (Z)-ethyl 2-cyano-3-hydroxybut-2-enoate, CAS: 794574-92-8, stock 16.7g, assay 98.3%, MWt 155.15, Formula C7H9NO3, Purity >98%, SMILES C/C(O)=C(C#N)/C(OCC)=O, MDL NA |
| Drug_Names: 4-Ethoxycarbonylmethylphenylboronic acid pinacol ester, CAS: 859169-20-3, stock 385.7g, assay 98.5%, MWt 290.16, Formula C16H23BO4, Purity >98%, SMILES O=C(OCC)CC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1, MDL MFCD08704684 |
| Drug_Names: Methyl 3-methylaminocrotonate, CAS: 13412-12-9, stock 42g, assay 98.8%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES C/C(NC)=C\C(OC)=O, MDL NA |
| Drug_Names: Methyl 5-(4-bromophenyl)-3-methylisoxazole-4-carboxylate, CAS: 1228689-61-9, stock 597.7g, assay 98.5%, MWt 296.12, Formula C12H10BrNO3, Purity >98%, SMILES O=C(C1=C(C2=CC=C(Br)C=C2)ON=C1C)OC, MDL MFCD18384841 |
| Drug_Names: (R)-1-(2-chlorophenyl)ethyl (5-(4-bromophenyl)-3-methylisoxazol-4-yl)carbamate, CAS: 1228690-20-7, stock 766.2g, assay 98.6%, MWt 435.70, Formula C19H16BrClN2O3, Purity >98%, SMILES O=C(O[C@@H](C1=CC=CC=C1Cl)C)NC2=C(C3=CC=C(Br)C=C3)ON=C2C, MDL NA |
| Drug_Names: [4'-[4-[[[[(R)-1-(2-Chlorophenyl)ethyl]oxy]carbonyl]amino]-3-methylisoxazol-5-yl]biphenyl-4-yl]acetic acid ethyl ester, CAS: 1228690-21-8, stock 610.1g, assay 99%, MWt 518.99, Formula C29H27ClN2O5, Purity >98%, SMILES O=C(OCC)CC1=CC=C(C2=CC=C(C3=C(NC(O[C@@H](C4=CC=CC=C4Cl)C)=O)C(C)=NO3)C=C2)C=C1, MDL NA |
| Drug_Names: (S)-5,6,7,8-Tetrahydroquinolin-8-amine dihydrochloride, CAS: 865303-57-7, stock 439.9g, assay 98.8%, MWt 221.13, Formula C9H14Cl2N2, Purity >98%, SMILES N[C@@H]1C2=NC=CC=C2CCC1.Cl.Cl, MDL NA |
| Drug_Names: (R)-5,6,7,8-tetrahydroquinolin-8-amine hydrochloride, CAS: 1431726-92-9, stock 428.4g, assay 98.4%, MWt 184.67, Formula C9H13ClN2, Purity >98%, SMILES N[C@H]1C2=NC=CC=C2CCC1.Cl, MDL NA |
| Drug_Names: 1-Bromo-3-isopropoxybenzene, CAS: 131738-73-3, stock 724.5g, assay 98.6%, MWt 215.09, Formula C9H11BrO, Purity >98%, SMILES BrC1=CC(OC(C)C)=CC=C1, MDL MFCD00070756 |
| Drug_Names: 4-(3-Isopropoxyphenyl)-1,3-dimethylpiperidin-4-ol, CAS: 145340-44-9, stock 400.4g, assay 98.5%, MWt 263.38, Formula C16H25NO2, Purity >98%, SMILES CC(C)OC1=CC=CC(C2(O)C(C)CN(C)CC2)=C1, MDL NA |
| Drug_Names: Ethyl (4-(3-isopropoxyphenyl)-1,3-dimethylpiperidin-4-yl) carbonate, CAS: 149541-62-8, stock 720.2g, assay 98.1%, MWt 335.44, Formula C19H29NO4, Purity >98%, SMILES CC(C)OC1=CC=CC(C2(OC(OCC)=O)C(C)CN(C)CC2)=C1, MDL NA |
| Drug_Names: Ethyl ((3S,4R)-4-(3-isopropoxyphenyl)-1,3-dimethylpiperidin-4-yl) carbonate, CAS: 143957-08-8, stock 62.3g, assay 98.4%, MWt 335.44, Formula C19H29NO4, Purity >98%, SMILES CC(C)OC1=CC=CC([C@]2(OC(OCC)=O)[C@@H](C)CN(C)CC2)=C1, MDL NA |
| Drug_Names: (R)-4-(3-isopropoxyphenyl)-1,3-dimethyl-1,2,3,6-tetrahydropyridine, CAS: 143919-32-8, stock 871.9g, assay 98.5%, MWt 245.36, Formula C16H23NO, Purity >98%, SMILES CC(C)OC1=CC=CC(C2=CCN(C)C[C@@H]2C)=C1, MDL NA |
| Drug_Names: (3R)-4-(3-isopropoxyphenyl)-1,3,4-trimethylpiperidine, CAS: 1431704-21-0, stock 50.2g, assay 99%, MWt 261.40, Formula C17H27NO, Purity >98%, SMILES CC(C)OC1=CC=CC(C2(C)[C@@H](C)CN(C)CC2)=C1, MDL NA |
| Drug_Names: (3R,4R)-4-(3-isopropoxyphenyl)-1,3,4-trimethylpiperidine, CAS: 143919-34-0, stock 810.3g, assay 98.4%, MWt 261.40, Formula C17H27NO, Purity >98%, SMILES CC(C)OC1=CC=CC([C@@]2(C)[C@@H](C)CN(C)CC2)=C1, MDL NA |
| Drug_Names: 2-Benzyl-1,3-propanediol, CAS: 2612-30-8, stock 394.4g, assay 98%, MWt 166.22, Formula C10H14O2, Purity >98%, SMILES OCC(CO)CC1=CC=CC=C1, MDL NA |
| Drug_Names: (S)-3-acetoxy-2-benzylpropanoic acid, CAS: 121232-85-7, stock 354.9g, assay 98.2%, MWt 222.24, Formula C12H14O4, Purity >98%, SMILES OC([C@H](COC(C)=O)CC1=CC=CC=C1)=O, MDL NA |
| Drug_Names: (S)-ethyl 2-(2-benzyl-3-hydroxypropanamido)acetate, CAS: 1314751-83-1, stock 164.6g, assay 98.4%, MWt 265.31, Formula C14H19NO4, Purity >98%, SMILES OC[C@@H](C(NCC(OCC)=O)=O)CC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Acetoxy-2-benzylpropanoic acid, CAS: 187610-68-0, stock 509.1g, assay 98%, MWt 222.24, Formula C12H14O4, Purity >98%, SMILES OC(C(COC(C)=O)CC1=CC=CC=C1)=O, MDL NA |
| Drug_Names: Ethyl 2-(2-benzyl-3-hydroxypropanamido)acetate, CAS: 1431697-70-9, stock 704.1g, assay 99%, MWt 265.31, Formula C14H19NO4, Purity >98%, SMILES OCC(C(NCC(OCC)=O)=O)CC1=CC=CC=C1, MDL NA |
| Drug_Names: Ethyl 2-(2-benzyl-3-(((4-nitrophenyl)sulfonyl)oxy)propanamido)acetate, CAS: 1431697-91-4, stock 152.2g, assay 98%, MWt 450.46, Formula C20H22N2O8S, Purity >98%, SMILES O=C(NCC(OCC)=O)C(CC1=CC=CC=C1)COS(C2=CC=C([N+]([O-])=O)C=C2)(=O)=O, MDL NA |
| Drug_Names: 2-Benzyl-3-hydroxypropyl acetate, CAS: 90107-01-0, stock 509.3g, assay 98.2%, MWt 208.25, Formula C12H16O3, Purity >98%, SMILES OCC(COC(C)=O)CC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-(7-Chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, CAS: 376608-75-2, stock 261.1g, assay 98.5%, MWt 429.92, Formula C17H24ClN5O4S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(SCCC)N=C3Cl)=C3N=N2)[C@H]4[C@@H]1OC(C)(C)O4, MDL MFCD23106418 |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, CAS: 274693-26-4, stock 75.9g, assay 98.1%, MWt 562.63, Formula C26H32F2N6O4S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(SCCC)N=C3N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H]6[C@@H]1OC(C)(C)O6, MDL NA |
| Drug_Names: (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, CAS: 274693-39-9, stock 615.4g, assay 98.1%, MWt 554.57, Formula C23H28F2N6O6S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)(=O)=O)N=C3N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H](O)[C@@H]1O, MDL NA |
| Drug_Names: (1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, CAS: 1251765-07-7, stock 636.2g, assay 98.6%, MWt 370.43, Formula C14H22N6O4S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(SCCC)N=C3N)=C3N=N2)[C@H](O)[C@@H]1O, MDL NA |
| Drug_Names: 2-Thioxo-2,3,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4(5H)-one, CAS: 35563-27-0, stock 550.8g, assay 98.9%, MWt 168.22, Formula C7H8N2OS, Purity >98%, SMILES S=C(N1)NC2=C(CCC2)C1=O, MDL NA |
| Drug_Names: 2-((4-Fluorobenzyl)thio)-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one, CAS: 451487-18-6, stock 554.8g, assay 98.3%, MWt 276.33, Formula C14H13FN2OS, Purity >98%, SMILES O=C1NC(SCC2=CC=C(F)C=C2)=NC3=C1CCC3, MDL NA |
| Drug_Names: 2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid, CAS: 356058-42-9, stock 657.3g, assay 98.9%, MWt 334.37, Formula C16H15FN2O3S, Purity >98%, SMILES O=C1N=C(SCC2=CC=C(F)C=C2)N(CC(O)=O)C3=C1CCC3, MDL NA |
| Drug_Names: 4'-Trifluoromethylbiphenyl-4-carboxaldehyde, CAS: 90035-34-0, stock 519.2g, assay 98%, MWt 250.22, Formula C14H9F3O, Purity >98%, SMILES O=CC1=CC=C(C2=CC=C(C(F)(F)F)C=C2)C=C1, MDL MFCD01862519 |
| Drug_Names: N,N-Diethyl-N'-(4'-trifluoromethylbiphenyl-4-ylmethyl)-ethane-1,2-diamine, CAS: 304694-40-4, stock 524g, assay 98.8%, MWt 350.42, Formula C20H25F3N2, Purity >98%, SMILES FC(C1=CC=C(C2=CC=C(C=C2)CNCCN(CC)CC)C=C1)(F)F, MDL NA |
| Drug_Names: Methyl 2-(((trifluoromethyl)sulfonyl)oxy)acetate, CAS: 88016-31-3, stock 428.6g, assay 98.1%, MWt 222.14, Formula C4H5F3O5S, Purity >98%, SMILES O=C(OC)COS(=O)(C(F)(F)F)=O, MDL NA |
| Drug_Names: [5-(4-Bromophenyl)-3-methylisoxazol-4-yl]carbamic acid 1-(2-chlorophenyl)ethyl ester, CAS: 1228689-78-8, stock 516.9g, assay 98.2%, MWt 435.70, Formula C19H16BrClN2O3, Purity >98%, SMILES O=C(OC(C1=CC=CC=C1Cl)C)NC2=C(C3=CC=C(Br)C=C3)ON=C2C, MDL NA |
| Drug_Names: 2-(4'-(4-(((1-(2-Chlorophenyl)ethoxy)carbonyl)amino)-3-methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid, CAS: 1228689-85-7, stock 667g, assay 98.2%, MWt 490.93, Formula C27H23ClN2O5, Purity >98%, SMILES O=C(O)CC1=CC=C(C2=CC=C(C3=C(NC(OC(C4=CC=CC=C4Cl)C)=O)C(C)=NO3)C=C2)C=C1, MDL NA |
| Drug_Names: 2,11-Dichlorodibenzo[b,f][1,4]oxazepine, CAS: 3455-14-9, stock 632g, assay 99%, MWt 264.11, Formula C13H7Cl2NO, Purity >98%, SMILES ClC1=NC2=CC=CC=C2OC3=C1C=C(Cl)C=C3, MDL NA |
| Drug_Names: (7-Bromo-2,6-dimethyl-4-oxoquinazolin-3(4H)-yl)methyl pivalate, CAS: 140373-65-5, stock 570.6g, assay 98.8%, MWt 367.24, Formula C16H19BrN2O3, Purity >98%, SMILES CC(C)(C)C(OCN1C(C)=NC2=C(C=C(C)C(Br)=C2)C1=O)=O, MDL NA |
| Drug_Names: (7-Bromo-6-(bromomethyl)-2-methyl-4-oxoquinazolin-3(4H)-yl)methyl pivalate, CAS: 140395-66-0, stock 111.6g, assay 98.3%, MWt 446.13, Formula C16H18Br2N2O3, Purity >98%, SMILES CC(C)(C)C(OCN1C(C)=NC2=C(C=C(CBr)C(Br)=C2)C1=O)=O, MDL NA |
| Drug_Names: 2-Furancarboxylic acid hydrazide, CAS: 3326-71-4, stock 753.9g, assay 98.7%, MWt 126.11, Formula C5H6N2O2, Purity >98%, SMILES NNC(C1=CC=CO1)=O, MDL MFCD00003235 |
| Drug_Names: 1-(4-(4-(2-Methoxyethoxy)phenyl)piperazin-1-yl)ethanone, CAS: 387358-27-2, stock 321.1g, assay 98.1%, MWt 278.35, Formula C15H22N2O3, Purity >98%, SMILES COCCOC1=CC=C(N2CCN(C(C)=O)CC2)C=C1, MDL NA |
| Drug_Names: 1-(4-(2-Methoxyethoxy)phenyl)piperazine, CAS: 515160-72-2, stock 747.5g, assay 98.8%, MWt 236.31, Formula C13H20N2O2, Purity >98%, SMILES COCCOC1=CC=C(N2CCNCC2)C=C1, MDL NA |
| Drug_Names: 2-Amino-4,6-dichloropyrimidine-5-carbaldehyde, CAS: 5604-46-6, stock 31g, assay 98.8%, MWt 192.00, Formula C5H3Cl2N3O, Purity >98%, SMILES O=CC1=C(Cl)N=C(N)N=C1Cl, MDL MFCD03001242 |
| Drug_Names: N'-(6-amino-1-(2-hydroxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)furan-2-carbohydrazide, CAS: 377729-86-7, stock 134.7g, assay 98.2%, MWt 303.28, Formula C12H13N7O3, Purity >98%, SMILES NC1=NC(N(CCO)N=C2)=C2C(NNC(C3=CC=CO3)=O)=N1, MDL NA |
| Drug_Names: 7-(2-Bromoethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, CAS: 377729-85-6, stock 138.5g, assay 98.1%, MWt 348.16, Formula C12H10BrN7O, Purity >98%, SMILES NC1=NC(N(CCBr)N=C2)=C2C3=NC(C4=CC=CO4)=NN13, MDL NA |
| Drug_Names: tert-Butyl 2-benzyl-1-oxo-2,5-diazaspiro[3.4]octane-5-carboxylate, CAS: 1206970-01-5, stock 208.2g, assay 98.1%, MWt 316.39, Formula C18H24N2O3, Purity >98%, SMILES O=C(N(CC1=CC=CC=C1)C2)C2(CCC3)N3C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: 1-(5-Chloro-2-aminophenyl)-1-phenylethanol, CAS: 3158-98-3, stock 147.6g, assay 98.7%, MWt 247.72, Formula C14H14ClNO, Purity >98%, SMILES OC(C1=CC=CC=C1)(C)C2=CC(Cl)=CC=C2N, MDL NA |
| Drug_Names: N-[4-Chloro-2-(1-hydroxy-1-phenylethyl)phenyl]-N'-ethylthiourea, CAS: 21740-97-6, stock 726.3g, assay 98.5%, MWt 334.86, Formula C17H19ClN2OS, Purity >98%, SMILES OC(C1=CC=CC=C1)(C)C2=CC(Cl)=CC=C2NC(NCC)=S, MDL NA |
| Drug_Names: (R)-2-allylpyrrolidine-2-carboxylic acid, CAS: 121772-98-3, stock 642.5g, assay 99%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES OC([C@@]1(CC=C)NCCC1)=O, MDL NA |
| Drug_Names: (4R)-2-(((R)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)pyrrolidin-2-yl)methyl)-1,3-thiazinane-4-carboxylic acid, CAS: 221040-36-4, stock 484.4g, assay 98.4%, MWt 388.48, Formula C17H28N2O6S, Purity >98%, SMILES O=C([C@@H]1NC(C[C@]2(C(OC)=O)N(C(OC(C)(C)C)=O)CCC2)SCC1)O, MDL NA |
| Drug_Names: (2R,4'R,8a'R)-1-tert-butyl 4'-methyl 6'-oxohexahydrospiro[pyrrolidine-2,7'-pyrrolo[2,1-b][1,3]thiazine]-1,4'-dicarboxylate, CAS: 221040-37-5, stock 784.7g, assay 98.1%, MWt 370.46, Formula C17H26N2O5S, Purity >98%, SMILES O=C(N([C@@H](C(OC)=O)CCS1)[C@@]1([H])C2)[C@@]32N(C(OC(C)(C)C)=O)CCC3, MDL NA |
| Drug_Names: 2-(4-(2-(2,4-Dichlorophenoxy)acetamido)phenyl)acetic acid, CAS: 1012207-68-9, stock 824.4g, assay 98.4%, MWt 354.18, Formula C16H13Cl2NO4, Purity >98%, SMILES ClC1=CC(Cl)=C(OCC(NC2=CC=C(CC(O)=O)C=C2)=O)C=C1, MDL NA |
| Drug_Names: (R)-2-Amino-4-mercaptobutanoic acid, CAS: 6027-14-1, stock 842.3g, assay 98.6%, MWt 135.18, Formula C4H9NO2S, Purity >98%, SMILES N[C@H](CCS)C(O)=O, MDL MFCD09842578 |
| Drug_Names: (2R,2'R)-4,4'-Disulfanediylbis(2-aminobutanoic acid), CAS: 6027-15-2, stock 314.3g, assay 98.4%, MWt 268.35, Formula C8H16N2O4S2, Purity >98%, SMILES O=C(O)[C@H](N)CCSSCC[C@@H](N)C(O)=O, MDL MFCD00068281 |
| Drug_Names: (2R,2'R)-4,4'-disulfanediylbis(2-((tert-butoxycarbonyl)amino)butanoic acid), CAS: 113132-85-7, stock 157.7g, assay 98.8%, MWt 468.59, Formula C18H32N2O8S2, Purity >98%, SMILES CC(C)(C)OC(N[C@@H](C(O)=O)CCSSCC[C@H](C(O)=O)NC(OC(C)(C)C)=O)=O, MDL NA |
| Drug_Names: N-[(1,1-Dimethylethoxy)carbonyl]-D-homocysteine, CAS: 1176833-85-4, stock 67.9g, assay 98.1%, MWt 235.30, Formula C9H17NO4S, Purity >98%, SMILES SCC[C@H](C(O)=O)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: 3-Fluoro-4-aminophenol, CAS: 399-95-1, stock 695.2g, assay 99%, MWt 127.12, Formula C6H6FNO, Purity >98%, SMILES OC1=CC(F)=C(N)C=C1, MDL MFCD00077452 |
| Drug_Names: 6-Bromo-7-(3-((tert-butyldimethylsilyl)oxy)propyl)-5-(p-tolyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 821794-85-8, stock 736.1g, assay 99%, MWt 475.50, Formula C22H31BrN4OSi, Purity >98%, SMILES NC1=C2C(N(CCCO[Si](C)(C)C(C)(C)C)C(Br)=C2C3=CC=C(C)C=C3)=NC=N1, MDL NA |
| Drug_Names: 7-(3-((tert-Butyldimethylsilyl)oxy)propyl)-6-(1-ethoxyvinyl)-5-(p-tolyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 821794-86-9, stock 377.9g, assay 98.2%, MWt 466.69, Formula C26H38N4O2Si, Purity >98%, SMILES NC1=C(C(C2=CC=C(C)C=C2)=C(C(OCC)=C)N3CCCO[Si](C)(C)C(C)(C)C)C3=NC=N1, MDL NA |
| Drug_Names: (3aS,4R,6S,6aR)-6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-amine, CAS: 1400665-85-1, stock 398.4g, assay 98.7%, MWt 331.52, Formula C16H33NO4Si, Purity >98%, SMILES N[C@H]1[C@H]2[C@H](OC(C)(C)O2)[C@@H](OCCO[Si](C)(C)C(C)(C)C)C1, MDL NA |
| Drug_Names: (3R,4S)-1-tert-butyl 3-ethyl 4-(((R)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate hydrochloride, CAS: 267230-41-1, stock 179.4g, assay 98.2%, MWt 398.92, Formula C20H31ClN2O4, Purity >98%, SMILES CC(C)(C)OC(N1C[C@@H](N[C@H](C)C2=CC=CC=C2)[C@H](C(OCC)=O)C1)=O.Cl, MDL NA |
| Drug_Names: rel-1-(tert-Butyl) 3-ethyl (3R,4S)-4-((2-(5-fluoro-2-hydroxyphenyl)-6,7-dimethoxyquinazolin-4-yl)amino)pyrrolidine-1,3-dicarboxylate, CAS: 1262849-80-8, stock 38.7g, assay 98.7%, MWt 556.58, Formula C28H33FN4O7, Purity >98%, SMILES COC1=C(OC)C=C(N=C(C2=C(O)C=CC(F)=C2)N=C3N[C@@H]4CN(C[C@H]4C(OCC)=O)C(OC(C)(C)C)=O)C3=C1, MDL NA |
| Drug_Names: 4-(4-Bromophenyl)piperidin-4-ol hydrochloride, CAS: 213480-97-8, stock 494.6g, assay 98.6%, MWt 292.60, Formula C11H15BrClNO, Purity >98%, SMILES OC1(C2=CC=C(Br)C=C2)CCNCC1.Cl, MDL NA |
| Drug_Names: 4-(4-Bromophenyl)-4-(4-chlorophenyl)piperidine hydrochloride, CAS: 857531-97-6, stock 444.4g, assay 99%, MWt 387.14, Formula C17H18BrCl2N, Purity >98%, SMILES ClC1=CC=C(C2(C3=CC=C(Br)C=C3)CCNCC2)C=C1.Cl, MDL NA |
| Drug_Names: tert-Butyl 4-(4-bromophenyl)-4-(4-chlorophenyl)-piperidine-1-carboxylate, CAS: 857532-23-1, stock 479.5g, assay 98.4%, MWt 450.80, Formula C22H25BrClNO2, Purity >98%, SMILES ClC1=CC=C(C2(C3=CC=C(Br)C=C3)CCN(C(OC(C)(C)C)=O)CC2)C=C1, MDL NA |
| Drug_Names: (3S,4R)-1-tert-butyl 3-ethyl 4-(((R)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate hydrochloride, CAS: 346610-81-9, stock 894.5g, assay 98.1%, MWt 398.92, Formula C20H31ClN2O4, Purity >98%, SMILES CC(C)(C)OC(N1C[C@H](N[C@H](C)C2=CC=CC=C2)[C@@H](C(OCC)=O)C1)=O.Cl, MDL NA |
| Drug_Names: N-(5-(4-bromophenyl)-6-(2-hydroxyethoxy)pyrimidin-4-yl)propane-1-sulfamide, CAS: 1393813-43-8, stock 780.2g, assay 99%, MWt 431.30, Formula C15H19BrN4O4S, Purity >98%, SMILES BrC1=CC=C(C2=C(NS(NCCC)(=O)=O)N=CN=C2OCCO)C=C1, MDL NA |
| Drug_Names: tert-Butyl N-propylsulfamoylcarbamate, CAS: 1393813-40-5, stock 597.5g, assay 98.7%, MWt 238.30, Formula C8H18N2O4S, Purity >98%, SMILES CCCNS(NC(OC(C)(C)C)=O)(=O)=O, MDL NA |
| Drug_Names: Methyl (2S,4R)-1-(tert-butoxycarbonyl)-4-aminopyrrolidine-2-carboxylate, CAS: 121148-00-3, stock 828.6g, assay 99%, MWt 244.29, Formula C11H20N2O4, Purity >98%, SMILES O=C(OC)[C@H]1N(C(OC(C)(C)C)=O)C[C@H](N)C1, MDL MFCD01861782 |
| Drug_Names: 1-(tert-Butyl) 2-methyl (2S,4R)-4-benzamidopyrrolidine-1,2-dicarboxylate, CAS: 943134-37-0, stock 755.1g, assay 98.7%, MWt 348.39, Formula C18H24N2O5, Purity >98%, SMILES O=C(N1[C@H](C(OC)=O)C[C@@H](NC(C2=CC=CC=C2)=O)C1)OC(C)(C)C, MDL NA |
| Drug_Names: Methyl (2S,4R)-4-benzamido-1-((tert-butoxycarbonyl)glycyl)pyrrolidine-2-carboxylate, CAS: 943134-40-5, stock 300.5g, assay 98.5%, MWt 405.44, Formula C20H27N3O6, Purity >98%, SMILES O=C([C@H]1N(C(CNC(OC(C)(C)C)=O)=O)C[C@H](NC(C2=CC=CC=C2)=O)C1)OC, MDL NA |
| Drug_Names: (2S,4R)-4-benzamido-1-(2-((tert-butoxycarbonyl)amino)acetyl)pyrrolidine-2-carboxylic acid, CAS: 943134-34-7, stock 135.5g, assay 98.9%, MWt 391.42, Formula C19H25N3O6, Purity >98%, SMILES O=C([C@H]1N(C(CNC(OC(C)(C)C)=O)=O)C[C@H](NC(C2=CC=CC=C2)=O)C1)O, MDL NA |
| Drug_Names: 2-Chloro-N-(3-chlorophenyl)-9H-purin-6-amine, CAS: 190654-76-3, stock 429.3g, assay 98.6%, MWt 280.11, Formula C11H7Cl2N5, Purity >98%, SMILES ClC1=NC(NC2=CC=CC(Cl)=C2)=C3N=CNC3=N1, MDL NA |
| Drug_Names: 2-Chloro-N-(3-chlorophenyl)-9-isopropyl-9H-purin-6-amine, CAS: 190654-78-5, stock 865.6g, assay 98.3%, MWt 322.19, Formula C14H13Cl2N5, Purity >98%, SMILES CC(N1C=NC2=C(NC3=CC=CC(Cl)=C3)N=C(Cl)N=C12)C, MDL NA |
| Drug_Names: Methyl (2S,4R)-4-benzamidopyrrolidine-2-carboxylate hydrochloride, CAS: 943134-38-1, stock 84.5g, assay 98.3%, MWt 284.74, Formula C13H17ClN2O3, Purity >98%, SMILES O=C([C@H]1NC[C@H](NC(C2=CC=CC=C2)=O)C1)OC.Cl, MDL NA |
| Drug_Names: N1-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-1,2-ethanediamine, CAS: 1227090-46-1, stock 247g, assay 98.3%, MWt 196.33, Formula C12H24N2, Purity >98%, SMILES NCCNC/C=C(C)/CC/C=C(C)\C, MDL NA |
| Drug_Names: (2R,3S)-2-(Hydroxymethyl)-5-methoxytetrahydrofuran-3-ol, CAS: 60134-26-1, stock 885.4g, assay 98.2%, MWt 148.16, Formula C6H12O4, Purity >98%, SMILES OC[C@@H](O1)[C@@H](O)CC1OC, MDL MFCD00134161 |
| Drug_Names: 5-tert-Butyl 2-ethyl 3-amino-6,6-dimethylpyrrolo[3,4-c]pyrazole-2,5(4H,6H)-dicarboxylate, CAS: 718632-46-3, stock 105.6g, assay 99%, MWt 324.38, Formula C15H24N4O4, Purity >98%, SMILES O=C(OC(C)(C)C)N1C(C)(C)C2=NN(C(OCC)=O)C(N)=C2C1, MDL MFCD20134032 |
| Drug_Names: 6-Maleimidocapronic acid, CAS: 55750-53-3, stock 861.4g, assay 98.1%, MWt 211.21, Formula C10H13NO4, Purity >98%, SMILES O=C(N1CCCCCC(O)=O)C=CC1=O, MDL MFCD00043140 |
| Drug_Names: 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide 2,2,2-trifluoroacetate, CAS: 151038-94-7, stock 234.8g, assay 98%, MWt 339.27, Formula C12H16F3N3O5, Purity >98%, SMILES O=C(NN)CCCCCN1C(C=CC1=O)=O.O=C(O)C(F)(F)F, MDL MFCD07357647 |
| Drug_Names: 2-Thioxodihydropyrimidine-4,6(1H,5H)-dione, CAS: 504-17-6, stock 302.5g, assay 98.8%, MWt 144.15, Formula C4H4N2O2S, Purity >98%, SMILES S=C(NC(C1)=O)NC1=O, MDL MFCD00006674 |
| Drug_Names: 5-Nitro-2-(propylthio)pyrimidine-4,6-diol, CAS: 145783-13-7, stock 806g, assay 98.5%, MWt 231.23, Formula C7H9N3O4S, Purity >98%, SMILES OC1=C([N+]([O-])=O)C(O)=NC(SCCC)=N1, MDL NA |
| Drug_Names: (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid, CAS: 220352-36-3, stock 607.1g, assay 98.4%, MWt 198.17, Formula C10H8F2O2, Purity >98%, SMILES FC1=CC([C@@H]2C[C@H]2C(O)=O)=CC=C1F, MDL MFCD20639702 |
| Drug_Names: Phenyl vinyl sulfone, CAS: 5535-48-8, stock 491.7g, assay 98.5%, MWt 168.21, Formula C8H8O2S, Purity >98%, SMILES O=S(C=C)(C1=CC=CC=C1)=O, MDL MFCD00007554 |
| Drug_Names: 5-(2-Chloroethyl)-2,3-dihydrobenzofuran, CAS: 943034-50-2, stock 182.4g, assay 98.8%, MWt 182.65, Formula C10H11ClO, Purity >98%, SMILES ClCCC1=CC=C(OCC2)C2=C1, MDL NA |
| Drug_Names: (S)-Alpha,Alpha-Diphenyl-3-pyrrolidine acetamide L-Tartaric acid salt, CAS: 134002-26-9, stock 557g, assay 98.3%, MWt 430.45, Formula C22H26N2O7, Purity >98%, SMILES O=C(C(C1=CC=CC=C1)([C@H]2CNCC2)C3=CC=CC=C3)N.O=C(O)[C@H](O)[C@@H](O)C(O)=O, MDL MFCD09750973 |
| Drug_Names: 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione, CAS: 150728-12-4, stock 153.2g, assay 98.8%, MWt 312.28, Formula C15H12N4O4, Purity >98%, SMILES O=C(N=C(C1=NC=CC=N1)N2)C(OC3=CC=CC=C3OC)C2=O, MDL MFCD09879703 |
| Drug_Names: N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide, CAS: 150727-06-3, stock 562.8g, assay 98.9%, MWt 526.01, Formula C25H24ClN5O4S, Purity >98%, SMILES O=S(NC1=NC(C2=NC=CC=N2)=NC(Cl)=C1OC3=CC=CC=C3OC)(C(C=C4)=CC=C4C(C)(C)C)=O, MDL MFCD09751194 |
| Drug_Names: 3-(Trifluoromethyl)cinnamic acid, CAS: 779-89-5, stock 456.6g, assay 98.9%, MWt 216.16, Formula C10H7F3O2, Purity >98%, SMILES O=C(O)/C=C/C1=CC=CC(C(F)(F)F)=C1, MDL MFCD00004393 |
| Drug_Names: (2S)-dimethyl 2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioate, CAS: 374777-77-2, stock 200.8g, assay 98%, MWt 505.53, Formula C25H27N7O5, Purity >98%, SMILES NC1=C2N=C(CC(CC#C)C3=CC=C(C(N[C@H](C(OC)=O)CCC(OC)=O)=O)C=C3)C=NC2=NC(N)=N1, MDL NA |
| Drug_Names: 3-Aminopiperidine-2,6-dione hydrochloride, CAS: 24666-56-6, stock 887.2g, assay 98.5%, MWt 164.59, Formula C5H9ClN2O2, Purity >98%, SMILES O=C(CC1)NC(C1N)=O.Cl, MDL NA |
| Drug_Names: 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione, CAS: 827026-45-9, stock 451.4g, assay 98.6%, MWt 289.24, Formula C13H11N3O5, Purity >98%, SMILES O=C(C(CC1)N(CC2=C3C=CC=C2[N+]([O-])=O)C3=O)NC1=O, MDL MFCD11977267 |
| Drug_Names: Methyl 4-(1-methoxy-1-oxopent-4-yn-2-yl)benzoate, CAS: 146464-90-6, stock 289.9g, assay 98.7%, MWt 246.26, Formula C14H14O4, Purity >98%, SMILES O=C(OC)C(CC#C)C1=CC=C(C(OC)=O)C=C1, MDL NA |
| Drug_Names: (S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, CAS: 93601-86-6, stock 79.3g, assay 98.7%, MWt 255.78, Formula C14H22ClNO, Purity >98%, SMILES COC1=CC=CC2=C1CC[C@H](NCCC)C2.Cl, MDL NA |
| Drug_Names: (S)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, CAS: 58349-17-0, stock 700.8g, assay 98.6%, MWt 213.70, Formula C11H16ClNO, Purity >98%, SMILES N[C@@H]1CC2=C(C(OC)=CC=C2)CC1.Cl, MDL MFCD08443937 |
| Drug_Names: (+)-(S)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid, CAS: 125602-71-3, stock 811.3g, assay 98.1%, MWt 388.89, Formula C21H25ClN2O3, Purity >98%, SMILES O=C(O)CCCN1CCC(CC1)O[C@H](C2=NC=CC=C2)C(C=C3)=CC=C3Cl, MDL NA |
| Drug_Names: 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-Benzoic acid methyl ester, CAS: 214601-17-9, stock 419g, assay 98.5%, MWt 369.50, Formula C23H31NO3, Purity >98%, SMILES OC1=CC=C(C(OC)=O)C=C1[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2, MDL NA |
| Drug_Names: Methyl 2-cyclohexyl-2-(pyrazine-5-carboxamido)acetate, CAS: 1415559-38-4, stock 241.3g, assay 98.6%, MWt 277.32, Formula C14H19N3O3, Purity >98%, SMILES O=C(NC(C(OC)=O)C1CCCCC1)C2=CN=CC=N2, MDL NA |
| Drug_Names: Methyl 4-(2-((2,4-diaminopteridin-6-yl)methyl)-1-methoxy-1-oxopent-4-yn-2-yl)benzoate, CAS: 146464-91-7, stock 304.2g, assay 98.3%, MWt 420.42, Formula C21H20N6O4, Purity >98%, SMILES O=C(OC)C1=CC=C(C(CC#C)(C(OC)=O)CC2=NC3=C(N)N=C(N)N=C3N=C2)C=C1, MDL NA |
| Drug_Names: (S)-Quinuclidin-3-amine dihydrochloride, CAS: 119904-90-4, stock 42.4g, assay 98.7%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES N[C@@H]1CN2CCC1CC2.Cl.Cl, MDL MFCD00191753 |
| Drug_Names: (S)-(+)-N-(2,3-Epoxypropyl)phthalimide, CAS: 161596-47-0, stock 280.5g, assay 98.5%, MWt 203.19, Formula C11H9NO3, Purity >98%, SMILES O=C(N1C[C@H]2CO2)C3=CC=CC=C3C1=O, MDL MFCD04973350 |
| Drug_Names: ((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide, CAS: 81522-68-1, stock 162.2g, assay 98.6%, MWt 582.90, Formula C33H51O3PSi2, Purity >98%, SMILES O=P(C1=CC=CC=C1)(C2=CC=CC=C2)C/C=C(C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]3O[Si](C)(C)C(C)(C)C)\C3=C, MDL NA |
| Drug_Names: (S)-methyl 2-cyclohexyl-2-(pyrazine-2-carboxamido)acetate, CAS: 848777-29-7, stock 658.3g, assay 98.5%, MWt 277.32, Formula C14H19N3O3, Purity >98%, SMILES O=C(N[C@H](C(OC)=O)C1CCCCC1)C2=CN=CC=N2, MDL NA |
| Drug_Names: 4,4-Dimethyl-6-ethynylthiochroman, CAS: 118292-06-1, stock 804.4g, assay 98.6%, MWt 202.32, Formula C13H14S, Purity >98%, SMILES CC1(C)C2=CC(C#C)=CC=C2SCC1, MDL MFCD00902029 |
| Drug_Names: (1,1-Dimethylethyl)dimethyl[[(3β,5E,7E)-9,10-secocholesta-5,7,10(19)-trien-3-yl]oxy]silane, CAS: 87649-55-6, stock 639.9g, assay 98.6%, MWt 498.90, Formula C33H58OSi, Purity >98%, SMILES C=C(CC1)/C(C[C@H]1O[Si](C)(C)C(C)(C)C)=C/C=C2[C@@]3([H])[C@@](CCC/2)(C)[C@@H]([C@H](C)CCCC(C)C)CC3, MDL NA |
| Drug_Names: 11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, CAS: 1180843-77-9, stock 821.5g, assay 98.2%, MWt 299.75, Formula C17H14ClNO2, Purity >98%, SMILES ClC(C=C1)=CC2=C1OC(C=CC=C3)=C3C(CN4C)C2C4=O, MDL NA |
| Drug_Names: (2-(4-methylpiperazin-1-yl)-4-phenylchroman-6-yl)methanol, CAS: 959624-43-2, stock 596.8g, assay 98.5%, MWt 338.44, Formula C21H26N2O2, Purity >98%, SMILES OCC1=CC(C(C2=CC=CC=C2)CC(N3CCN(C)CC3)O4)=C4C=C1, MDL NA |
| Drug_Names: L-Norvalinol, CAS: 22724-81-8, stock 632.8g, assay 98.5%, MWt 103.16, Formula C5H13NO, Purity >98%, SMILES CCC[C@H](N)CO, MDL MFCD02683229 |
| Drug_Names: (2S,3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride, CAS: 944716-73-8, stock 551.6g, assay 98.4%, MWt 222.71, Formula C9H19ClN2O2, Purity >98%, SMILES [H]Cl.N[C@@H](CCC)[C@H](O)C(NC1CC1)=O, MDL NA |
| Drug_Names: Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate hydrochloride, CAS: 765935-67-9, stock 277.4g, assay 98.6%, MWt 310.78, Formula C15H19ClN2O3, Purity >98%, SMILES O=C(OCC)C1=CC2=CC(N3CCNCC3)=CC=C2O1.Cl, MDL NA |
| Drug_Names: (3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride, CAS: 850252-34-5, stock 347.8g, assay 98.5%, MWt 222.71, Formula C9H19ClN2O2, Purity >98%, SMILES N[C@@H](CCC)C(O)C(NC1CC1)=O.Cl, MDL MFCD21606965 |
| Drug_Names: tert-Butyl 2-(2-(2-amino-2-cyclohexylacetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylate, CAS: 926276-18-8, stock 81.7g, assay 98.7%, MWt 463.65, Formula C26H45N3O4, Purity >98%, SMILES O=C(OC(C)(C)C)[C@H]1N(C([C@@H](NC([C@H](C2CCCCC2)N)=O)C(C)(C)C)=O)C[C@@]3([H])[C@]1([H])CCC3, MDL NA |
| Drug_Names: 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine, CAS: 145783-14-8, stock 757g, assay 98.6%, MWt 268.12, Formula C7H7Cl2N3O2S, Purity >98%, SMILES CCCSC1=NC(Cl)=C([N+]([O-])=O)C(Cl)=N1, MDL MFCD10698669 |
| Drug_Names: 3-(4-Hydroxybutyl)-1H-Indole-5-carbonitrile, CAS: 914927-40-5, stock 876g, assay 98%, MWt 214.26, Formula C13H14N2O, Purity >98%, SMILES N#CC1=CC2=C(NC=C2CCCCO)C=C1, MDL MFCD22573300 |
| Drug_Names: 4,6-dichloro-2-(propylthio)pyrimidin-5-amine, CAS: 145783-15-9, stock 84.7g, assay 98.4%, MWt 238.14, Formula C7H9Cl2N3S, Purity >98%, SMILES ClC1=C(N)C(Cl)=NC(SCCC)=N1, MDL MFCD16875503 |
| Drug_Names: (S)-(-)-Indoline-2-carboxylic acid, CAS: 79815-20-6, stock 637.7g, assay 98.2%, MWt 163.17, Formula C9H9NO2, Purity >98%, SMILES O=C([C@@H]1CC2=C(N1)C=CC=C2)O, MDL MFCD00070578 |
| Drug_Names: NSC 16598, CAS: 1477-50-5, stock 469.7g, assay 98.1%, MWt 161.16, Formula C9H7NO2, Purity >98%, SMILES O=C(O)C(N1)=CC2=C1C=CC=C2, MDL MFCD00005611 |
| Drug_Names: 1-Acetyl-1H-indole-2-carboxylic acid, CAS: 10441-26-6, stock 95.1g, assay 98.4%, MWt 203.19, Formula C11H9NO3, Purity >98%, SMILES O=C(C)N1C(C(O)=O)=CC2=C1C=CC=C2, MDL NA |
| Drug_Names: (2R,3S)-5-Methoxy-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate, CAS: 4330-34-1, stock 467.7g, assay 98.5%, MWt 384.42, Formula C22H24O6, Purity >98%, SMILES CC1=CC=C(C(OC[C@@H](O2)[C@@H](OC(C3=CC=C(C)C=C3)=O)CC2OC)=O)C=C1, MDL NA |
| Drug_Names: 4-tert-Butylcalix[4]arene, CAS: 60705-62-6, stock 152.7g, assay 98.8%, MWt 648.91, Formula C44H56O4, Purity >98%, SMILES CC(C)(C)C1=CC(C2)=C(O)C(CC3=C(O)C(CC4=CC(C(C)(C)C)=CC(CC5=CC(C(C)(C)C)=CC2=C5O)=C4O)=CC(C(C)(C)C)=C3)=C1, MDL MFCD00066280 |
| Drug_Names: (2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate, CAS: 402958-95-6, stock 613.2g, assay 98.3%, MWt 390.48, Formula C20H30N4O4, Purity >98%, SMILES O=C(OC)[C@H](C(C)(C)C)NC([C@H](C1CCCCC1)NC(C2=CN=CC=N2)=O)=O, MDL MFCD27922595 |
| Drug_Names: 5-(Piperazin-1-yl)benzofuran-2-carboxylic acid, CAS: 183288-47-3, stock 82.5g, assay 98.4%, MWt 246.26, Formula C13H14N2O3, Purity >98%, SMILES O=C(O)C1=CC2=CC(N3CCNCC3)=CC=C2O1, MDL MFCD22200203 |
| Drug_Names: 2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(methoxymethyl)phenol, CAS: 250214-69-8, stock 181.1g, assay 99%, MWt 355.51, Formula C23H33NO2, Purity >98%, SMILES OC1=CC=C(COC)C=C1C(C2=CC=CC=C2)CCN(C(C)C)C(C)C, MDL NA |
| Drug_Names: (R)-4-(hydroxymethyl)-2-(3-(isopropylamino)-1-phenylpropyl)phenol, CAS: 194482-42-3, stock 105.3g, assay 98.3%, MWt 299.41, Formula C19H25NO2, Purity >98%, SMILES OC1=CC=C(CO)C=C1[C@@H](C2=CC=CC=C2)CCNC(C)C, MDL NA |
| Drug_Names: 2-(3-Hydroxy-1-phenylpropyl)-4-(hydroxymethyl)phenol, CAS: 1312416-97-9, stock 228.2g, assay 98.2%, MWt 258.31, Formula C16H18O3, Purity >98%, SMILES OC1=CC=C(CO)C=C1C(C2=CC=CC=C2)CCO, MDL NA |
| Drug_Names: (R)-(4-(benzyloxy)-3-(3-(diisopropylamino)-1-phenylpropyl)phenyl)methanol, CAS: 156755-37-2, stock 722.6g, assay 98.7%, MWt 431.61, Formula C29H37NO2, Purity >98%, SMILES OCC1=CC=C(OCC2=CC=CC=C2)C([C@@H](C3=CC=CC=C3)CCN(C(C)C)C(C)C)=C1, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol oxalate, CAS: 1215268-15-7, stock 367.7g, assay 98.3%, MWt 307.30, Formula C12H21NO8, Purity >98%, SMILES N[C@H]1[C@H]2[C@H](OC(C)(C)O2)[C@@H](OCCO)C1.O=C(O)C(O)=O, MDL NA |
| Drug_Names: 3-(4-Chlorobutanoyl)-1H-indole-5-carbonitrile, CAS: 276863-95-7, stock 491.8g, assay 98.3%, MWt 246.69, Formula C13H11ClN2O, Purity >98%, SMILES O=C(CCCCl)C1=CNC2=CC=C(C#N)C=C21, MDL MFCD09833260 |
| Drug_Names: N-(4-Oxocyclohexyl)acetamide, CAS: 27514-08-5, stock 795.1g, assay 98.4%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES CC(NC(CC1)CCC1=O)=O, MDL MFCD03703462 |
| Drug_Names: (S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride, CAS: 898543-06-1, stock 778.8g, assay 98.3%, MWt 327.76, Formula C14H18ClN3O4, Purity >98%, SMILES O=C(O[C@H]1CN)N(C1)C(C=C2)=CC=C2N3C(COCC3)=O.Cl, MDL MFCD20133901 |
| Drug_Names: (3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, CAS: 32138-69-5, stock 5.9g, assay 98.4%, MWt 398.32, Formula C19H27IO, Purity >98%, SMILES C[C@@]12C(I)=CC[C@@]1([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC2, MDL MFCD00199204 |
| Drug_Names: (S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid, CAS: 402958-96-7, stock 465.6g, assay 98.6%, MWt 376.45, Formula C19H28N4O4, Purity >98%, SMILES CC(C)(C)[C@@H](C(O)=O)NC([C@H](C1CCCCC1)NC(C2=NC=CN=C2)=O)=O, MDL MFCD11865138 |
| Drug_Names: (S)-2-amino-2-cyclohexylacetic acid, CAS: 14328-51-9, stock 116.7g, assay 98.7%, MWt 157.21, Formula C8H15NO2, Purity >98%, SMILES N[C@H](C(O)=O)C1CCCCC1, MDL NA |
| Drug_Names: (S)-Methyl 2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanoate hydrochloride, CAS: 170098-28-9, stock 843.6g, assay 98.3%, MWt 417.97, Formula C24H32ClNO3, Purity >98%, SMILES OC1=CC=CC([C@@]2(C)[C@@H](C)CN(C[C@H](CC3=CC=CC=C3)C(OC)=O)CC2)=C1.Cl, MDL MFCD19440819 |
| Drug_Names: tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate, CAS: 183288-43-9, stock 133.9g, assay 98.2%, MWt 374.43, Formula C20H26N2O5, Purity >98%, SMILES O=C(OCC)C1=CC2=CC(N3CCN(C(OC(C)(C)C)=O)CC3)=CC=C2O1, MDL MFCD21607421 |
| Drug_Names: tert-Butyl 4-(2-carbamoylbenzofuran-5-yl)piperazine-1-carboxylate, CAS: 183288-44-0, stock 536.6g, assay 98.9%, MWt 345.39, Formula C18H23N3O4, Purity >98%, SMILES O=C(N1CCN(C2=CC=C(OC(C(N)=O)=C3)C3=C2)CC1)OC(C)(C)C, MDL MFCD22208558 |
| Drug_Names: 5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole, CAS: 1276666-13-7, stock 211.7g, assay 98.4%, MWt 265.74, Formula C13H16ClN3O, Purity >98%, SMILES ClC1=CC(N=C(N2CCNC(C)CC2)O3)=C3C=C1, MDL NA |
| Drug_Names: Methyl 4-amino-2-methoxy-5-nitrobenzoate, CAS: 59338-84-0, stock 851.9g, assay 98.9%, MWt 226.19, Formula C9H10N2O5, Purity >98%, SMILES O=C(OC)C1=CC([N+]([O-])=O)=C(N)C=C1OC, MDL MFCD09952401 |
| Drug_Names: 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine, CAS: 401566-79-8, stock 264.4g, assay 98.2%, MWt 242.32, Formula C14H18N4, Purity >98%, SMILES CC1=NN(C2=CC=CC=C2)C(N3CCNCC3)=C1, MDL MFCD22398471 |
| Drug_Names: (S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate, CAS: 401564-36-1, stock 369.2g, assay 98.6%, MWt 300.37, Formula C13H20N2O4S, Purity >98%, SMILES O=C(N1[C@H](C(N2CSCC2)=O)CC(C1)=O)OC(C)(C)C, MDL NA |
| Drug_Names: (2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester, CAS: 401566-80-1, stock 457.6g, assay 98.9%, MWt 526.69, Formula C27H38N6O3S, Purity >98%, SMILES O=C(N1CSCC1)[C@H]2N(C(OC(C)(C)C)=O)C[C@@H](N3CCN(C4=CC(C)=NN4C5=CC=CC=C5)CC3)C2, MDL NA |
| Drug_Names: (S)-5-methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, CAS: 1232344-37-4, stock 176.6g, assay 98.6%, MWt 365.96, Formula C20H28ClNOS, Purity >98%, SMILES CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C=CC=C3OC)C2.Cl, MDL NA |
| Drug_Names: (2R,3aR,10Z,11aS,12aR,14aR)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-Tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid, CAS: 923604-58-4, stock 837.6g, assay 98.9%, MWt 646.80, Formula C35H42N4O6S, Purity >98%, SMILES CC1=C2N=C(C3=NC(C(C)C)=CS3)C=C(O[C@H](C4)C[C@@H](C(N(C)CCCC/C=C\[C@H]5[C@](C(O)=O)(N6)C5)=O)[C@@H]4C6=O)C2=CC=C1OC, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate, CAS: 376608-65-0, stock 190.2g, assay 98.6%, MWt 367.35, Formula C14H25NO10, Purity >98%, SMILES N[C@@H]1C[C@H](OCCO)[C@]2([H])[C@@]1([H])OC(C)(C)O2.OC([C@H](O)[C@@H](O)C(O)=O)=O, MDL MFCD22200635 |
| Drug_Names: (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate, CAS: 376608-71-8, stock 240.2g, assay 98.7%, MWt 321.32, Formula C17H17F2NO3, Purity >98%, SMILES N[C@H]1[C@H](C2=CC=C(F)C(F)=C2)C1.O=C(O)[C@H](O)C3=CC=CC=C3, MDL NA |
| Drug_Names: 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone, CAS: 1267610-26-3, stock 832.2g, assay 98.1%, MWt 273.33, Formula C15H19N3O2, Purity >98%, SMILES O=C1C(N2CCOCC2)=CCCN1C3=CC=C(N)C=C3, MDL NA |
| Drug_Names: 1-(2-(4-(Chloromethyl)phenoxy)ethyl)azepane hydrochloride, CAS: 223251-25-0, stock 455.7g, assay 98.7%, MWt 304.26, Formula C15H23Cl2NO, Purity >98%, SMILES ClCC1=CC=C(OCCN2CCCCCC2)C=C1.[H]Cl, MDL MFCD11865353 |
| Drug_Names: L-tert-Leucine Methyl Ester Hydrochloride, CAS: 63038-27-7, stock 880.4g, assay 98.1%, MWt 181.66, Formula C7H16ClNO2, Purity >98%, SMILES N[C@@H](C(C)(C)C)C(OC)=O.[H]Cl, MDL MFCD00040604 |
| Drug_Names: 2-Cyanophenothiazine, CAS: 38642-74-9, stock 195.6g, assay 98.4%, MWt 224.28, Formula C13H8N2S, Purity >98%, SMILES N#CC1=CC2=C(C=C1)SC3=CC=CC=C3N2, MDL MFCD00129784 |
| Drug_Names: ITMN 4077, CAS: 790305-05-4, stock 805.3g, assay 98%, MWt 568.68, Formula C26H40N4O8S, Purity >98%, SMILES O=C(N1)[C@@H]2C[C@@H](O)CN2C([C@@H](NC(OC(C)(C)C)=O)CCCCC/C=C\[C@H](C3)[C@]13C(NS(C4CC4)(=O)=O)=O)=O, MDL NA |
| Drug_Names: (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride, CAS: 1156491-10-9, stock 138.2g, assay 98.2%, MWt 411.26, Formula C18H20Cl2F4N2, Purity >98%, SMILES N[C@H]1C[C@@H]1C2=CC=C(F)C(F)=C2.N[C@@H]3C[C@H]3C4=CC=C(F)C(F)=C4.Cl.Cl, MDL NA |
| Drug_Names: 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl]thiophene, CAS: 1030825-20-7, stock 594.3g, assay 98.1%, MWt 361.27, Formula C18H14BrFS, Purity >98%, SMILES CC1=C(CC2=CC=C(C3=CC=C(F)C=C3)S2)C=C(Br)C=C1, MDL MFCD21496340 |
| Drug_Names: 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl) methyl]thiophene, CAS: 898566-17-1, stock 565.3g, assay 98%, MWt 408.27, Formula C18H14FIS, Purity >98%, SMILES CC1=C(CC2=CC=C(C3=CC=C(F)C=C3)S2)C=C(I)C=C1, MDL MFCD12405593 |
| Drug_Names: Methyl 5-(piperazin-1-yl)benzofuran-2-carboxylate, CAS: 1186225-86-4, stock 123.7g, assay 98.8%, MWt 260.29, Formula C14H16N2O3, Purity >98%, SMILES O=C(C1=CC2=CC(N3CCNCC3)=CC=C2O1)OC, MDL NA |
| Drug_Names: Benzyl octahydro-1H-indole-2-carboxylate 4-methylbenzenesulfonate, CAS: 82717-91-7, stock 145.8g, assay 98.6%, MWt 431.55, Formula C23H29NO5S, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)C2CC3C(N2)CCCC3.CC4=CC=C(S(=O)(O)=O)C=C4, MDL NA |
| Drug_Names: 1-(4,4-Dimethylthiochroman-6-yl)ethanone, CAS: 88579-23-1, stock 590.9g, assay 99%, MWt 220.33, Formula C13H16OS, Purity >98%, SMILES O=C(C)C(C=C1)=CC2=C1SCCC2(C)C, MDL MFCD09833012 |
| Drug_Names: 4-Amino-5-ethylsulfonyl-2-Methoxybenzoic acid, CAS: 71675-87-1, stock 24.7g, assay 98.3%, MWt 259.28, Formula C10H13NO5S, Purity >98%, SMILES O=C(O)C1=CC(S(=O)(CC)=O)=C(N)C=C1OC, MDL MFCD04973619 |
| Drug_Names: (2R,3R)-3-(3-Methoxyphenyl)-N,N,2-trimethylpentan-1-amine hydrochloride, CAS: 175591-17-0, stock 528.1g, assay 98.5%, MWt 271.83, Formula C15H26ClNO, Purity >98%, SMILES C[C@@H](CN(C)C)[C@@H](CC)C1=CC(OC)=CC=C1.Cl, MDL NA |
| Drug_Names: 1-(2-(Cyclopropylmethoxy)-6-(4-methoxybenzyloxy)phenyl)ethanone, CAS: 405239-71-6, stock 30.3g, assay 98.1%, MWt 326.39, Formula C20H22O4, Purity >98%, SMILES O=C(C)C(C(OCC1=CC=C(OC)C=C1)=CC=C2)=C2OCC3CC3, MDL NA |
| Drug_Names: 4-tert-Butylbenzenesulfonamide, CAS: 6292-59-7, stock 451.8g, assay 98.7%, MWt 213.30, Formula C10H15NO2S, Purity >98%, SMILES O=S(C(C=C1)=CC=C1C(C)(C)C)(N)=O, MDL MFCD00068599 |
| Drug_Names: (R)-2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethan-1-amine hydrochloride, CAS: 1174496-11-7, stock 159.9g, assay 98.2%, MWt 239.74, Formula C13H18ClNO, Purity >98%, SMILES NCC[C@@H]1C2=C(CC1)C=CC3=C2CCO3.Cl, MDL NA |
| Drug_Names: 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid, CAS: 763114-26-7, stock 372.8g, assay 98.3%, MWt 298.27, Formula C16H11FN2O3, Purity >98%, SMILES O=C1NN=C(CC2=CC=C(F)C(C(O)=O)=C2)C3=CC=CC=C13, MDL MFCD14636678 |
| Drug_Names: 2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine, CAS: 448964-37-2, stock 129.6g, assay 98.4%, MWt 203.28, Formula C13H17NO, Purity >98%, SMILES NCCC1C2=C3C(OCC3)=CC=C2CC1, MDL MFCD11865054 |
| Drug_Names: 2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride, CAS: 1053239-39-6, stock 235.1g, assay 98.9%, MWt 239.74, Formula C13H18ClNO, Purity >98%, SMILES NCCC1C2=C3C(OCC3)=CC=C2CC1.Cl, MDL MFCD11865055 |
| Drug_Names: 1-Acetyl-5-bromo-4-chloro-1H-indol-3-yl acetate, CAS: 3030-06-6, stock 500g, assay 98.3%, MWt 330.56, Formula C12H9BrClNO3, Purity >98%, SMILES O=C(C)N1C2=CC=C(Br)C(Cl)=C2C(OC(C)=O)=C1, MDL NA |
| Drug_Names: 3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one, CAS: 79098-75-2, stock 762g, assay 98.3%, MWt 231.29, Formula C13H17N3O, Purity >98%, SMILES O=C1N(C2CCNCC2)CC3=CC=CC=C3N1, MDL MFCD11043062 |
| Drug_Names: 5-Nitrosalicylaldehyde, CAS: 97-51-8, stock 555.3g, assay 98.3%, MWt 167.12, Formula C7H5NO4, Purity >98%, SMILES O=CC1=CC([N+]([O-])=O)=CC=C1O, MDL MFCD00007337 |
| Drug_Names: 2-Amino-5-(4-fluorophenyl)thiophene-3-carboxamide, CAS: 61019-14-5, stock 602.6g, assay 98.5%, MWt 236.27, Formula C11H9FN2OS, Purity >98%, SMILES NC1=C(C(N)=O)C=C(C2=CC=C(F)C=C2)S1, MDL NA |
| Drug_Names: tert-Butyl (((S,E)-3-(2-((1R,3aS,7aR,E)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexyl)oxy)dimethylsilane, CAS: 104846-63-1, stock 79.2g, assay 98.2%, MWt 510.91, Formula C34H58OSi, Purity >98%, SMILES C=C(CC1)/C(C[C@H]1O[Si](C)(C)C(C)(C)C)=C/C=C2[C@@]3([H])[C@@](CCC/2)(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC3, MDL NA |
| Drug_Names: N-(6-acetyl-3-methoxy-2-methylphenyl)-4-isopropylthiazole-2-carboxamide, CAS: 923289-20-7, stock 189.2g, assay 98.6%, MWt 332.42, Formula C17H20N2O3S, Purity >98%, SMILES O=C(NC1=C(C(C)=O)C=CC(OC)=C1C)C2=NC(C(C)C)=CS2, MDL NA |
| Drug_Names: 2-Acetamido-3-(6-methoxy-1H-indol-3-yl)propanoic acid, CAS: 92256-74-1, stock 845.6g, assay 98.5%, MWt 276.29, Formula C14H16N2O4, Purity >98%, SMILES O=C(O)C(NC(C)=O)CC1=CNC2=CC(OC)=CC=C21, MDL NA |
| Drug_Names: Oxetan-3-one, CAS: 6704-31-0, stock 537.7g, assay 98.9%, MWt 72.06, Formula C3H4O2, Purity >98%, SMILES O=C1COC1, MDL MFCD09263255 |
| Drug_Names: Methyl 3-bromo-2,6-dimethoxybenzoate, CAS: 65977-12-0, stock 301.1g, assay 98.1%, MWt 275.10, Formula C10H11BrO4, Purity >98%, SMILES O=C(OC)C1=C(OC)C(Br)=CC=C1OC, MDL NA |
| Drug_Names: 2-Allyl-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one, CAS: 955368-90-8, stock 639g, assay 99%, MWt 222.27, Formula C9H10N4OS, Purity >98%, SMILES O=C1C2=CN=C(SC)N=C2NN1CC=C, MDL MFCD19443206 |
| Drug_Names: 2-(6-Bromopyridin-2-yl)propan-2-ol, CAS: 638218-78-7, stock 309g, assay 98.3%, MWt 216.08, Formula C8H10BrNO, Purity >98%, SMILES BrC1=CC=CC(C(C)(C)O)=N1, MDL MFCD16657880 |
| Drug_Names: 6,6-Dimethyl-3-Azabicyclo[3.1.0]hexane-2,4-dione, CAS: 194421-56-2, stock 507.7g, assay 98.8%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES O=C1C(C(C)2C)C2C(N1)=O, MDL MFCD12923551 |
| Drug_Names: 3-((3R,4R)-3,4-dimethylpiperidin-4-yl)phenol, CAS: 119193-19-0, stock 117.3g, assay 98.2%, MWt 205.30, Formula C13H19NO, Purity >98%, SMILES C[C@@]1([C@@H](C)CNCC1)C2=CC(O)=CC=C2, MDL NA |
| Drug_Names: (2S,6R)-tert-butyl 2-(benzyloxymethyl)-6-(hydroxymethyl)morpholine-4-carboxylate, CAS: 1093085-90-5, stock 274.9g, assay 98.4%, MWt 337.41, Formula C18H27NO5, Purity >98%, SMILES O=C(OC(C)(C)C)N1C[C@H](O[C@@H](CO)C1)COCC2=CC=CC=C2, MDL NA |
| Drug_Names: 4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid, CAS: 146464-93-9, stock 772.3g, assay 98.1%, MWt 348.36, Formula C18H16N6O2, Purity >98%, SMILES C#CCC(CC1=NC2=C(N)N=C(N)N=C2N=C1)C3=CC=C(C=C3)C(O)=O, MDL NA |
| Drug_Names: 1,2-Bis(2-nitrophenyl)disulfane, CAS: 1155-00-6, stock 887.8g, assay 98.5%, MWt 308.33, Formula C12H8N2O4S2, Purity >98%, SMILES O=[N+]([O-])C1=CC=CC=C1SSC2=C([N+]([O-])=O)C=CC=C2, MDL MFCD00007130 |
| Drug_Names: (Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid, CAS: 356068-93-4, stock 518.6g, assay 98.5%, MWt 300.28, Formula C16H13FN2O3, Purity >98%, SMILES O=C(NC1=C/2C=C(F)C=C1)C2=C/C3=C(C)C(C(O)=O)=C(C)N3, MDL MFCD11521323 |
| Drug_Names: Ethyl 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylate, CAS: 163521-11-7, stock 70.4g, assay 98.7%, MWt 470.56, Formula C28H30N4O3, Purity >98%, SMILES N#CC1=CC=C(NC=C2CCCCN(CC3)CCN3C4=CC=C5C(C=C(C(OCC)=O)O5)=C4)C2=C1, MDL MFCD09833263 |
| Drug_Names: 4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline, CAS: 630125-91-6, stock 561.1g, assay 98.5%, MWt 287.32, Formula C14H20F3N3, Purity >98%, SMILES FC(F)(F)C(C=C1N)=C(C=C1)CN(CC2)CCN2CC, MDL NA |
| Drug_Names: (E)-2-(4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2-dihydrocyclopenta[b]indol-3(4H)-ylidene)acetic acid, CAS: 866215-99-8, stock 838.3g, assay 98%, MWt 433.88, Formula C21H17ClFNO4S, Purity >98%, SMILES O=S(C1=C(C2=CC(F)=C1)N(CC3=CC=C(Cl)C=C3)C4=C2CC/C4=C\C(O)=O)(C)=O, MDL MFCD22124622 |
| Drug_Names: 3-(3-(Diisopropylamino)-1-phenylpropyl)-4-hydroxybenzaldehyde, CAS: 214601-15-7, stock 784.2g, assay 98.6%, MWt 339.47, Formula C22H29NO2, Purity >98%, SMILES O=CC1=CC(C(C2=CC=CC=C2)CCN(C(C)C)C(C)C)=C(O)C=C1, MDL NA |
| Drug_Names: (R)-2-(benzyloxycarbonylamino)-3-methoxypropanoic acid, CAS: 86096-35-7, stock 603.1g, assay 98.5%, MWt 253.25, Formula C12H15NO5, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N[C@H](COC)C(O)=O, MDL NA |
| Drug_Names: 4,6-Diamino-5-nitropyrimidine, CAS: 2164-84-3, stock 350.9g, assay 98.8%, MWt 155.11, Formula C4H5N5O2, Purity >98%, SMILES NC1=NC=NC(N)=C1[N+]([O-])=O, MDL MFCD00023268 |
| Drug_Names: 5-(1-Piperazinyl)-2-benzofurancarboxylic acid ethyl ester dihydrochloride hydrate, CAS: 1422956-31-7, stock 521g, assay 98.1%, MWt 365.25, Formula C15H22Cl2N2O4, Purity >98%, SMILES O=C(C1=CC2=CC(N3CCNCC3)=CC=C2O1)OCC.Cl.Cl.O, MDL NA |
| Drug_Names: (4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, CAS: 565429-94-9, stock 496.3g, assay 98.6%, MWt 641.13, Formula C39H68O3Si2, Purity >98%, SMILES C[Si](C)(C(C)(C)C)O[C@@H](C[C@@H](C/1=C)O[Si](C)(C(C)(C)C)C)CC1=C/C=C2[C@@]([H])([C@@]3(CCC/2)C)CC[C@@H]3[C@H](C)/C=C/C(C4CC4)O, MDL NA |
| Drug_Names: 5-Amino-1-benzofuran-2-carboxylic acid, CAS: 42933-44-8, stock 86.4g, assay 98.3%, MWt 177.16, Formula C9H7NO3, Purity >98%, SMILES NC1=CC=C2C(C=C(C(O)=O)O2)=C1, MDL MFCD11505019 |
| Drug_Names: N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide, CAS: 918504-27-5, stock 156.5g, assay 98.1%, MWt 458.28, Formula C17H14BrF2N3O3S, Purity >98%, SMILES FC1=C(C(C2=CNC3=NC=C(Br)C=C32)=O)C(F)=C(NS(=O)(CCC)=O)C=C1, MDL MFCD18207768 |
| Drug_Names: N-(3-(5-Bromo-1-(2,6-dichlorobenzoyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide, CAS: 1262985-24-9, stock 541.1g, assay 98.2%, MWt 631.27, Formula C24H16BrCl2F2N3O4S, Purity >98%, SMILES FC1=C(C(C2=CN(C(C3=C(Cl)C=CC=C3Cl)=O)C4=NC=C(Br)C=C42)=O)C(F)=C(NS(=O)(CCC)=O)C=C1, MDL MFCD22573286 |
| Drug_Names: N-(3-(5-(4-Chlorophenyl)-1-(2,6-dichlorobenzoyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide, CAS: 1262985-23-8, stock 875.8g, assay 99%, MWt 662.92, Formula C30H20Cl3F2N3O4S, Purity >98%, SMILES FC1=C(C(C2=CN(C(C3=C(Cl)C=CC=C3Cl)=O)C4=NC=C(C5=CC=C(Cl)C=C5)C=C42)=O)C(F)=C(NS(=O)(CCC)=O)C=C1, MDL MFCD22573287 |
| Drug_Names: 3,6-Dichloropyrazine-2-carbonitrile, CAS: 356783-16-9, stock 67.3g, assay 98.5%, MWt 173.99, Formula C5HCl2N3, Purity >98%, SMILES N#CC1=NC(Cl)=CN=C1Cl, MDL MFCD22199269 |
| Drug_Names: 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile, CAS: 356783-31-8, stock 429g, assay 98.1%, MWt 139.09, Formula C5H2FN3O, Purity >98%, SMILES N#CC1=NC(F)=CN=C1O, MDL NA |
| Drug_Names: (1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-one, CAS: 95716-68-0, stock 895.1g, assay 98.1%, MWt 292.46, Formula C19H32O2, Purity >98%, SMILES O=C1[C@@]2([H])[C@@](CCC1)(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC2, MDL NA |
| Drug_Names: Methyl 4-amino-3-fluoro-2-((2-fluorophenyl)amino)-5-nitrobenzoate, CAS: 606143-94-6, stock 347.6g, assay 98.7%, MWt 323.25, Formula C14H11F2N3O4, Purity >98%, SMILES FC1=C(N)C([N+]([O-])=O)=CC(C(OC)=O)=C1NC2=CC=CC=C2F, MDL NA |
| Drug_Names: Methyl 4,5-diamino-3-fluoro-2-((2-fluorophenyl)amino)benzoate, CAS: 1415560-46-1, stock 375.2g, assay 98.3%, MWt 293.27, Formula C14H13F2N3O2, Purity >98%, SMILES FC1=C(N)C(N)=CC(C(OC)=O)=C1NC2=CC=CC=C2F, MDL NA |
| Drug_Names: Methyl 4-fluoro-5-((2-fluorophenyl)amino)-1-methyl-1H-benzo[d]imidazole-6-carboxylate, CAS: 1415559-89-5, stock 795.6g, assay 98.6%, MWt 317.29, Formula C16H13F2N3O2, Purity >98%, SMILES FC1=C(N=CN2C)C2=CC(C(OC)=O)=C1NC3=C(F)C=CC=C3, MDL NA |
| Drug_Names: 5-((4-Bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid, CAS: 1415564-99-6, stock 664.7g, assay 98.3%, MWt 382.16, Formula C15H10BrF2N3O2, Purity >98%, SMILES FC1=C(N=CN2C)C2=CC(C(O)=O)=C1NC3=C(F)C=C(Br)C=C3, MDL NA |
| Drug_Names: 5-((4-Bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]imidazole-6-carboxamide, CAS: 1415559-75-9, stock 229.4g, assay 98.9%, MWt 467.26, Formula C19H17BrF2N4O3, Purity >98%, SMILES FC1=C(N=CN2C)C2=CC(C(NOCCOC=C)=O)=C1NC3=C(F)C=C(Br)C=C3, MDL NA |
| Drug_Names: trans-4-Phenylcyclohexaneacetic acid, CAS: 52092-29-2, stock 868.3g, assay 98.1%, MWt 218.29, Formula C14H18O2, Purity >98%, SMILES O=C(O)C[C@H]1CC[C@H](C2=CC=CC=C2)CC1, MDL NA |
| Drug_Names: Ethyl 2-((trans-4-(4-(bromomethyl)phenyl)cyclohexyl)acetate, CAS: 1359943-47-7, stock 387.8g, assay 98.8%, MWt 339.27, Formula C17H23BrO2, Purity >98%, SMILES O=C(OCC)C[C@H]1CC[C@H](C2=CC=C(CBr)C=C2)CC1, MDL NA |
| Drug_Names: Ethyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylate, CAS: 634602-84-9, stock 728.4g, assay 98.9%, MWt 206.20, Formula C10H10N2O3, Purity >98%, SMILES O=C(OCC)C1=CC(NC(N2)=O)=C2C=C1, MDL NA |
| Drug_Names: 5-Chloro-1H-benzo[d][1,3]oxazine-2,4-dione, CAS: 20829-96-3, stock 323.7g, assay 98.1%, MWt 197.58, Formula C8H4ClNO3, Purity >98%, SMILES ClC1=C2C(NC(OC2=O)=O)=CC=C1, MDL MFCD09032504 |
| Drug_Names: 5-Chloro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione, CAS: 40707-01-5, stock 281.1g, assay 98.3%, MWt 211.60, Formula C9H6ClNO3, Purity >98%, SMILES ClC1=C2C(N(C)C(OC2=O)=O)=CC=C1, MDL NA |
| Drug_Names: Methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate, CAS: 637027-41-9, stock 425.7g, assay 98.4%, MWt 267.67, Formula C12H10ClNO4, Purity >98%, SMILES ClC1=C2C(N(C)C(C(C(OC)=O)=C2O)=O)=CC=C1, MDL NA |
| Drug_Names: 2-(6-Hydroxy-1-benzofuran-3-yl)acetic acid, CAS: 69716-04-7, stock 388.1g, assay 98.9%, MWt 192.17, Formula C10H8O4, Purity >98%, SMILES O=C(O)CC1=COC2=CC(O)=CC=C12, MDL NA |
| Drug_Names: 7-tert-Butoxycarbonyl-2,3-benzo-7-azabicyclo[2.2.1]hepta-2,5-diene, CAS: 5176-28-3, stock 748g, assay 98.8%, MWt 243.30, Formula C15H17NO2, Purity >98%, SMILES O=C(N1C2C3=CC=CC=C3C1C=C2)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl-1,2,3,4-tetrahydro-naphthalen-1,4-imine-9-carboxylate, CAS: 5176-32-9, stock 107.5g, assay 98.1%, MWt 245.32, Formula C15H19NO2, Purity >98%, SMILES O=C(N1C2CCC1C3=C2C=CC=C3)OC(C)(C)C, MDL NA |
| Drug_Names: 1,2,3,4-Tetrahydronaphthalen-1,4-imine, CAS: 5176-30-7, stock 629.1g, assay 98.4%, MWt 145.20, Formula C10H11N, Purity >98%, SMILES C1(N2)CCC2C3=C1C=CC=C3, MDL NA |
| Drug_Names: 2,2,2-Trifluoro-1-(1,2,3,4-tetrahydronaphthalen-1,4-imin-9-yl)ethanone, CAS: 942491-77-2, stock 619.2g, assay 98.1%, MWt 241.21, Formula C12H10F3NO, Purity >98%, SMILES FC(F)(F)C(N1C2CCC1C3=C2C=CC=C3)=O, MDL NA |
| Drug_Names: 2-Methyl-2-propanyl 4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate, CAS: 942492-08-2, stock 779.1g, assay 98%, MWt 290.31, Formula C15H18N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N1C2CCC1C3=CC=C([N+]([O-])=O)C=C32, MDL NA |
| Drug_Names: 2-Methyl-2-propanyl(1R,8S)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate, CAS: 942492-09-3, stock 383.1g, assay 98%, MWt 290.31, Formula C15H18N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N1[C@@H]2CC[C@H]1C3=CC=C([N+]([O-])=O)C=C32, MDL NA |
| Drug_Names: 2-Methyl-2-propanyl(1S,8R)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate, CAS: 942492-10-6, stock 123.6g, assay 98.7%, MWt 290.31, Formula C15H18N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N1[C@H]2CC[C@@H]1C3=CC=C([N+]([O-])=O)C=C32, MDL NA |
| Drug_Names: (1S,4R)-tert-butyl 6-amino-1,2,3,4-tetrahydro-1,4-epiminonaphthalene-9-carboxylate, CAS: 942492-23-1, stock 521.6g, assay 98%, MWt 260.33, Formula C15H20N2O2, Purity >98%, SMILES O=C(OC(C)(C)C)N1[C@@H]2CC[C@H]1C3=CC=C(N)C=C32, MDL NA |
| Drug_Names: (1S,4R)-N-(4-chloro-5-(trifluoromethyl)pyrimidin-2-yl)-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-6-amine dihydrochloride, CAS: 942492-26-4, stock 767.2g, assay 98.7%, MWt 413.65, Formula C15H14Cl3F3N4, Purity >98%, SMILES FC(C1=CN=C(NC2=CC3=C([C@]4([H])CC[C@@]3([H])N4)C=C2)N=C1Cl)(F)F.[H]Cl.[H]Cl, MDL NA |
| Drug_Names: N-(2-((1S,4R)-6-((4-chloro-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-9-yl)-2-oxoethyl)acetamide, CAS: 942492-29-7, stock 459.7g, assay 98.4%, MWt 439.82, Formula C19H17ClF3N5O2, Purity >98%, SMILES CC(NCC(N1[C@@]2([H])CC[C@]1([H])C3=C2C=CC(NC4=NC=C(C(F)(F)F)C(Cl)=N4)=C3)=O)=O, MDL NA |
| Drug_Names: Methyl 4-hydroxy-5-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate, CAS: 1354639-61-4, stock 390.6g, assay 98.9%, MWt 263.25, Formula C13H13NO5, Purity >98%, SMILES O=C1N(C)C2=CC=CC(OC)=C2C(O)=C1C(OC)=O, MDL NA |
| Drug_Names: Ethyl N-[4-(trifluoromethyl)phenyl]carbamate, CAS: 23794-73-2, stock 113.1g, assay 98.7%, MWt 233.19, Formula C10H10F3NO2, Purity >98%, SMILES O=C(OCC)NC1=CC=C(C(F)(F)F)C=C1, MDL MFCD04038879 |
| Drug_Names: 4-(Trifluoromethyl)-N-methylaniline, CAS: 22864-65-9, stock 324.5g, assay 98.4%, MWt 175.15, Formula C8H8F3N, Purity >98%, SMILES FC(C1=CC=C(NC)C=C1)(F)F, MDL MFCD07369717 |
| Drug_Names: Methyl 3-(5-chloro-2-fluorobenzamido)pyrazine-2-carboxylate, CAS: 1415559-90-8, stock 785.1g, assay 98.8%, MWt 309.68, Formula C13H9ClFN3O3, Purity >98%, SMILES O=C(OC)C1=NC=CN=C1NC(C2=CC(Cl)=CC=C2F)=O, MDL NA |
| Drug_Names: 3-(5-Chloro-2-fluorobenzamido)pyrazine-2-carboxamide, CAS: 936564-98-6, stock 331.5g, assay 98.4%, MWt 294.67, Formula C12H8ClFN4O2, Purity >98%, SMILES NC(C1=NC=CN=C1NC(C2=CC(Cl)=CC=C2F)=O)=O, MDL NA |
| Drug_Names: 2-(5-Chloro-2-fluorophenyl)pteridin-4(3H)-one, CAS: 914289-59-1, stock 850.9g, assay 98.2%, MWt 276.65, Formula C12H6ClFN4O, Purity >98%, SMILES O=C1NC(C2=CC(Cl)=CC=C2F)=NC3=NC=CN=C13, MDL NA |
| Drug_Names: Ethyl 1-(2-chloroethyl)piperidine-4-carboxylate, CAS: 869112-14-1, stock 41.4g, assay 99%, MWt 219.71, Formula C10H18ClNO2, Purity >98%, SMILES O=C(OCC)C1CCN(CCCl)CC1, MDL NA |
| Drug_Names: (E)-methyl 3-(naphthalen-2-yl)but-2-enoate, CAS: 212078-20-1, stock 613.4g, assay 98.2%, MWt 226.27, Formula C15H14O2, Purity >98%, SMILES C/C(C1=CC=C2C=CC=CC2=C1)=C\C(OC)=O, MDL NA |
| Drug_Names: Methyl (Z)-3-(naphthalen-2-yl)but-2-enoate, CAS: 565190-67-2, stock 586.4g, assay 98.9%, MWt 226.27, Formula C15H14O2, Purity >98%, SMILES C/C(C1=CC=C2C=CC=CC2=C1)=C/C(OC)=O, MDL NA |
| Drug_Names: (E)-3-(naphthalen-2-yl)but-2-enoic acid, CAS: 565190-69-4, stock 65.8g, assay 98.7%, MWt 212.24, Formula C14H12O2, Purity >98%, SMILES C/C(C1=CC=C2C=CC=CC2=C1)=C\C(O)=O, MDL NA |
| Drug_Names: (E)-methyl 2-(3-(naphthalen-2-yl)but-2-enamido)benzoate, CAS: 321674-72-0, stock 293.3g, assay 98.6%, MWt 345.39, Formula C22H19NO3, Purity >98%, SMILES C/C(C1=CC=C2C=CC=CC2=C1)=C\C(NC3=CC=CC=C3C(OC)=O)=O, MDL NA |
| Drug_Names: Methyl 2-(4-(4-hydroxyphenyl)cyclohexylidene)acetate, CAS: 701232-66-8, stock 409g, assay 98.3%, MWt 246.30, Formula C15H18O3, Purity >98%, SMILES O=C(OC)/C=C1CCC(C2=CC=C(O)C=C2)CC\1, MDL NA |
| Drug_Names: (2-Chloro-5-methoxyphenyl)boronic acid, CAS: 89694-46-2, stock 425.8g, assay 98.2%, MWt 186.40, Formula C7H8BClO3, Purity >98%, SMILES ClC1=CC=C(OC)C=C1B(O)O, MDL MFCD06659858 |
| Drug_Names: 4-Bromo-2-methyl-6-nitroaniline, CAS: 77811-44-0, stock 254.2g, assay 98.1%, MWt 231.05, Formula C7H7BrN2O2, Purity >98%, SMILES NC1=C([N+]([O-])=O)C=C(Br)C=C1C, MDL MFCD00052919 |
| Drug_Names: 7-Bromo-5-methylbenzo[e][1,2,4]triazin-3-amine, CAS: 867330-26-5, stock 109.5g, assay 98.4%, MWt 239.07, Formula C8H7BrN4, Purity >98%, SMILES NC1=NC2=C(C)C=C(Br)C=C2N=N1, MDL MFCD12031506 |
| Drug_Names: 7-(2-Chloro-5-methoxyphenyl)-5-methyl-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)benzo[e][1,2,4]triazin-3-amine, CAS: 867331-63-3, stock 767.8g, assay 99%, MWt 490.00, Formula C27H28ClN5O2, Purity >98%, SMILES CC1=C(N=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=N4)C4=CC(C5=CC(OC)=CC=C5Cl)=C1, MDL NA |
| Drug_Names: 5-([1,1'-Biphenyl]-4-ylmethyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide, CAS: 1010096-65-7, stock 222.1g, assay 98%, MWt 307.35, Formula C17H17N5O, Purity >98%, SMILES O=C(N1N=C(CC2=CC=C(C3=CC=CC=C3)C=C2)N=N1)N(C)C, MDL NA |
| Drug_Names: 1-((4-Chlorophenethyl)amino)propan-2-ol, CAS: 847063-13-2, stock 213.5g, assay 98.8%, MWt 213.70, Formula C11H16ClNO, Purity >98%, SMILES ClC1=CC=C(CCNCC(O)C)C=C1, MDL MFCD10698793 |
| Drug_Names: 1-((4-Chlorophenethyl)amino)propan-2-ol hydrochloride, CAS: 1030624-41-9, stock 753g, assay 98.6%, MWt 250.16, Formula C11H17Cl2NO, Purity >98%, SMILES ClC1=CC=C(CCNCC(O)C)C=C1.Cl, MDL NA |
| Drug_Names: N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 923036-25-3, stock 541.8g, assay 98.6%, MWt 369.89, Formula C20H24ClN5, Purity >98%, SMILES C[C@H]1[C@@H](N(C2=NC(Cl)=NC3=C2C=CN3)C)CN(CC4=CC=CC=C4)CC1, MDL NA |
| Drug_Names: 1,7-Dihydro-pyrrolo[2,3-d]pyrimidin-4-one, CAS: 3680-71-5, stock 420.7g, assay 98.8%, MWt 135.12, Formula C6H5N3O, Purity >98%, SMILES OC1=C2C(NC=C2)=NC=N1, MDL MFCD08234923 |
| Drug_Names: (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, CAS: 1354486-07-9, stock 788.2g, assay 98.4%, MWt 291.26, Formula C14H24Cl2N2, Purity >98%, SMILES C[C@H]1CCN(CC2=CC=CC=C2)C[C@H]1NC.Cl.Cl, MDL NA |
| Drug_Names: (2S)-2-{[(tert-butoxy)carbonyl]amino}non-8-enoic acid, CAS: 300831-21-4, stock 64.4g, assay 99%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES C=CCCCCC[C@@H](C(O)=O)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: 1-((2R,3R,4S,5S)-3,4-Dihydroxy-5-(iodomethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, CAS: 14259-58-6, stock 545.1g, assay 99%, MWt 354.10, Formula C9H11IN2O5, Purity >98%, SMILES O[C@@H]1[C@@H](CI)O[C@@H](N2C=CC(NC2=O)=O)[C@@H]1O, MDL NA |
| Drug_Names: 4',5'-Didehydro-5'-deoxyuridine, CAS: 14365-63-0, stock 373g, assay 98.2%, MWt 226.19, Formula C9H10N2O5, Purity >98%, SMILES O[C@@H]([C@@H](O)[C@H](N1C=CC(NC1=O)=O)O2)C2=C, MDL NA |
| Drug_Names: (2S,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(iodomethyl)tetrahydrofuran-3,4-diyl dibenzoate, CAS: 139419-02-6, stock 466.4g, assay 98.8%, MWt 603.32, Formula C23H18IN5O7, Purity >98%, SMILES IC[C@]1(N=[N+]=[N-])[C@@H](OC(C2=CC=CC=C2)=O)[C@@H](OC(C3=CC=CC=C3)=O)[C@H](N4C=CC(NC4=O)=O)O1, MDL NA |
| Drug_Names: (2R,3S,4R,5R)-2-azido-2-((benzoyloxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate, CAS: 1365255-42-0, stock 890.7g, assay 98.9%, MWt 597.53, Formula C30H23N5O9, Purity >98%, SMILES O=C(N(C=C1)[C@H]2[C@H](OC(C3=CC=CC=C3)=O)[C@H](OC(C4=CC=CC=C4)=O)[C@](COC(C5=CC=CC=C5)=O)(N=[N+]=[N-])O2)NC1=O, MDL NA |
| Drug_Names: 4'-C-azidouridine, CAS: 139442-01-6, stock 432.5g, assay 98.5%, MWt 285.21, Formula C9H11N5O6, Purity >98%, SMILES O[C@@H]1[C@](CO)(N=[N+]=[N-])O[C@@H](N2C=CC(NC2=O)=O)[C@@H]1O, MDL NA |
| Drug_Names: 1-(Dimethoxymethyl)-4-methoxybenzene, CAS: 2186-92-7, stock 351.5g, assay 98.8%, MWt 182.22, Formula C10H14O3, Purity >98%, SMILES COC1=CC=C(C(OC)OC)C=C1, MDL MFCD00036507 |
| Drug_Names: 5-(4-Bromo-phenyl)-3-methyl-isoxazole-4-carboxylic acid, CAS: 91182-60-4, stock 568.5g, assay 98.3%, MWt 282.09, Formula C11H8BrNO3, Purity >98%, SMILES O=C(C1=C(C2=CC=C(Br)C=C2)ON=C1C)O, MDL MFCD16447083 |
| Drug_Names: 2-Chloro-N-(5-cyclopropyl-1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine, CAS: 918538-08-6, stock 103.6g, assay 98.2%, MWt 274.71, Formula C12H11ClN6, Purity >98%, SMILES ClC(N=C1NC2=NNC(C3CC3)=C2)=NN4C1=CC=C4, MDL NA |
| Drug_Names: (S)-1-(4-((5-Cyclopropyl-1H-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-2-methylpyrrolidine-2-carboxylic acid, CAS: 1001353-78-1, stock 114.1g, assay 98.2%, MWt 367.41, Formula C18H21N7O2, Purity >98%, SMILES C[C@@]1(C(O)=O)CCCN1C(N=C2NC3=NNC(C4CC4)=C3)=NN5C2=CC=C5, MDL NA |
| Drug_Names: N4-((3aS,4R,6S,6aR)-6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-6-chloro-2-(propylthio)pyrimidine-4,5-diamine, CAS: 1400665-91-9, stock 599.8g, assay 98.5%, MWt 533.20, Formula C23H41ClN4O4SSi, Purity >98%, SMILES CC(O1)(C)O[C@H]2[C@@H]1[C@H](NC3=NC(SCCC)=NC(Cl)=C3N)C[C@@H]2OCCO[Si](C)(C)C(C)(C)C, MDL NA |
| Drug_Names: 2-Bromo-5-fluoro-4-nitroaniline, CAS: 952664-69-6, stock 131.3g, assay 98.2%, MWt 235.01, Formula C6H4BrFN2O2, Purity >98%, SMILES FC1=C([N+]([O-])=O)C=C(Br)C(N)=C1, MDL MFCD22381005 |
| Drug_Names: 4-Benzyloxy-3,3-dimethylbut-1-yne, CAS: 1092536-54-3, stock 661.1g, assay 98.6%, MWt 188.27, Formula C13H16O, Purity >98%, SMILES CC(COCC1=CC=CC=C1)(C)C#C, MDL NA |
| Drug_Names: 2-Methyl-4-(trimethylsilyl)but-3-yn-2-ol, CAS: 5272-33-3, stock 382.1g, assay 98.8%, MWt 156.30, Formula C8H16OSi, Purity >98%, SMILES CC(O)(C)C#C[Si](C)(C)C, MDL MFCD00160794 |
| Drug_Names: (3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane, CAS: 18387-63-8, stock 286.1g, assay 98.1%, MWt 174.74, Formula C8H15ClSi, Purity >98%, SMILES CC(Cl)(C)C#C[Si](C)(C)C, MDL NA |
| Drug_Names: (4-(Benzyloxy)-3,3-dimethylbut-1-yn-1-yl)trimethylsilane, CAS: 1294504-65-6, stock 808.6g, assay 98.2%, MWt 260.45, Formula C16H24OSi, Purity >98%, SMILES CC(COCC1=CC=CC=C1)(C)C#C[Si](C)(C)C, MDL NA |
| Drug_Names: 1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarboxylic acid, CAS: 862574-88-7, stock 863.2g, assay 98.4%, MWt 242.18, Formula C11H8F2O4, Purity >98%, SMILES OC(C1(CC1)C2=CC3=C(OC(F)(F)O3)C=C2)=O, MDL MFCD13190001 |
| Drug_Names: (S)-Methyl 3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-chloro-4-oxobutanoate, CAS: 596095-91-9, stock 479.3g, assay 98.9%, MWt 387.81, Formula C20H18ClNO5, Purity >98%, SMILES ClC([C@@H](NC(OCC1C2=C(C=CC=C2)C3=C1C=CC=C3)=O)CC(OC)=O)=O, MDL NA |
| Drug_Names: 6-Methoxy-2-methyl-4H-benzo[d][1,3]oxazin-4-one, CAS: 38527-50-3, stock 667g, assay 98%, MWt 191.18, Formula C10H9NO3, Purity >98%, SMILES O=C1C2=CC(OC)=CC=C2N=C(C)O1, MDL NA |
| Drug_Names: (2-Amino-5-methoxyphenyl)(4-chlorophenyl)methanone, CAS: 91713-54-1, stock 893g, assay 98.3%, MWt 261.70, Formula C14H12ClNO2, Purity >98%, SMILES O=C(C1=C(N)C=CC(OC)=C1)C2=CC=C(Cl)C=C2, MDL NA |
| Drug_Names: (S)-Methyl 2-(5-(4-chlorophenyl)-7-methoxy-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)acetate, CAS: 1300019-46-8, stock 24.3g, assay 98.7%, MWt 372.80, Formula C19H17ClN2O4, Purity >98%, SMILES O=C(OC)C[C@H]1C(NC2=CC=C(OC)C=C2C(C3=CC=C(Cl)C=C3)=N1)=O, MDL NA |
| Drug_Names: Methyl 2-(5-(4-chlorophenyl)-7-methoxy-2-thioxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)acetate, CAS: 1260530-39-9, stock 253.2g, assay 98.5%, MWt 388.87, Formula C19H17ClN2O3S, Purity >98%, SMILES O=C(OC)CC1C(NC2=CC=C(OC)C=C2C(C3=CC=C(Cl)C=C3)=N1)=S, MDL NA |
| Drug_Names: Methyl 2-(6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)acetate, CAS: 1260530-41-3, stock 278.7g, assay 98.2%, MWt 410.85, Formula C21H19ClN4O3, Purity >98%, SMILES O=C(OC)CC1C2=NN=C(C)N2C3=CC=C(OC)C=C3C(C4=CC=C(Cl)C=C4)=N1, MDL NA |
| Drug_Names: 2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)acetic acid, CAS: 1260530-42-4, stock 368g, assay 98.5%, MWt 396.83, Formula C20H17ClN4O3, Purity >98%, SMILES O=C(O)CC1C2=NN=C(C)N2C3=CC=C(OC)C=C3C(C4=CC=C(Cl)C=C4)=N1, MDL NA |
| Drug_Names: Methyl 2-bromohexanoate, CAS: 5445-19-2, stock 425.4g, assay 98.8%, MWt 209.08, Formula C7H13BrO2, Purity >98%, SMILES CCCCC(Br)C(OC)=O, MDL MFCD00045038 |
| Drug_Names: Ethyl 2-chloro-2-(2-(4-chlorophenyl)hydrazono)acetate, CAS: 27143-09-5, stock 285g, assay 98.1%, MWt 261.10, Formula C10H10Cl2N2O2, Purity >98%, SMILES O=C(OCC)/C(Cl)=N/NC1=CC=C(Cl)C=C1, MDL NA |
| Drug_Names: 2-(2-Nitroethylidene)aminobenzoic acid, CAS: 121845-92-9, stock 439.3g, assay 98.3%, MWt 208.17, Formula C9H8N2O4, Purity >98%, SMILES O=C(O)C1=CC=CC=C1/N=C/C[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Nitroquinolin-4-ol, CAS: 50332-66-6, stock 455.6g, assay 98.2%, MWt 190.16, Formula C9H6N2O3, Purity >98%, SMILES OC1=C([N+]([O-])=O)C=NC2=CC=CC=C12, MDL MFCD00277722 |
| Drug_Names: 3-nitroquinolin-4-amine, CAS: 42606-33-7, stock 336.6g, assay 98.2%, MWt 189.17, Formula C9H7N3O2, Purity >98%, SMILES NC1=C([N+]([O-])=O)C=NC2=CC=CC=C12, MDL NA |
| Drug_Names: Quinoline-3,4-diamine, CAS: 87751-33-5, stock 320.2g, assay 98.8%, MWt 159.19, Formula C9H9N3, Purity >98%, SMILES NC1=C(N)C=NC2=CC=CC=C12, MDL MFCD00666954 |
| Drug_Names: 4-Chloro-2-cyclohexyl-3H-imidazo[4,5-c]quinoline, CAS: 890087-03-3, stock 774.6g, assay 98.5%, MWt 285.77, Formula C16H16ClN3, Purity >98%, SMILES ClC1=NC2=CC=CC=C2C3=C1N=C(C4CCCCC4)N3, MDL NA |
| Drug_Names: 4-(2-Hydroxyethoxy)benzaldehyde, CAS: 22042-73-5, stock 156.2g, assay 98%, MWt 166.17, Formula C9H10O3, Purity >98%, SMILES O=CC1=CC=C(OCCO)C=C1, MDL MFCD00191450 |
| Drug_Names: 4-(Chloromethyl)-2-(4-chlorophenyl)-1,3-thiazole, CAS: 17969-22-1, stock 373.3g, assay 98.4%, MWt 244.14, Formula C10H7Cl2NS, Purity >98%, SMILES ClC1=CC=C(C2=NC(CCl)=CS2)C=C1, MDL NA |
| Drug_Names: Ethyl 5-methyl-1-(5-methyl-2-nitrophenyl)-1H-imidazole-4-carboxylate, CAS: 164330-34-1, stock 416.8g, assay 98.2%, MWt 289.29, Formula C14H15N3O4, Purity >98%, SMILES CC1=CC=C([N+]([O-])=O)C(N2C=NC(C(OCC)=O)=C2C)=C1, MDL NA |
| Drug_Names: Ethyl 1-(2-amino-5-methylphenyl)-5-methyl-1H-imidazole-4-carboxylate, CAS: 164330-69-2, stock 257g, assay 98.7%, MWt 259.30, Formula C14H17N3O2, Purity >98%, SMILES NC1=CC=C(C)C=C1N2C=NC(C(OCC)=O)=C2C, MDL NA |
| Drug_Names: Ethyl 1,8-dimethyl-4-oxo-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylate, CAS: 164329-39-9, stock 721.8g, assay 98.6%, MWt 285.30, Formula C15H15N3O3, Purity >98%, SMILES CC1=CC=C(NC(C2=NC(C(OCC)=O)=C(C)N23)=O)C3=C1, MDL NA |
| Drug_Names: 1,8-Dimethyl-4-oxo-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylic acid, CAS: 164329-73-1, stock 189.1g, assay 98.7%, MWt 257.24, Formula C13H11N3O3, Purity >98%, SMILES CC1=CC=C(NC(C2=NC(C(O)=O)=C(C)N23)=O)C3=C1, MDL NA |
| Drug_Names: 1,8-Dimethylimidazo[1,2-a]quinoxalin-4(5H)-one, CAS: 445430-61-5, stock 394.3g, assay 98.9%, MWt 213.24, Formula C12H11N3O, Purity >98%, SMILES CC1=CC=C(NC(C2=NC=C(C)N23)=O)C3=C1, MDL NA |
| Drug_Names: 4-Chloro-1,8-dimethyl-imidazo[1,2-a]quinoxaline, CAS: 445430-62-6, stock 8g, assay 98.1%, MWt 231.68, Formula C12H10ClN3, Purity >98%, SMILES CC1=CC=C(N=C(Cl)C2=NC=C(C)N23)C3=C1, MDL NA |
| Drug_Names: Methyl 5-fluoro-2-methyl-3-nitrobenzoate, CAS: 697739-03-0, stock 825.1g, assay 99%, MWt 213.16, Formula C9H8FNO4, Purity >98%, SMILES O=C(OC)C1=CC(F)=CC([N+]([O-])=O)=C1C, MDL MFCD11845442 |
| Drug_Names: 5-Fluoro-2-methyl-3-nitrobenzoic acid, CAS: 850462-64-5, stock 769g, assay 98.3%, MWt 199.14, Formula C8H6FNO4, Purity >98%, SMILES O=C(O)C1=CC(F)=CC([N+]([O-])=O)=C1C, MDL NA |
| Drug_Names: Methyl 2-(bromomethyl)-5-fluoro-3-nitrobenzoate, CAS: 850462-65-6, stock 175.5g, assay 98.1%, MWt 292.06, Formula C9H7BrFNO4, Purity >98%, SMILES O=C(OC)C1=CC(F)=CC([N+]([O-])=O)=C1CBr, MDL NA |
| Drug_Names: 6-Fluoro-4-nitroisobenzofuran-1(3H)-one, CAS: 1207453-90-4, stock 160.6g, assay 98.7%, MWt 197.12, Formula C8H4FNO4, Purity >98%, SMILES O=C1OCC2=C1C=C(F)C=C2[N+]([O-])=O, MDL MFCD22370184 |
| Drug_Names: (Z)-6-fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one, CAS: 1322616-34-1, stock 428.1g, assay 98.9%, MWt 290.21, Formula C12H7FN4O4, Purity >98%, SMILES O=C1O/C(C2=C1C=C(F)C=C2[N+]([O-])=O)=C\C3=NC=NN3C, MDL NA |
| Drug_Names: Methyl 5-fluoro-2-(2-(1-methyl-1H-1,2,4-triazol-5-yl)acetyl)-3-nitrobenzoate hydrochloride, CAS: 1322616-35-2, stock 587.7g, assay 98.7%, MWt 358.71, Formula C13H12ClFN4O5, Purity >98%, SMILES [H]Cl.O=C(OC)C1=CC(F)=CC([N+]([O-])=O)=C1C(CC2=NC=NN2C)=O, MDL NA |
| Drug_Names: Methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate, CAS: 1322616-36-3, stock 181.1g, assay 99%, MWt 398.36, Formula C20H16F2N4O3, Purity >98%, SMILES O=C(C1=CC(F)=CC(NC(C2=CC=C(F)C=C2)C3C4=NC=NN4C)=C1C3=O)OC, MDL NA |
| Drug_Names: (2S,3S)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate, CAS: 1373329-52-2, stock 340.4g, assay 98.1%, MWt 398.36, Formula C20H16F2N4O3, Purity >98%, SMILES O=C(C1=CC(F)=CC(N[C@H](C2=CC=C(F)C=C2)[C@H]3C4=NC=NN4C)=C1C3=O)OC, MDL NA |
| Drug_Names: (2R,3R)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate, CAS: 1425767-92-5, stock 694.4g, assay 98.4%, MWt 398.36, Formula C20H16F2N4O3, Purity >98%, SMILES O=C(C1=CC(F)=CC(N[C@@H](C2=CC=C(F)C=C2)[C@@H]3C4=NC=NN4C)=C1C3=O)OC, MDL NA |
| Drug_Names: 1-Methoxy-2-(2-nitroethenyl)benzene, CAS: 3316-24-3, stock 227.1g, assay 98.2%, MWt 179.17, Formula C9H9NO3, Purity >98%, SMILES O=[N+](/C=C/C1=CC=CC=C1OC)[O-], MDL MFCD00070647 |
| Drug_Names: 2-Methoxybenzeneacetamide, CAS: 33390-80-6, stock 872.3g, assay 98.4%, MWt 165.19, Formula C9H11NO2, Purity >98%, SMILES COC1=CC=CC=C1CC(N)=O, MDL NA |
| Drug_Names: 2-Methoxyphenylethylamine Hydrochloride, CAS: 3167-07-5, stock 697.8g, assay 99%, MWt 187.67, Formula C9H14ClNO, Purity >98%, SMILES NCCC1=CC=CC=C1OC.Cl, MDL NA |
| Drug_Names: Methyl 4-(((2-methoxyphenethyl)amino)methyl)benzoate, CAS: 329774-40-5, stock 741.3g, assay 98.8%, MWt 299.36, Formula C18H21NO3, Purity >98%, SMILES O=C(OC)C1=CC=C(CNCCC2=CC=CC=C2OC)C=C1, MDL NA |
| Drug_Names: Methyl 4-(((5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino)methyl)benzoate, CAS: 329774-41-6, stock 43.1g, assay 98.4%, MWt 427.53, Formula C25H33NO5, Purity >98%, SMILES O=C(OC)C1=CC=C(CN(CCCCC(OCC)=O)CCC2=CC=CC=C2OC)C=C1, MDL NA |
| Drug_Names: Methyl 4-(((2-hydroxyphenethyl)(5-methoxy-5-oxopentyl)amino)methyl)benzoate, CAS: 329774-42-7, stock 766.6g, assay 98.2%, MWt 399.48, Formula C23H29NO5, Purity >98%, SMILES O=C(OC)C1=CC=C(CN(CCCCC(OC)=O)CCC2=CC=CC=C2O)C=C1, MDL NA |
| Drug_Names: 4-[(E)-Phenylethenyl)]benzyl chloride, CAS: 150253-59-1, stock 572g, assay 98.9%, MWt 228.72, Formula C15H13Cl, Purity >98%, SMILES ClCC1=CC=C(/C=C/C2=CC=CC=C2)C=C1, MDL NA |
| Drug_Names: Methyl 4-(((5-methoxy-5-oxopentyl)(2-((4-phenethylbenzyl)oxy)phenethyl)amino)methyl)benzoate, CAS: 329773-33-3, stock 505.7g, assay 98.6%, MWt 593.75, Formula C38H43NO5, Purity >98%, SMILES O=C(OC)C1=CC=C(CN(CCCCC(OC)=O)CCC2=CC=CC=C2OCC3=CC=C(CCC4=CC=CC=C4)C=C3)C=C1, MDL NA |
| Drug_Names: Benzyl ((4S,8S,11S)-4,8-diisobutyl-3,13-dimethyl-5,7,10-trioxo-2-oxa-3,6,9-triazatetradecan-11-yl)carbamate, CAS: 170590-15-5, stock 848.2g, assay 98.5%, MWt 534.69, Formula C28H46N4O6, Purity >98%, SMILES CC(C)C[C@@H](C(N[C@@H](CC(C)C)C(N(OC)C)=O)=O)NC([C@H](CC(C)C)NC(OCC1=CC=CC=C1)=O)=O, MDL NA |
| Drug_Names: Ethyl 2-(ethoxymethylene)-3-oxobutyrate, CAS: 3788-94-1, stock 19.5g, assay 98.6%, MWt 186.21, Formula C9H14O4, Purity >98%, SMILES CC(/C(C(OCC)=O)=C\OCC)=O, MDL NA |
| Drug_Names: 1-(4-hydroxy-6-methoxy-1,5-naphthyridin-3-yl)ethanone, CAS: 1431697-92-5, stock 409.9g, assay 98.5%, MWt 218.21, Formula C11H10N2O3, Purity >98%, SMILES CC(C1=C(O)C2=NC(OC)=CC=C2N=C1)=O, MDL NA |
| Drug_Names: 1-(4,6-Dihydroxy-1,5-naphthyridin-3-yl)ethanone, CAS: 1431697-83-4, stock 793.3g, assay 99%, MWt 204.18, Formula C10H8N2O3, Purity >98%, SMILES CC(C1=C(O)C2=NC(O)=CC=C2N=C1)=O, MDL NA |
| Drug_Names: trans-4-(((tert-Butoxycarbonyl)amino)methyl)cyclohexanecarboxylic acid, CAS: 27687-14-5, stock 199.7g, assay 98.2%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES O=C(O)[C@H]1CC[C@H](CNC(OC(C)(C)C)=O)CC1, MDL MFCD00673773 |
| Drug_Names: tert-Butyl ((trans-4-(((benzyloxy)carbonyl)amino)cyclohexyl)methyl)carbamate, CAS: 192323-61-8, stock 719g, assay 98.5%, MWt 362.46, Formula C20H30N2O4, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N[C@H]2CC[C@H](CNC(OC(C)(C)C)=O)CC2, MDL NA |
| Drug_Names: Benzyl ((1R,4R)-4-((dimethylamino)methyl)cyclohexyl)carbamate, CAS: 1356953-43-9, stock 343.2g, assay 98%, MWt 290.40, Formula C17H26N2O2, Purity >98%, SMILES CN(C)C[C@H]1CC[C@H](NC(OCC2=CC=CC=C2)=O)CC1, MDL NA |
| Drug_Names: trans-4-((Dimethylamino)methyl)cyclohexanamine diacetate, CAS: 1356953-44-0, stock 485.3g, assay 98.7%, MWt 276.37, Formula C13H28N2O4, Purity >98%, SMILES N[C@H]1CC[C@H](CN(C)C)CC1.CC(O)=O.CC(O)=O, MDL NA |
| Drug_Names: 2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, CAS: 1003298-87-0, stock 556.7g, assay 98.2%, MWt 288.96, Formula C12H15BCl2O3, Purity >98%, SMILES OC1=C(Cl)C=C(B2OC(C)(C)C(C)(C)O2)C=C1Cl, MDL NA |
| Drug_Names: 2-Fluoro-5-sulfinobenzoic acid, CAS: 1229627-84-2, stock 843.5g, assay 98.6%, MWt 204.18, Formula C7H5FO4S, Purity >98%, SMILES OC(C1=CC(S(O)=O)=CC=C1F)=O, MDL NA |
| Drug_Names: Methyl 2-fluoro-5-(methylsulfonyl)benzoate, CAS: 865663-98-5, stock 171.8g, assay 98.1%, MWt 232.23, Formula C9H9FO4S, Purity >98%, SMILES O=C(OC)C1=CC(S(=O)(C)=O)=CC=C1F, MDL NA |
| Drug_Names: 2-Fluoro-5-(methanesulfonyl)benzoic acid, CAS: 247569-56-8, stock 634.4g, assay 98.8%, MWt 218.20, Formula C8H7FO4S, Purity >98%, SMILES OC(C1=CC(S(=O)(C)=O)=CC=C1F)=O, MDL NA |
| Drug_Names: (S)-2-(1-Methyl-2,2,2-trifluoroethoxy)-5-methylsulfonylbenzoic acid, CAS: 845616-82-2, stock 747.1g, assay 98.7%, MWt 312.26, Formula C11H11F3O5S, Purity >98%, SMILES OC(C1=CC(S(=O)(C)=O)=CC=C1O[C@H](C(F)(F)F)C)=O, MDL NA |
| Drug_Names: 5-Methylsulfonyl-2-[((R)-2,2,2-trifluoro-1-methylethyl)oxy]benzoic acid, CAS: 845616-83-3, stock 649.5g, assay 98.4%, MWt 312.26, Formula C11H11F3O5S, Purity >98%, SMILES OC(C1=CC(S(=O)(C)=O)=CC=C1O[C@@H](C(F)(F)F)C)=O, MDL NA |
| Drug_Names: 5-Methylsulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)benzoic acid methyl ester, CAS: 845617-19-8, stock 854.2g, assay 98.1%, MWt 326.29, Formula C12H13F3O5S, Purity >98%, SMILES O=C(C1=CC(S(=O)(C)=O)=CC=C1OC(C(F)(F)F)C)OC, MDL NA |
| Drug_Names: 5-Methylsulfonyl-2-[((S)-2,2,2-trifluoro-1-methylethyl)oxy]benzoic acid methyl ester, CAS: 845617-20-1, stock 259.7g, assay 98.1%, MWt 326.29, Formula C12H13F3O5S, Purity >98%, SMILES O=C(C1=CC(S(=O)(C)=O)=CC=C1O[C@H](C(F)(F)F)C)OC, MDL NA |
| Drug_Names: 5-Methylsulfonyl-2-[((R)-2,2,2-trifluoro-1-methylethyl)oxy]benzoic acid methyl ester, CAS: 845617-21-2, stock 166.1g, assay 98.3%, MWt 326.29, Formula C12H13F3O5S, Purity >98%, SMILES O=C(C1=CC(S(=O)(C)=O)=CC=C1O[C@@H](C(F)(F)F)C)OC, MDL NA |
| Drug_Names: 1-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazine, CAS: 845616-81-1, stock 516.6g, assay 98.3%, MWt 249.21, Formula C10H11F4N3, Purity >98%, SMILES FC1=CC(C(F)(F)F)=CN=C1N2CCNCC2, MDL NA |
| Drug_Names: 4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester, CAS: 897376-76-0, stock 674.8g, assay 98.9%, MWt 349.32, Formula C15H19F4N3O2, Purity >98%, SMILES FC1=CC(C(F)(F)F)=CN=C1N2CCN(C(OC(C)(C)C)=O)CC2, MDL NA |
| Drug_Names: rel-dimethyl (2R,3R)-2-methyloxirane-2,3-dicarboxylate, CAS: 53282-74-9, stock 409.5g, assay 98.6%, MWt 174.15, Formula C7H10O5, Purity >98%, SMILES C[C@@]1(C(OC)=O)[C@@]([H])(C(OC)=O)O1, MDL NA |
| Drug_Names: (2S,3R)-2-methyl-5-oxotetrahydrofuran-2,3-dicarboxylic acid, CAS: 905719-15-5, stock 155.2g, assay 98.4%, MWt 188.13, Formula C7H8O6, Purity >98%, SMILES C[C@@]1(C(O)=O)[C@]([H])(C(O)=O)CC(O1)=O, MDL NA |
| Drug_Names: 3,4,5-Trichloro-2,6-dimethylpyridine, CAS: 28597-08-2, stock 554.7g, assay 99%, MWt 210.49, Formula C7H6Cl3N, Purity >98%, SMILES CC1=C(Cl)C(Cl)=C(Cl)C(C)=N1, MDL NA |
| Drug_Names: (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, CAS: 1644461-85-7, stock 851.2g, assay 98.6%, MWt 538.57, Formula C23H28F2N6O5S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)=O)N=C3N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H](O)[C@@H]1O, MDL NA |
| Drug_Names: (S)-tert-Butyl (1-(2-methyl-6-nitro-N-(o-tolyl)benzamido)-1-oxopropan-2-yl)carbamate, CAS: 936025-18-2, stock 391.2g, assay 98.8%, MWt 441.48, Formula C23H27N3O6, Purity >98%, SMILES O=C(C1=C([N+]([O-])=O)C=CC=C1C)N(C([C@@H](NC(OC(C)(C)C)=O)C)=O)C2=CC=CC=C2C, MDL NA |
| Drug_Names: (S)-tert-Butyl (1-(5-methyl-4-oxo-3-(o-tolyl)-3,4-dihydroquinazolin-2-yl)ethyl)carbamate, CAS: 936024-96-3, stock 168g, assay 99%, MWt 393.48, Formula C23H27N3O3, Purity >98%, SMILES O=C1N(C2=CC=CC=C2C)C([C@H](C)NC(OC(C)(C)C)=O)=NC3=C1C(C)=CC=C3, MDL NA |
| Drug_Names: (S)-2-(1-aminoethyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one, CAS: 1431699-63-6, stock 303g, assay 98.3%, MWt 293.36, Formula C18H19N3O, Purity >98%, SMILES O=C1N(C2=CC=CC=C2C)C([C@H](C)N)=NC3=C1C(C)=CC=C3, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, CAS: 376608-74-1, stock 290g, assay 98.6%, MWt 418.94, Formula C17H27ClN4O4S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](NC2=NC(SCCC)=NC(Cl)=C2N)[C@H]3[C@@H]1OC(C)(C)O3, MDL MFCD21362979 |
| Drug_Names: 5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-amine, CAS: 1180132-17-5, stock 744.1g, assay 98.1%, MWt 220.31, Formula C12H20N4, Purity >98%, SMILES NC1=NC=C(CN2CCN(CC)CC2)C=C1, MDL MFCD14706690 |
| Drug_Names: 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole, CAS: 1231930-33-8, stock 228g, assay 98%, MWt 271.13, Formula C11H12BrFN2, Purity >98%, SMILES CC1=NC2=C(F)C=C(Br)C=C2N1C(C)C, MDL MFCD16660227 |
| Drug_Names: 4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, CAS: 1231930-37-2, stock 244g, assay 98.9%, MWt 318.19, Formula C17H24BFN2O2, Purity >98%, SMILES CC1=NC2=C(F)C=C(B3OC(C)(C)C(C)(C)O3)C=C2N1C(C)C, MDL MFCD25977327 |
| Drug_Names: 6-(2-Chloro-5-fluoropyrimidin-4-yl)-4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazole, CAS: 1231930-42-9, stock 530.2g, assay 98.2%, MWt 322.74, Formula C15H13ClF2N4, Purity >98%, SMILES CC1=NC2=C(F)C=C(C3=NC(Cl)=NC=C3F)C=C2N1C(C)C, MDL NA |
| Drug_Names: 1-(3,5-Dichloropyridin-4-yl)ethanol, CAS: 1254473-66-9, stock 478.9g, assay 98.5%, MWt 192.04, Formula C7H7Cl2NO, Purity >98%, SMILES ClC1=C(C(O)C)C(Cl)=CN=C1, MDL NA |
| Drug_Names: N-(4-Bromophenyl)-N'-ethyl urea, CAS: 82745-18-4, stock 526.5g, assay 98.1%, MWt 243.10, Formula C9H11BrN2O, Purity >98%, SMILES O=C(NCC)NC1=CC=C(Br)C=C1, MDL NA |
| Drug_Names: 7-Benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione, CAS: 62459-02-3, stock 615.7g, assay 98%, MWt 257.29, Formula C14H15N3O2, Purity >98%, SMILES O=C(N1)NC(C2=C1CN(CC3=CC=CC=C3)CC2)=O, MDL NA |
| Drug_Names: (S)-tert-butyl 2-(4-(3-ethylureido)phenyl)-4-(3-methylmorpholino)-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate, CAS: 1207365-47-6, stock 523.1g, assay 98.1%, MWt 496.60, Formula C26H36N6O4, Purity >98%, SMILES O=C(NCC)NC(C=C1)=CC=C1C2=NC3=C(CCN(C(OC(C)(C)C)=O)C3)C(N4[C@@H](C)COCC4)=N2, MDL NA |
| Drug_Names: 3-Methylcinnamic acid, CAS: 3029-79-6, stock 616.6g, assay 98.7%, MWt 162.19, Formula C10H10O2, Purity >98%, SMILES OC(/C=C/C1=CC(C)=CC=C1)=O, MDL MFCD00016844 |
| Drug_Names: 3-(3-Methylphenyl)propionic acid, CAS: 3751-48-2, stock 552.3g, assay 98.9%, MWt 164.20, Formula C10H12O2, Purity >98%, SMILES OC(CCC1=CC(C)=CC=C1)=O, MDL MFCD00060326 |
| Drug_Names: Ethyl 3-(3-methylphenyl)propanoate, CAS: 7297-13-4, stock 141.5g, assay 98.1%, MWt 192.25, Formula C12H16O2, Purity >98%, SMILES O=C(OCC)CCC1=CC(C)=CC=C1, MDL NA |
| Drug_Names: 3-Methylbenzenepropanol, CAS: 111171-94-9, stock 20.2g, assay 98.1%, MWt 150.22, Formula C10H14O, Purity >98%, SMILES OCCCC1=CC(C)=CC=C1, MDL NA |
| Drug_Names: 1-Phenylethyl hydrogen phthalate, CAS: 33533-53-8, stock 135.5g, assay 98.8%, MWt 270.28, Formula C16H14O4, Purity >98%, SMILES CC(OC(C1=C(C(O)=O)C=CC=C1)=O)C2=CC=CC=C2, MDL NA |
| Drug_Names: (R)-1-Phenylethanol, CAS: 1517-69-7, stock 377.7g, assay 98.1%, MWt 122.16, Formula C8H10O, Purity >98%, SMILES O[C@H](C)C1=CC=CC=C1, MDL MFCD00064263 |
| Drug_Names: [5-(4-Bromophenyl)-3-methylisoxazol-4-yl]carbamic acid(R)-1-phenylethyl ester, CAS: 1228690-37-6, stock 511.4g, assay 98.9%, MWt 401.25, Formula C19H17BrN2O3, Purity >98%, SMILES O=C(O[C@@H](C1=CC=CC=C1)C)NC2=C(C3=CC=C(Br)C=C3)ON=C2C, MDL NA |
| Drug_Names: [4'-[3-Methyl-4-[[[((R)-1-phenylethyl)oxy]carbonyl]amino]isoxazol-5-yl]biphenyl-4-yl]acetic acid ethyl ester, CAS: 1228690-38-7, stock 758.6g, assay 98.8%, MWt 484.54, Formula C29H28N2O5, Purity >98%, SMILES O=C(OCC)CC1=CC=C(C2=CC=C(C3=C(NC(O[C@@H](C4=CC=CC=C4)C)=O)C(C)=NO3)C=C2)C=C1, MDL NA |
| Drug_Names: 4-(tert-butyl)-N-(6-hydroxy-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide, CAS: 174227-14-6, stock 526.5g, assay 98.9%, MWt 507.56, Formula C25H25N5O5S, Purity >98%, SMILES O=S(C1=CC=C(C(C)(C)C)C=C1)(NC2=NC(C3=NC=CC=N3)=NC(O)=C2OC4=CC=CC=C4OC)=O, MDL NA |
| Drug_Names: Bosentan Related Compound C, CAS: 1097263-60-9, stock 751.6g, assay 98.8%, MWt 1041.16, Formula C52H52N10O10S2, Purity >98%, SMILES O=S(C1=CC=C(C(C)(C)C)C=C1)(NC2=NC(C3=NC=CC=N3)=NC(OCCOC4=C(OC5=CC=CC=C5OC)C(NS(C6=CC=C(C(C)(C)C)C=C6)(=O)=O)=NC(C7=NC=CC=N7)=N4)=C2OC8=CC=CC=C8OC)=O, MDL NA |
| Drug_Names: (3S,8R,9S,10R,13S,14S,E)-17-hydrazono-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, CAS: 63015-10-1, stock 31.9g, assay 99%, MWt 302.45, Formula C19H30N2O, Purity >98%, SMILES C[C@]1([C@](CC/2)([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC1)C2=N/N, MDL NA |
| Drug_Names: [(tert-butoxycarbonyl)amino](3-chlorophenyl)acetic acid, CAS: 669713-92-2, stock 213.7g, assay 98.5%, MWt 285.72, Formula C13H16ClNO4, Purity >98%, SMILES ClC1=CC(C(C(O)=O)NC(OC(C)(C)C)=O)=CC=C1, MDL MFCD03426365 |
| Drug_Names: 2-Amino-2-(3-chlorophenyl)ethanol hydrochloride, CAS: 1334146-19-8, stock 141.2g, assay 98.3%, MWt 208.09, Formula C8H11Cl2NO, Purity >98%, SMILES ClC1=CC(C(CO)N)=CC=C1.Cl, MDL NA |
| Drug_Names: [1-(3-Chlorophenyl)-2-hydroxyethyl]carbamic acid tert-butyl ester, CAS: 926643-26-7, stock 390.1g, assay 98.8%, MWt 271.74, Formula C13H18ClNO3, Purity >98%, SMILES ClC1=CC(C(CO)NC(OC(C)(C)C)=O)=CC=C1, MDL NA |
| Drug_Names: Ethyl 2-amino-1-methyl-1H-imidazole-5-carboxylate, CAS: 177760-04-2, stock 574.6g, assay 98.4%, MWt 169.18, Formula C7H11N3O2, Purity >98%, SMILES O=C(C1=CN=C(N)N1C)OCC, MDL MFCD09997799 |
| Drug_Names: 1-Methyl-2-nitro-1H-Imidazole-5-carboxylic acid, CAS: 50700-55-5, stock 100g, assay 98.4%, MWt 171.11, Formula C5H5N3O4, Purity >98%, SMILES O=C(C1=CN=C([N+]([O-])=O)N1C)O, MDL MFCD19443277 |
| Drug_Names: NSC 307224, CAS: 39070-14-9, stock 533.4g, assay 98.3%, MWt 157.13, Formula C5H7N3O3, Purity >98%, SMILES OCC1=CN=C([N+]([O-])=O)N1C, MDL MFCD06738747 |
| Drug_Names: N,N'-Bis(2-bromoethyl)phosphorodiamidic acid, CAS: 141025-16-3, stock 764.2g, assay 98.6%, MWt 309.92, Formula C4H11Br2N2O2P, Purity >98%, SMILES O=P(NCCBr)(NCCBr)O, MDL NA |
| Drug_Names: 1-(2-Chloro-4-fluorophenyl)guanidine, CAS: 896720-31-3, stock 795.6g, assay 98.4%, MWt 187.60, Formula C7H7ClFN3, Purity >98%, SMILES NC(NC1=CC=C(F)C=C1Cl)=N, MDL NA |
| Drug_Names: 1-(5-(2,2,2-Trichloroacetyl)-1H-pyrrol-3-yl)propan-1-one, CAS: 111468-90-7, stock 383.4g, assay 98.8%, MWt 268.52, Formula C9H8Cl3NO2, Purity >98%, SMILES O=C(C(Cl)(Cl)Cl)C1=CC(C(CC)=O)=CN1, MDL MFCD00141837 |
| Drug_Names: Methyl 4-propionyl-1H-pyrrole-2-carboxylate, CAS: 1135282-93-7, stock 165.4g, assay 98.7%, MWt 181.19, Formula C9H11NO3, Purity >98%, SMILES O=C(OC)C1=CC(C(CC)=O)=CN1, MDL NA |
| Drug_Names: Methyl 4-propionyl-1-tosyl-1H-pyrrole-2-carboxylate, CAS: 1191272-69-1, stock 389g, assay 98.3%, MWt 335.37, Formula C16H17NO5S, Purity >98%, SMILES O=C(OC)C1=CC(C(CC)=O)=CN1S(C2=CC=C(C)C=C2)(=O)=O, MDL NA |
| Drug_Names: 6-bromo-N-(3-fluorobenzyl)pyridin-2-amine, CAS: 1263374-07-7, stock 378.6g, assay 98.7%, MWt 281.12, Formula C12H10BrFN2, Purity >98%, SMILES FC1=CC(CNC2=NC(Br)=CC=C2)=CC=C1, MDL NA |
| Drug_Names: 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene, CAS: 1103738-29-9, stock 320.1g, assay 99%, MWt 372.63, Formula C15H14ClIO, Purity >98%, SMILES CCOC1=CC=C(CC2=CC(I)=CC=C2Cl)C=C1, MDL MFCD18642361 |
| Drug_Names: (4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methanone, CAS: 1103738-30-2, stock 611.6g, assay 98.8%, MWt 432.89, Formula C23H25ClO6, Purity >98%, SMILES O=C(C1=CC=C(Cl)C(CC2=CC=C(OCC)C=C2)=C1)[C@@H]3O[C@](O4)([H])[C@@H](OC4(C)C)[C@@H]3O, MDL NA |
| Drug_Names: (3S,4R,5S,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, CAS: 1018898-84-4, stock 432.1g, assay 98.5%, MWt 562.99, Formula C28H31ClO10, Purity >98%, SMILES CCOC1=CC=C(CC2=CC([C@H]3[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)C(OC(C)=O)O3)=CC=C2Cl)C=C1, MDL NA |
| Drug_Names: ((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone, CAS: 1103738-19-7, stock 102g, assay 98.3%, MWt 273.28, Formula C12H19NO6, Purity >98%, SMILES O[C@H]([C@H](C(N1CCOCC1)=O)O2)[C@H](O3)[C@@H]2OC3(C)C, MDL NA |
| Drug_Names: N-(2-carbamoylphenyl)-3-methoxybenzamide, CAS: 330657-87-9, stock 856.6g, assay 98.1%, MWt 270.28, Formula C15H14N2O3, Purity >98%, SMILES O=C(N)C1=CC=CC=C1NC(C2=CC=CC(OC)=C2)=O, MDL NA |
| Drug_Names: 3-(4-Oxo-3,4-dihydroquinazolin-2-yl)phenyl acetate, CAS: 371947-93-2, stock 460.5g, assay 98.4%, MWt 280.28, Formula C16H12N2O3, Purity >98%, SMILES O=C1NC(C2=CC=CC(OC(C)=O)=C2)=NC3=C1C=CC=C3, MDL NA |
| Drug_Names: 5-Nitroindazole-1-carboxylic acid tert-butyl ester, CAS: 129488-09-1, stock 238.5g, assay 98%, MWt 263.25, Formula C12H13N3O4, Purity >98%, SMILES CC(C)(C)OC(N1N=CC2=C1C=CC([N+]([O-])=O)=C2)=O, MDL MFCD07779196 |
| Drug_Names: 2-(4-Fluorophenyl)thiophene, CAS: 58861-48-6, stock 461.8g, assay 98.5%, MWt 178.23, Formula C10H7FS, Purity >98%, SMILES FC(C=C1)=CC=C1C2=CC=CS2, MDL NA |
| Drug_Names: 2-(5-Bromo-2-methylbenzoyl)-5-(4-fluorophenyl)thiophene, CAS: 1132832-75-7, stock 843.7g, assay 98.8%, MWt 375.25, Formula C18H12BrFOS, Purity >98%, SMILES CC1=C(C(C2=CC=C(C3=CC=C(F)C=C3)S2)=O)C=C(Br)C=C1, MDL NA |
| Drug_Names: trimethyl (S)-5-((3-phenoxybenzyl)(1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)benzene-1,2,4-tricarboxylate, CAS: 1332577-02-2, stock 596.6g, assay 98.9%, MWt 607.65, Formula C36H33NO8, Purity >98%, SMILES O=C(OC)C1=C(C(N(CC2=CC=CC(OC3=CC=CC=C3)=C2)[C@H]4CCCC5=CC=CC=C54)=O)C=C(C(OC)=O)C(C(OC)=O)=C1, MDL NA |
| Drug_Names: 4-Amino-2-chloro-3-methylbenzonitrile hydrochloride, CAS: 864361-78-4, stock 78g, assay 98.6%, MWt 203.07, Formula C8H8Cl2N2, Purity >98%, SMILES NC1=CC=C(C#N)C(Cl)=C1C.Cl, MDL NA |
| Drug_Names: (2S,3R)-3-Hydroxypyrrolidine-2-carboxylic acid, CAS: 567-35-1, stock 828.2g, assay 98.2%, MWt 131.13, Formula C5H9NO3, Purity >98%, SMILES O=C(O)[C@H]1NCC[C@H]1O, MDL NA |
| Drug_Names: 5-Methyl-5H-dibenz[b,d]azepine-6,7-dione 7-oxime, CAS: 209984-31-6, stock 187.3g, assay 98.2%, MWt 252.27, Formula C15H12N2O2, Purity >98%, SMILES O=C(C1=NO)N(C)C2=C(C3=C1C=CC=C3)C=CC=C2, MDL NA |
| Drug_Names: tert-Butyl ((S)-1-(((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)amino)-1-oxopropan-2-yl)carbamate, CAS: 209984-33-8, stock 599.4g, assay 98.1%, MWt 409.48, Formula C23H27N3O4, Purity >98%, SMILES C[C@H](NC(OC(C)(C)C)=O)C(N[C@H](C(N1C)=O)C2=CC=CC=C2C3=C1C=CC=C3)=O, MDL NA |
| Drug_Names: (S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide, CAS: 253324-50-4, stock 47g, assay 98%, MWt 309.36, Formula C18H19N3O2, Purity >98%, SMILES N[C@@H](C)C(N[C@H](C(N1C)=O)C2=CC=CC=C2C3=C1C=CC=C3)=O, MDL NA |
| Drug_Names: (2S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide, CAS: 1103722-91-3, stock 557.8g, assay 98.5%, MWt 479.48, Formula C26H23F2N3O4, Purity >98%, SMILES C[C@H](NC([C@@H](O)C1=CC(F)=CC(F)=C1)=O)C(NC(C(N2C)=O)C3=CC=CC=C3C4=C2C=CC=C4)=O, MDL NA |
| Drug_Names: 4-Fluoro-4-methyl-2-(pent-4-enamido)pentanoic acid, CAS: 848949-88-2, stock 171.2g, assay 98.4%, MWt 231.26, Formula C11H18FNO3, Purity >98%, SMILES CC(F)(CC(C(O)=O)NC(CCC=C)=O)C, MDL NA |
| Drug_Names: 5-(Bromomethyl)butyrolactone, CAS: 32730-32-8, stock 668.2g, assay 98.2%, MWt 179.01, Formula C5H7BrO2, Purity >98%, SMILES O=C1CCC(CBr)O1, MDL NA |
| Drug_Names: 1,1-Dimethylhydrazine hydrochloride, CAS: 593-82-8, stock 410.6g, assay 98%, MWt 96.56, Formula C2H9ClN2, Purity >98%, SMILES NN(C)C.Cl, MDL MFCD00060207 |
| Drug_Names: N',N'-Dimethylformohydrazide, CAS: 3298-49-5, stock 569.5g, assay 98.3%, MWt 88.11, Formula C3H8N2O, Purity >98%, SMILES CN(C)NC=O, MDL NA |
| Drug_Names: N,N,N'-Trimethyl-hydrazine dihydrochloride, CAS: 339539-94-5, stock 38g, assay 98.3%, MWt 147.05, Formula C3H12Cl2N2, Purity >98%, SMILES CN(C)NC.Cl.Cl, MDL MFCD07369993 |
| Drug_Names: Ethyl 1-Boc-3-benzylpiperidine-3-carboxylate, CAS: 170842-80-5, stock 762.8g, assay 98.2%, MWt 347.45, Formula C20H29NO4, Purity >98%, SMILES CC(C)(C)OC(N1CCCC(C(OCC)=O)(CC2=CC=CC=C2)C1)=O, MDL MFCD11500859 |
| Drug_Names: 1-Boc-3-benzyl-3-piperidinecarboxylic acid, CAS: 170838-83-2, stock 379.9g, assay 98.6%, MWt 319.40, Formula C18H25NO4, Purity >98%, SMILES CC(C)(C)OC(N1CCCC(C(O)=O)(CC2=CC=CC=C2)C1)=O, MDL MFCD03840043 |
| Drug_Names: (R)-3-Benzyl-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid, CAS: 339539-81-0, stock 268.3g, assay 98.2%, MWt 319.40, Formula C18H25NO4, Purity >98%, SMILES CC(C)(C)OC(N1CCC[C@@](C(O)=O)(CC2=CC=CC=C2)C1)=O, MDL MFCD26960973 |
| Drug_Names: Ethyl 3-benzylpiperidine-3-carboxylate, CAS: 170844-89-0, stock 331.5g, assay 98.8%, MWt 247.33, Formula C15H21NO2, Purity >98%, SMILES O=C(OCC)C1(CC2=CC=CC=C2)CNCCC1, MDL NA |
| Drug_Names: (R)-Ethyl 3-benzylpiperidine-3-carboxylate, CAS: 170844-43-6, stock 892.1g, assay 98.6%, MWt 247.33, Formula C15H21NO2, Purity >98%, SMILES O=C(OCC)[C@]1(CC2=CC=CC=C2)CNCCC1, MDL NA |
| Drug_Names: ethyl (S)-3-benzylpiperidine-3-carboxylate, CAS: 170844-45-8, stock 313.9g, assay 99%, MWt 247.33, Formula C15H21NO2, Purity >98%, SMILES O=C(OCC)[C@@]1(CC2=CC=CC=C2)CNCCC1, MDL NA |
| Drug_Names: Methyl 2-pyridyl ketone oxime, CAS: 1758-54-9, stock 302.2g, assay 98.1%, MWt 136.15, Formula C7H8N2O, Purity >98%, SMILES C/C(C1=NC=CC=C1)=N/O, MDL NA |
| Drug_Names: 1-(2-Pyridinyl)ethanamine, CAS: 42088-91-5, stock 484.9g, assay 98.6%, MWt 122.17, Formula C7H10N2, Purity >98%, SMILES NC(C1=NC=CC=C1)C, MDL MFCD05215238 |
| Drug_Names: (R)-1-(2-Pyridyl)ethylamine, CAS: 45695-03-2, stock 643.9g, assay 98.9%, MWt 122.17, Formula C7H10N2, Purity >98%, SMILES N[C@@H](C1=NC=CC=C1)C, MDL MFCD07776289 |
| Drug_Names: Diethyl 2-(((3-iodo-4-methoxyphenyl)amino)methylene)malonate, CAS: 2055350-37-1, stock 543.3g, assay 98.7%, MWt 419.21, Formula C15H18INO5, Purity >98%, SMILES COC1=C(I)C=C(C=C1)N/C=C(C(OCC)=O)/C(OCC)=O, MDL NA |
| Drug_Names: 7-(3,5-Dimethylisoxazol-4-yl)-6-methoxy-4-(((R)-1-(pyridin-2-yl)ethyl)amino)quinoline-3-carboxamide, CAS: 1300737-69-2, stock 233.7g, assay 98.9%, MWt 417.46, Formula C23H23N5O3, Purity >98%, SMILES O=C(C1=C(N[C@@H](C2=NC=CC=C2)C)C3=CC(OC)=C(C4=C(C)ON=C4C)C=C3N=C1)N, MDL NA |
| Drug_Names: 2-Thiooxamic acid ethyl ester, CAS: 16982-21-1, stock 450.8g, assay 98%, MWt 133.17, Formula C4H7NO2S, Purity >98%, SMILES NC(C(OCC)=O)=S, MDL MFCD00074903 |
| Drug_Names: 1,1,1-Trifluoro-2-(2-fluoropyridin-3-yl)-3-nitropropan-2-ol, CAS: 892414-45-8, stock 725.6g, assay 98.3%, MWt 254.14, Formula C8H6F4N2O3, Purity >98%, SMILES OC(C1=CC=CN=C1F)(C(F)(F)F)C[N+]([O-])=O, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-ol, CAS: 892414-46-9, stock 514.1g, assay 98.7%, MWt 204.15, Formula C8H7F3N2O, Purity >98%, SMILES OC(CN1)(C(F)(F)F)C2=C1N=CC=C2, MDL NA |
| Drug_Names: 3-Trifluoromethyl-1H-pyrrolo[2,3-b]pyridine, CAS: 892414-47-0, stock 520g, assay 98.4%, MWt 186.13, Formula C8H5F3N2, Purity >98%, SMILES FC(F)(F)C1=CNC2=C1C=CC=N2, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine 7-oxide, CAS: 892414-48-1, stock 265.4g, assay 98.8%, MWt 202.13, Formula C8H5F3N2O, Purity >98%, SMILES [O-][N+]1=CC=CC2=C1NC=C2C(F)(F)F, MDL NA |
| Drug_Names: 4-nitro-3-(trifluoromethyl)-7-azaindole-7-oxide, CAS: 892414-49-2, stock 31.9g, assay 98.5%, MWt 247.13, Formula C8H4F3N3O3, Purity >98%, SMILES [O-][N+]1=CC=C([N+]([O-])=O)C2=C1NC=C2C(F)(F)F, MDL NA |
| Drug_Names: 6-Chloro-4-nitro-3-(trifluoromethyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine, CAS: 892414-51-6, stock 655.9g, assay 98.9%, MWt 395.84, Formula C14H17ClF3N3O3Si, Purity >98%, SMILES ClC1=NC2=C(C(C(F)(F)F)=CN2COCC[Si](C)(C)C)C([N+]([O-])=O)=C1, MDL NA |
| Drug_Names: 3,5-Difluoro-4-hydroxyaniline, CAS: 126058-97-7, stock 307.1g, assay 98%, MWt 145.11, Formula C6H5F2NO, Purity >98%, SMILES OC1=C(F)C=C(N)C=C1F, MDL MFCD03094493 |
| Drug_Names: 2-(benzyloxy)-1,3-difluoro-5-nitrobenzene, CAS: 847861-84-1, stock 380.1g, assay 98.3%, MWt 265.21, Formula C13H9F2NO3, Purity >98%, SMILES FC1=C(OCC2=CC=CC=C2)C(F)=CC([N+]([O-])=O)=C1, MDL NA |
| Drug_Names: 4-((6-Chloro-3-(trifluoromethyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)-3,5-difluoroaniline, CAS: 892414-55-0, stock 561.4g, assay 98.7%, MWt 493.93, Formula C20H21ClF5N3O2Si, Purity >98%, SMILES ClC1=NC2=C(C(C(F)(F)F)=CN2COCC[Si](C)(C)C)C(OC3=C(F)C=C(N)C=C3F)=C1, MDL NA |
| Drug_Names: 4-((6-Chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)-3,5-difluoroaniline, CAS: 1203656-90-9, stock 377.3g, assay 98.9%, MWt 363.67, Formula C14H7ClF5N3O, Purity >98%, SMILES ClC1=NC2=C(C(C(F)(F)F)=CN2)C(OC3=C(F)C=C(N)C=C3F)=C1, MDL NA |
| Drug_Names: 2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile, CAS: 865759-24-6, stock 235.1g, assay 98.9%, MWt 293.68, Formula C13H9ClFN3O2, Purity >98%, SMILES O=C(C=C(Cl)N1CC2=CC(F)=CC=C2C#N)N(C)C1=O, MDL MFCD23695357 |
| Drug_Names: 3-Aminopyrazolo[3,4-b]pyridine, CAS: 6752-16-5, stock 714.5g, assay 98.9%, MWt 134.14, Formula C6H6N4, Purity >98%, SMILES NC1=NNC2=NC=CC=C21, MDL NA |
| Drug_Names: 3-Iodo-1H-pyrazolo[3,4-b]pyridine, CAS: 117007-52-0, stock 369.6g, assay 98.7%, MWt 245.02, Formula C6H4IN3, Purity >98%, SMILES IC1=NNC2=NC=CC=C21, MDL MFCD09749818 |
| Drug_Names: 1-(2-Fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-b]pyridine, CAS: 1313738-72-5, stock 440.4g, assay 98.9%, MWt 353.13, Formula C13H9FIN3, Purity >98%, SMILES IC1=NN(CC2=CC=CC=C2F)C3=NC=CC=C31, MDL MFCD19443949 |
| Drug_Names: 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile, CAS: 256376-65-5, stock 161.4g, assay 98.4%, MWt 252.25, Formula C14H9FN4, Purity >98%, SMILES FC1=CC=CC=C1CN2C3=NC=CC=C3C(C#N)=N2, MDL MFCD20268231 |
| Drug_Names: 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide, CAS: 256376-68-8, stock 206.1g, assay 98.3%, MWt 269.28, Formula C14H12FN5, Purity >98%, SMILES NC(C1=NN(CC2=CC=CC=C2F)C3=NC=CC=C31)=N, MDL NA |
| Drug_Names: 2-[1-[(2-Fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(2-phenyldiazenyl)-4,6-pyrimidinediamine, CAS: 428854-23-3, stock 65.6g, assay 98.6%, MWt 439.45, Formula C23H18FN9, Purity >98%, SMILES FC1=CC=CC=C1CN2N=C(C3=NC(N)=C(/N=N/C4=CC=CC=C4)C(N)=N3)C5=CC=CN=C52, MDL NA |
| Drug_Names: 2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine, CAS: 428854-24-4, stock 833.9g, assay 98.5%, MWt 350.35, Formula C17H15FN8, Purity >98%, SMILES NC1=C(N)N=C(C2=NN(CC3=CC=CC=C3F)C4=NC=CC=C42)N=C1N, MDL MFCD22741544 |
| Drug_Names: (Phenylazo)malononitrile, CAS: 6017-21-6, stock 607.2g, assay 98.8%, MWt 170.17, Formula C9H6N4, Purity >98%, SMILES N#CC(/N=N/C1=CC=CC=C1)C#N, MDL NA |
| Drug_Names: (2-Bromophenyl)(2,4-dimethylphenyl)sulfane, CAS: 960203-41-2, stock 833.9g, assay 98.2%, MWt 293.22, Formula C14H13BrS, Purity >98%, SMILES CC1=CC=C(SC2=C(Br)C=CC=C2)C(C)=C1, MDL NA |
| Drug_Names: 1-Phenylpiperazine hydrobromide, CAS: 153121-53-0, stock 111.2g, assay 98.6%, MWt 243.14, Formula C10H15BrN2, Purity >98%, SMILES C1(N2CCNCC2)=CC=CC=C1.Br, MDL NA |
| Drug_Names: 4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine, CAS: 941685-27-4, stock 783.1g, assay 98.9%, MWt 315.45, Formula C15H21N5OSi, Purity >98%, SMILES C[Si](C)(C)CCOCN(C=C1)C2=C1C(C3=CNN=C3)=NC=N2, MDL MFCD11857754 |
| Drug_Names: 3-Cyclopentyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile, CAS: 941685-39-8, stock 270.7g, assay 98.2%, MWt 436.63, Formula C23H32N6OSi, Purity >98%, SMILES C[Si](C)(C)CCOCN(C=C1)C2=C1C(C3=CN(C(C4CCCC4)CC#N)N=C3)=NC=N2, MDL NA |
| Drug_Names: (S)-1-tert-Butoxycarbonyl-2-tert-butyl-3-methyl-1,3-imidazolidin-4-one, CAS: 119838-38-9, stock 537.8g, assay 98.9%, MWt 256.34, Formula C13H24N2O3, Purity >98%, SMILES O=C1N(C)[C@H](C(C)(C)C)N(C(OC(C)(C)C)=O)C1, MDL MFCD00075101 |
| Drug_Names: 5-Bromo-3-(hydroxymethyl)benzyl alcohol, CAS: 51760-22-6, stock 713.9g, assay 98.4%, MWt 217.06, Formula C8H9BrO2, Purity >98%, SMILES BrC1=CC(CO)=CC(CO)=C1, MDL MFCD00229250 |
| Drug_Names: (2S,5S)-tert-butyl 5-(3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, CAS: 174575-06-5, stock 173.6g, assay 98.2%, MWt 575.47, Formula C25H40BrN2O6P, Purity >98%, SMILES BrC1=CC(C[C@@H]2N(C(OC(C)(C)C)=O)[C@@H](C(C)(C)C)N(C)C2=O)=CC(CP(OCC)(OCC)=O)=C1, MDL NA |
| Drug_Names: 2-Bromo-N,N-dibutylacetamide, CAS: 40124-27-4, stock 38.3g, assay 98.9%, MWt 250.18, Formula C10H20BrNO, Purity >98%, SMILES O=C(CBr)N(CCCC)CCCC, MDL NA |
| Drug_Names: (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid, CAS: 173864-48-7, stock 237g, assay 98.8%, MWt 441.47, Formula C24H27NO7, Purity >98%, SMILES COC1=CC=C([C@H]2[C@H](C(O)=O)[C@@H](C3=CC=C(OCO4)C4=C3)CN2C(OC(C)(C)C)=O)C=C1, MDL NA |
| Drug_Names: 4-((S)-1-((1S,3aS,7aS,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)ethoxy)-2-methylbutan-2-ol, CAS: 152517-44-7, stock 499.8g, assay 98.9%, MWt 647.13, Formula C38H70O4Si2, Purity >98%, SMILES C[C@H](OCCC(C)(O)C)[C@H]1CC[C@@]2([H])/C(CCC[C@@]21C)=C/C=C3C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C/3=C, MDL NA |
| Drug_Names: N-(2,6-dimethylphenyl)-1H-benzo[d]imidazol-2-amine, CAS: 435280-98-1, stock 288.7g, assay 98.3%, MWt 237.30, Formula C15H15N3, Purity >98%, SMILES CC1=C(NC2=NC3=CC=CC=C3N2)C(C)=CC=C1, MDL NA |
| Drug_Names: 6-(2,6-Dimethylphenyl)-2-(methylthio)pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one, CAS: 847950-97-4, stock 606.2g, assay 98.5%, MWt 387.46, Formula C21H17N5OS, Purity >98%, SMILES O=C1N(C2=C(C)C=CC=C2C)C3=NC4=CC=CC=C4N3C5=NC(SC)=NC=C15, MDL NA |
| Drug_Names: 1-(3-Bromophenyl)ethanamine hydrochloride, CAS: 90151-46-5, stock 705.4g, assay 98.4%, MWt 236.54, Formula C8H11BrClN, Purity >98%, SMILES BrC1=CC(C(N)C)=CC=C1.Cl, MDL MFCD26960538 |
| Drug_Names: Ethyl 4-((2,4-dimethylphenyl)(methoxycarbonyl)amino)butanoate, CAS: 1643803-26-2, stock 345.2g, assay 98.9%, MWt 293.36, Formula C16H23NO4, Purity >98%, SMILES CC1=CC(C)=C(N(C(OC)=O)CCCC(OCC)=O)C=C1, MDL NA |
| Drug_Names: Methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carboxylate, CAS: 1259393-27-5, stock 320.9g, assay 98.3%, MWt 247.29, Formula C14H17NO3, Purity >98%, SMILES CC1=C(N(C(OC)=O)CCCC2=O)C2=CC(C)=C1, MDL NA |
| Drug_Names: N-(3,5-bis(trifluoromethyl)benzyl)-7,9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine, CAS: 1539285-92-1, stock 28.5g, assay 98.9%, MWt 498.47, Formula C23H24F6N6, Purity >98%, SMILES CC1=C(NCCCC2N(CC3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)C4=NN(C)N=N4)C2=CC(C)=C1, MDL NA |
| Drug_Names: Methyl benzenesulfinate, CAS: 670-98-4, stock 552.8g, assay 98.3%, MWt 156.20, Formula C7H8O2S, Purity >98%, SMILES O=S(C1=CC=CC=C1)OC, MDL MFCD00674051 |
| Drug_Names: L 651580, CAS: 103335-44-0, stock 382.4g, assay 98.1%, MWt 345.48, Formula C21H31NO3, Purity >98%, SMILES O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=CC(N(C)[C@]4([H])CC[C@]32[H])=O)OC, MDL NA |
| Drug_Names: (4aR,4bS,6aS,7S,9aS,9bS,11aR)-methyl 1,4a,6a-trimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate, CAS: 86283-81-0, stock 579.4g, assay 98.8%, MWt 347.49, Formula C21H33NO3, Purity >98%, SMILES O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)CCC(N(C)[C@]4([H])CC[C@]32[H])=O)OC, MDL NA |
| Drug_Names: (4aR,4bS,6aS,7S,9aS,9bS,11aR)-methyl 3-fluoro-1,4a,6a-trimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate, CAS: 914087-65-3, stock 759.4g, assay 98.7%, MWt 365.48, Formula C21H32FNO3, Purity >98%, SMILES O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)CC(F)C(N(C)[C@]4([H])CC[C@]32[H])=O)OC, MDL NA |
| Drug_Names: Methyl (4aS,4bS,6aS,7S,9aS,9bS,11aR)-3-fluoro-1,4a,6a-trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate, CAS: 606101-78-4, stock 329g, assay 98.5%, MWt 363.47, Formula C21H30FNO3, Purity >98%, SMILES O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=C(F)C(N(C)[C@]4([H])CC[C@]32[H])=O)OC, MDL NA |
| Drug_Names: 2-Fluoro-4-methyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxylic acid, CAS: 606101-79-5, stock 751.5g, assay 98.1%, MWt 349.44, Formula C20H28FNO3, Purity >98%, SMILES O=C(O)[C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=C(F)C(N(C)[C@]4([H])CC[C@]32[H])=O, MDL NA |
| Drug_Names: {3H-imidazo[4,5-b]pyridin-2-yl}methanamine dihydrochloride, CAS: 914087-69-7, stock 579.6g, assay 98.7%, MWt 221.09, Formula C7H10Cl2N4, Purity >98%, SMILES NCC1=NC2=CC=CN=C2N1.Cl.Cl, MDL NA |
| Drug_Names: 2-(2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid, CAS: 342639-02-5, stock 611.6g, assay 99%, MWt 424.53, Formula C25H32N2O4, Purity >98%, SMILES OC1=CC=CC([C@@]2(C)[C@@H](C)CN(CC(CC3=CC=CC=C3)C(NCC(O)=O)=O)CC2)=C1, MDL NA |
| Drug_Names: (1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, CAS: 2096989-56-7, stock 190.7g, assay 98.6%, MWt 522.57, Formula C23H28F2N6O4S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(SCCC)N=C3N[C@@H]4[C@@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H](O)[C@@H]1O, MDL NA |
| Drug_Names: (1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, CAS: 2096989-55-6, stock 830g, assay 98.3%, MWt 522.57, Formula C23H28F2N6O4S, Purity >98%, SMILES OCCO[C@@H]1C[C@H](N2C(N=C(SCCC)N=C3N[C@@H]4[C@@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@@H](O)[C@H]1O, MDL NA |
| Drug_Names: Ethyl (3S)-3-hydroxy-3-[6-[(methylamino)carbonyl]-2-naphthyl]-3-(1-trityl-1H-imidazol-4-yl)propanoate, CAS: 566200-78-0, stock 522.6g, assay 99%, MWt 609.71, Formula C39H35N3O4, Purity >98%, SMILES O=C(OCC)C[C@@](C1=CC=C2C=C(C(NC)=O)C=CC2=C1)(O)C3=CN(C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C=N3, MDL NA |
| Drug_Names: 5,6-Dihydro-7H-pyrrolo[1,2-c]imidazol-7-one, CAS: 426219-43-4, stock 18g, assay 98.5%, MWt 122.12, Formula C6H6N2O, Purity >98%, SMILES O=C1CCN2C=NC=C21, MDL MFCD17013182 |
| Drug_Names: Methyl 2-(trans-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate, CAS: 701232-69-1, stock 93.8g, assay 98.9%, MWt 358.28, Formula C21H31BO4, Purity >98%, SMILES O=C(OC)C[C@@H]1CC[C@@H](C2=CC=C(B3OC(C)(C)C(C)(C)O3)C=C2)CC1, MDL NA |
| Drug_Names: Ethyl 2-(2-((tert-butoxycarbonyl)amino)propanamido)-3-oxobutanoate, CAS: 1259022-54-2, stock 590.9g, assay 98.2%, MWt 316.35, Formula C14H24N2O6, Purity >98%, SMILES CC(C(NC(C(NC(OC(C)(C)C)=O)C)=O)C(OCC)=O)=O, MDL NA |
| Drug_Names: Ethyl 6-hydroxy-3,5-dimethylpyrazine-2-carboxylate, CAS: 1166827-49-1, stock 819.6g, assay 98.6%, MWt 196.20, Formula C9H12N2O3, Purity >98%, SMILES O=C(C1=C(C)N=C(C)C(O)=N1)OCC, MDL NA |
| Drug_Names: Ethyl 6-chloro-3,5-dimethylpyrazine-2-carboxylate, CAS: 1166827-48-0, stock 244.1g, assay 98.9%, MWt 214.65, Formula C9H11ClN2O2, Purity >98%, SMILES O=C(C1=C(C)N=C(C)C(Cl)=N1)OCC, MDL NA |
| Drug_Names: 6-Chloro-3,5-dimethylpyrazine-2-carboxamide, CAS: 1166828-19-8, stock 126.9g, assay 98.4%, MWt 185.61, Formula C7H8ClN3O, Purity >98%, SMILES O=C(C1=C(C)N=C(C)C(Cl)=N1)N, MDL NA |
| Drug_Names: trans-4-[4-[6-(Aminocarbonyl)-3,5-dimethyl-2-pyrazinyl]phenyl]cyclohexaneacetic acid methyl ester, CAS: 1166831-68-0, stock 401.5g, assay 98.4%, MWt 381.47, Formula C22H27N3O3, Purity >98%, SMILES O=C(OC)C[C@H]1CC[C@H](C2=CC=C(C3=NC(C(N)=O)=C(C)N=C3C)C=C2)CC1, MDL NA |
| Drug_Names: N-Boc-1,2-phenylenediamine, CAS: 146651-75-4, stock 203.9g, assay 98.3%, MWt 208.26, Formula C11H16N2O2, Purity >98%, SMILES NC1=CC=CC=C1NC(OC(C)(C)C)=O, MDL MFCD02169707 |
| Drug_Names: 6-(4-Methylbenzamido)hexanoic acid, CAS: 78521-43-4, stock 845.6g, assay 98.4%, MWt 249.31, Formula C14H19NO3, Purity >98%, SMILES O=C(O)CCCCCNC(C1=CC=C(C)C=C1)=O, MDL NA |
| Drug_Names: 4-Bromo-2-ethylaniline, CAS: 45762-41-2, stock 543.3g, assay 98.4%, MWt 200.08, Formula C8H10BrN, Purity >98%, SMILES NC1=CC=C(Br)C=C1CC, MDL MFCD00041434 |
| Drug_Names: (S)-tert-butyl (1-((5-bromopyridin-3-yl)oxy)-3-(1H-indol-3-yl)propan-2-yl)carbamate, CAS: 882169-91-7, stock 5.1g, assay 98.2%, MWt 446.34, Formula C21H24BrN3O3, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@@H](CC1=CNC2=C1C=CC=C2)COC3=CC(Br)=CN=C3, MDL NA |
| Drug_Names: (R)-tert-butyl (1-((5-bromopyridin-3-yl)oxy)-3-(1H-indol-3-yl)propan-2-yl)carbamate, CAS: 882169-92-8, stock 797.7g, assay 98.4%, MWt 446.34, Formula C21H24BrN3O3, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H](CC1=CNC2=C1C=CC=C2)COC3=CC(Br)=CN=C3, MDL NA |
| Drug_Names: (1S,3S)-3-(8-chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol, CAS: 867163-02-8, stock 337.9g, assay 98.9%, MWt 440.92, Formula C26H21ClN4O, Purity >98%, SMILES O[C@@]1(C)C[C@@H](C2=NC(C3=CC=C4C=CC(C5=CC=CC=C5)=NC4=C3)=C6C(Cl)=NC=CN62)C1, MDL NA |
| Drug_Names: (3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 220241-60-1, stock 763g, assay 98.2%, MWt 374.89, Formula C15H23ClN4O3S, Purity >98%, SMILES O[C@H]1C[C@@H](NC2=NC(SCCC)=NC(Cl)=C2N)[C@@]3([H])[C@]1([H])OC(C)(C)O3, MDL NA |
| Drug_Names: (3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 220241-61-2, stock 628.5g, assay 98.6%, MWt 385.87, Formula C15H20ClN5O3S, Purity >98%, SMILES O[C@H]1C[C@@H](N2N=NC3=C(Cl)N=C(SCCC)N=C32)[C@@]4([H])[C@]1([H])OC(C)(C)O4, MDL NA |
| Drug_Names: (3aR,4S,6R,6aS)-6-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol, CAS: 274693-49-1, stock 445.3g, assay 99%, MWt 518.58, Formula C24H28F2N6O3S, Purity >98%, SMILES O[C@H]1C[C@@H](N2N=NC3=C(N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)N=C(SCCC)N=C32)[C@@]6([H])[C@]1([H])OC(C)(C)O6, MDL NA |
| Drug_Names: AR-C 124910XX, CAS: 220347-05-7, stock 821g, assay 98.8%, MWt 478.52, Formula C21H24F2N6O3S, Purity >98%, SMILES O[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2N=NC3=C(N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)N=C(SCCC)N=C32)C1, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-(7-chloro-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol, CAS: 1863036-45-6, stock 95.8g, assay 98.8%, MWt 445.92, Formula C17H24ClN5O5S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)=O)N=C3Cl)=C3N=N2)[C@H]4[C@@H]1OC(C)(C)O4, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-(7-chloro-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol, CAS: 1863036-47-8, stock 573g, assay 98%, MWt 461.92, Formula C17H24ClN5O6S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)(=O)=O)N=C3Cl)=C3N=N2)[C@H]4[C@@H]1OC(C)(C)O4, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol, CAS: 1863036-49-0, stock 829.4g, assay 98.8%, MWt 578.63, Formula C26H32F2N6O5S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)=O)N=C3N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H]6[C@@H]1OC(C)(C)O6, MDL NA |
| Drug_Names: 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol, CAS: 1863036-51-4, stock 173.6g, assay 98.6%, MWt 594.63, Formula C26H32F2N6O6S, Purity >98%, SMILES OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)(=O)=O)N=C3N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H]6[C@@H]1OC(C)(C)O6, MDL NA |
| Drug_Names: N-(4-Nitrophenyl)guanidine nitrate, CAS: 142992-72-1, stock 130.1g, assay 98.2%, MWt 243.18, Formula C7H9N5O5, Purity >98%, SMILES NC(NC1=CC=C([N+]([O-])=O)C=C1)=N.[O-][N+](O)=O, MDL NA |
| Drug_Names: N-(4-Nitrophenyl)-4-(3-pyridyl)-2-pyrimidineamine, CAS: 181065-58-7, stock 356.2g, assay 98.6%, MWt 293.28, Formula C15H11N5O2, Purity >98%, SMILES O=[N+](C1=CC=C(NC2=NC=CC(C3=CC=CN=C3)=N2)C=C1)[O-], MDL NA |
| Drug_Names: 3-Amino-N-(4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide, CAS: 1437315-22-4, stock 262.4g, assay 98.4%, MWt 382.42, Formula C22H18N6O, Purity >98%, SMILES O=C(NC1=CC=C(NC2=NC=CC(C3=CC=CN=C3)=N2)C=C1)C4=CC=CC(N)=C4, MDL NA |
